Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in J Alzheimers Dis Retrieve available abstracts of 1410 articles: HTML format

Single Articles

October 2025
1. ZHAO M, Yang J, Cheng H, Fan Y, et al
   Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease.
   J Alzheimers Dis. 2025 Oct 10:13872877251384967. doi: 10.1177/13872877251384967.
   PubMed     Abstract available
   
   
   
2. KENNEMER AA, Gao Z, Davis PB, Kaelber DC, et al
   Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States.
   J Alzheimers Dis. 2025 Oct 9:13872877251385262. doi: 10.1177/13872877251385262.
   PubMed     Abstract available
   
   
   
3. HANSON M, Liu Y, Ozawa T, Yin H, et al
   Potential barriers to timely Alzheimer's disease diagnosis and treatment: Tracer delivery and patient travel to amyloid PET scanners in the United States.
   J Alzheimers Dis. 2025 Oct 9:13872877251385118. doi: 10.1177/13872877251385118.
   PubMed     Abstract available
   
   
   
4. WEISS S, Harris K, Carney OL, Maza VI, et al
   Initial development of the writing to heal app: A structured writing series for caregivers of spouses living with Alzheimer's disease and related dementias.
   J Alzheimers Dis. 2025 Oct 9:13872877251378478. doi: 10.1177/13872877251378478.
   PubMed     Abstract available
   
   
   
5. TEIPEL S, Singh D, Dubbelman MA, Pan G, et al
   Early detection of Alzheimer's disease: From multiplex assays and imaging to point of care devices and AI-based functional monitoring.
   J Alzheimers Dis. 2025 Oct 7:13872877251383339. doi: 10.1177/13872877251383339.
   PubMed     Abstract available
   
   
   
6. LYU J, Zhang W, De J, Shan B, et al
   The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's disease.
   J Alzheimers Dis. 2025 Oct 3:13872877251379419. doi: 10.1177/13872877251379419.
   PubMed     Abstract available
   
   
   
7. BOONGIRD C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, et al
   Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis.
   J Alzheimers Dis. 2025 Oct 3:13872877251378354. doi: 10.1177/13872877251378354.
   PubMed     Abstract available
   
   
   
8. CHEN C, Babulal GM
   Longitudinal associations between plasma biomarkers and changes in naturalistic driving behaviors in older adults.
   J Alzheimers Dis. 2025;107:1275-1284.
   PubMed     Abstract available
   
   
   
9. AGBOJI A
   Navigating life after diagnosis: Insights from people with early-stage dementia.
   J Alzheimers Dis. 2025;107:997-998.
   PubMed     Abstract available
   
   
   
10. DUCHESNE S, Potvin O, Hudon C, Bocti C, et al
    A brain health framework with application to the study of neurodegeneration.
    J Alzheimers Dis. 2025;107:960-972.
    PubMed     Abstract available
    
    
    September 2025
11. TANAKA E, Nihashi T, Kato T, Arahata Y, et al
    Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 26:13872877251379466. doi: 10.1177/13872877251379466.
    PubMed     Abstract available
    
    
    
12. HOU H, Yu J, Hao S, Zhang X, et al
    Electroencephalography microstates as biomarkers for screening Alzheimer's disease: Feasibility analysis and a machine learning classification scheme.
    J Alzheimers Dis. 2025 Sep 26:13872877251379072. doi: 10.1177/13872877251379072.
    PubMed     Abstract available
    
    
    
13. MUKESHA D, Sarter M, Dubray M, Durand F, et al
    Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.
    J Alzheimers Dis. 2025 Sep 26:13872877251378653. doi: 10.1177/13872877251378653.
    PubMed     Abstract available
    
    
    
14. ROJAS-ALVAREZ A, Chung H, Cabrero Castro JE, Umucu E, et al
    Profile and disparities in health outcomes for older adults with dual diagnoses of diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 25:13872877251380260. doi: 10.1177/13872877251380260.
    PubMed     Abstract available
    
    
    
15. RICO V, Zelinsky M, Ford PJ, Leverenz J, et al
    Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
    J Alzheimers Dis. 2025 Sep 25:13872877251379076. doi: 10.1177/13872877251379076.
    PubMed     Abstract available
    
    
    
16. FAIZAN ALI M, Ahmad H, Fawzi Hemida M, Faizan Tahir M, et al
    Aging, Alzheimer's disease, and stroke: A 25-year longitudinal analysis of U.S. mortality trends.
    J Alzheimers Dis. 2025 Sep 24:13872877251380689. doi: 10.1177/13872877251380689.
    PubMed     Abstract available
    
    
    
17. NASERRAMEZANI Z, Palizvan MR, Ganji A, Ghazavi A, et al
    Synergistic neuroprotection of chitosan-cannabidiol nanoparticles in a rat model of Alzheimer's disease: Amelioration of cognitive deficits and neuroinflammation.
    J Alzheimers Dis. 2025 Sep 24:13872877251379420. doi: 10.1177/13872877251379420.
    PubMed     Abstract available
    
    
    
18. QI T, Feng Y, Kononenko N, Ising C, et al
    Axonal degeneration and retinal neurovascular dysfunction in the TgF344-AD rat model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 23:13872877251379844. doi: 10.1177/13872877251379844.
    PubMed     Abstract available
    
    
    
19. BOROJE I, Sanchez-Solino O, Yue EX, Vinikoor-Imler L, et al
    Medication prescriptions among patients with mild cognitive impairment and Alzheimer's disease: A large nationwide electronic health record cohort study.
    J Alzheimers Dis. 2025 Sep 22:13872877251376032. doi: 10.1177/13872877251376032.
    PubMed     Abstract available
    
    
    
20. YAN Y, Pan Y, Lu S, Kou J, et al
    Gut microbiota-mediated targeting of EHMT2 in individuals of European ancestry: A novel therapeutic approach for Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 22:13872877251372945. doi: 10.1177/13872877251372945.
    PubMed     Abstract available
    
    
    
21. LI J, Yi Y, Gao X, Ren Y, et al
    High brain network dynamics mediate audiovisual integration deficits and cognitive impairment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 22:13872877251376717. doi: 10.1177/13872877251376717.
    PubMed     Abstract available
    
    
    
22. SUBRAMANIAN ML, Sampani K, Ness S, Tuz-Zahra F, et al
    Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy.
    J Alzheimers Dis. 2025 Sep 22:13872877251378759. doi: 10.1177/13872877251378759.
    PubMed     Abstract available
    
    
    
23. ONUH VC
    Advancing Alzheimer's disease treatment: A literature review on senolytic intervention.
    J Alzheimers Dis. 2025 Sep 22:13872877251376540. doi: 10.1177/13872877251376540.
    PubMed     Abstract available
    
    
    
24. GITLIN-LEIGH G, Wilson J, Howard R, Howard R, et al
    Effects of monoclonal antibody therapies on depression in Parkinson's disease and Alzheimer's disease: Systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Sep 19:13872877251378156. doi: 10.1177/13872877251378156.
    PubMed     Abstract available
    
    
    
25. SU X, Chen H, Cao J, Zhang Y, et al
    The effect of deprivation of whisker stimulation on cognition and synaptic plasticity in male and female Alzheimer's disease mice.
    J Alzheimers Dis. 2025 Sep 19:13872877251379079. doi: 10.1177/13872877251379079.
    PubMed     Abstract available
    
    
    
26. DONG M, Qian Y, Geng Y, Wang R, et al
    HIF-1alpha-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis.
    J Alzheimers Dis. 2025 Sep 19:13872877251378007. doi: 10.1177/13872877251378007.
    PubMed     Abstract available
    
    
    
27. WANG W, Liu H, Chen Y, Xiong Z, et al
    Identifying differential brain structures and genetic mechanisms between Alzheimer's disease and idiopathic normal pressure hydrocephalus.
    J Alzheimers Dis. 2025 Sep 17:13872877251379046. doi: 10.1177/13872877251379046.
    PubMed     Abstract available
    
    
    
28. MAO C, Zou Y, Wang T, Sha L, et al
    Comparison of diagnostic accuracy of Alzheimer's disease cerebrospinal fluid core biomarkers using INNOTEST, Lumipulse G, and Elecsys assays: Insights from the PUMCH dementia cohort study.
    J Alzheimers Dis. 2025 Sep 17:13872877251379084. doi: 10.1177/13872877251379084.
    PubMed     Abstract available
    
    
    
29. DENG T, Duan J, Yu W, Deng Z, et al
    Education as a domain-specific moderator: Shaping the impact of cerebral structural changes on clinical manifestations in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 17:13872877251379078. doi: 10.1177/13872877251379078.
    PubMed     Abstract available
    
    
    
30. LIU Y, Chen Y, Chen Z, Wan H, et al
    Tau seeding activity in Alzheimer's disease: Characteristics, factors, and applications.
    J Alzheimers Dis. 2025 Sep 17:13872877251378772. doi: 10.1177/13872877251378772.
    PubMed     Abstract available
    
    
    
31. KITAYAMA Y, Nakano Y, Hirano S, Hanayama S, et al
    Multimodal neuroimaging related to cerebrospinal fluid biomarkers and cognitive function in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 17:13872877251376601. doi: 10.1177/13872877251376601.
    PubMed     Abstract available
    
    
    
32. LEE J, Kim CW, Kim Y, Lee S, et al
    Environmental noise exposure and a new biomarker of Alzheimer's disease: A pilot study.
    J Alzheimers Dis. 2025 Sep 16:13872877251376920. doi: 10.1177/13872877251376920.
    PubMed     Abstract available
    
    
    
33. SHAKER A, Ljunggren G, Vossen LE, Religa D, et al
    Impact of socio-economic and patient-centered characteristics on access to Alzheimer's disease medication in primary care: A population-based study in the Stockholm county, Sweden.
    J Alzheimers Dis. 2025 Sep 16:13872877251375900. doi: 10.1177/13872877251375900.
    PubMed     Abstract available
    
    
    
34. HAALAND B, Dickson SP, Santana AF, Tanzi RE, et al
    Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial.
    J Alzheimers Dis. 2025 Sep 15:13872877251375985. doi: 10.1177/13872877251375985.
    PubMed     Abstract available
    
    
    
35. LI H, Wu Y, Huang T, Sun Y, et al
    Development of a risk prediction model for Alzheimer's disease based on the UK Biobank prospective study.
    J Alzheimers Dis. 2025 Sep 15:13872877251375473. doi: 10.1177/13872877251375473.
    PubMed     Abstract available
    
    
    
36. CARDOSO S, Montalvo A, Maroco J, Silva D, et al
    Long-term predictive accuracy of the 'mild cognitive impairment due to Alzheimer's disease' criteria.
    J Alzheimers Dis. 2025 Sep 15:13872877251375927. doi: 10.1177/13872877251375927.
    PubMed     Abstract available
    
    
    
37. CHEN H, Guo Y, Zhang Z, Huang W, et al
    Neurovascular coupling dysfunction associated with cognition and glial fibrillary acidic protein along the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Sep 12:13872877251375476. doi: 10.1177/13872877251375476.
    PubMed     Abstract available
    
    
    
38. XU J, Sun A, Yang Y, Shi Y, et al
    Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 12:13872877251376291. doi: 10.1177/13872877251376291.
    PubMed     Abstract available
    
    
    
39. KAKKAR A, Singh H, Singh BK, Kumar A, et al
    Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms.
    J Alzheimers Dis. 2025 Sep 12:13872877251374353. doi: 10.1177/13872877251374353.
    PubMed     Abstract available
    
    
    
40. FAKOREDE S, Sodiq TA, Ajagbe AO, Adeleke AJ, et al
    Interplay of Glut1 alteration and Alzheimer's disease: A narrative review on glucose transport and energy metabolism.
    J Alzheimers Dis. 2025 Sep 12:13872877251377793. doi: 10.1177/13872877251377793.
    PubMed     Abstract available
    
    
    
41. ZHOU Y, Su T, Yuan M, Li WL, et al
    A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits.
    J Alzheimers Dis. 2025 Sep 11:13872877251372587. doi: 10.1177/13872877251372587.
    PubMed     Abstract available
    
    
    
42. CHATTERJEE P, Ivanic S, Southon A, McCarthy C, et al
    Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting.
    J Alzheimers Dis. 2025 Sep 11:13872877251376694. doi: 10.1177/13872877251376694.
    PubMed     Abstract available
    
    
    
43. MOTOLESE F, Norata D, Iaccarino G, Sapio E, et al
    Predicting cognitive decline in Alzheimer's disease: A real-life proof-of-principle study on multimodal assessment.
    J Alzheimers Dis. 2025 Sep 10:13872877251376676. doi: 10.1177/13872877251376676.
    PubMed     Abstract available
    
    
    
44. TARAGANO F, Seinhart D, Epstein P, Sylvestre V, et al
    A real-world study on the safety and efficacy of therapeutic plasma exchange in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 10:13872877251375430. doi: 10.1177/13872877251375430.
    PubMed     Abstract available
    
    
    
45. SCHAFFNER E, Sandoz M, Chatton P, Iglesias K, et al
    Tense production in French-speaking participants with Alzheimer's disease: What about discourse? Contribution of a storytelling-in-sequence task.
    J Alzheimers Dis. 2025 Sep 9:13872877251376028. doi: 10.1177/13872877251376028.
    PubMed     Abstract available
    
    
    
46. ARSLAN B, Zetterberg H, Ashton NJ
    Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Sep 9:13872877251375101. doi: 10.1177/13872877251375101.
    PubMed     Abstract available
    
    
    
47. KATSUMI Y
    Alterations of the brain functional organization in young-onset Alzheimer's disease: Is it a matter of "time"?
    J Alzheimers Dis. 2025 Sep 9:13872877251375094. doi: 10.1177/13872877251375094.
    PubMed     Abstract available
    
    
    
48. HAYES CA, Odden MC, Thorpe RJ Jr
    Application of modified Poisson regression for risk estimation of major neuropathology outcomes: National Alzheimer's coordinating center.
    J Alzheimers Dis. 2025 Sep 9:13872877251375099. doi: 10.1177/13872877251375099.
    PubMed     Abstract available
    
    
    
49. WANG L, Zuo X, Xu M, Hu Q, et al
    Interaction between gut microbiota and Alzheimer's disease: Re-analysis of the same sample.
    J Alzheimers Dis. 2025 Sep 4:13872877251367359. doi: 10.1177/13872877251367359.
    PubMed     Abstract available
    
    
    
50. LIU G, Sun Y
    Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments.
    J Alzheimers Dis. 2025 Sep 3:13872877251374149. doi: 10.1177/13872877251374149.
    PubMed     Abstract available
    
    
    
51. ZHU Y, Chen Q, Chen F, Lu J, et al
    Functional connectivity signatures of olfactory networks linked to cognitive risk: A functional MRI study in subjective cognitive decline at risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 3:13872877251373017. doi: 10.1177/13872877251373017.
    PubMed     Abstract available
    
    
    
52. JIANG X, Liu Y, Lu Q, Liu J, et al
    Identification of exosome-related genes in Alzheimer's disease: Evidence from transcriptomic and Mendelian randomization analyses.
    J Alzheimers Dis. 2025 Sep 3:13872877251372065. doi: 10.1177/13872877251372065.
    PubMed     Abstract available
    
    
    
53. STREIBER AM, Neitzel J, Yaqub A, Vernooij MW, et al
    Arteriosclerosis in the heart-brain axis and Alzheimer's disease plasma markers in the Rotterdam Study.
    J Alzheimers Dis. 2025 Sep 3:13872877251372641. doi: 10.1177/13872877251372641.
    PubMed     Abstract available
    
    
    
54. SU FJ, Li YC, Shi XC, Yi C, et al
    Visual Cognitive Assessment Test correlates with brain amyloid status in Alzheimer's disease-related mild cognitive impairment.
    J Alzheimers Dis. 2025 Sep 1:13872877251371718. doi: 10.1177/13872877251371718.
    PubMed     Abstract available
    
    
    
55. KRAMER M, Alekseyenko AV, Mollalo A
    The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach.
    J Alzheimers Dis. 2025 Sep 1:13872877251372144. doi: 10.1177/13872877251372144.
    PubMed     Abstract available
    
    
    
56. TANG Q, Zhang X, Zhang C, Lang Q, et al
    Optimized sequential classification models for mild cognitive impairment screening based on handwriting and speech data.
    J Alzheimers Dis. 2025;107:112-127.
    PubMed     Abstract available
    
    
    
57. STROPE TA, Troutwine B, Hauger BM, Smith KP, et al
    Amyloid-beta protein precursor modulates mitophagy and mitochondrial function through its cellular localization.
    J Alzheimers Dis. 2025;107:277-293.
    PubMed     Abstract available
    
    
    
58. MOSER VA
    The gap between amyloid pathology and cognition.
    J Alzheimers Dis. 2025;107:46-48.
    PubMed     Abstract available
    
    
    
59. JIANG D, Yue A, Nan H, Hou J, et al
    Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;107:806-818.
    PubMed     Abstract available
    
    
    
60. ZHANG J, Wang C, Chang K, Peng T, et al
    A novel traditional Chinese medicine formula restores sleep and cognitive function in APP/PS1 mice by targeting glycolytic pathways and neuroinflammatory responses.
    J Alzheimers Dis. 2025;107:617-627.
    PubMed     Abstract available
    
    
    August 2025
61. CHEN J, Lin B, Seow E, Kim S, et al
    Prediction of infusion capacity to deliver Alzheimer's disease treatments in the United States relative to expected demand.
    J Alzheimers Dis. 2025 Aug 29:13872877251372129. doi: 10.1177/13872877251372129.
    PubMed     Abstract available
    
    
    
62. LIN H, Huang Z, Lu J, Wang J, et al
    The asymmetry of tau deposition and its correlation with cerebral metabolic asymmetry in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 29:13872877251372523. doi: 10.1177/13872877251372523.
    PubMed     Abstract available
    
    
    
63. CHEN Y, Dong C, Chen J, Li Q, et al
    Clinical observations on treating Alzheimer's disease with umbilical cord blood mononuclear cells.
    J Alzheimers Dis. 2025 Aug 28:13872877251366669. doi: 10.1177/13872877251366669.
    PubMed     Abstract available
    
    
    
64. JIANG C, Qi J, Zou H, Lopez O, et al
    Impact of antidiabetic therapy on cognitive function in patients with type 2 diabetes and Alzheimer's disease: A comprehensive analysis.
    J Alzheimers Dis. 2025 Aug 25:13872877251365662. doi: 10.1177/13872877251365662.
    PubMed     Abstract available
    
    
    
65. SAMPATH R, Baskar M
    Biomarker extraction-based Alzheimer's disease stage detection using optimized deep learning approach.
    J Alzheimers Dis. 2025 Aug 19:13872877251360394. doi: 10.1177/13872877251360394.
    PubMed     Abstract available
    
    
    
66. GIM J
    Revisiting APOE: Insights from rare variants and the expanding landscape of Alzheimer's disease genetics.
    J Alzheimers Dis. 2025 Aug 17:13872877251366662. doi: 10.1177/13872877251366662.
    PubMed     Abstract available
    
    
    
67. KONISHI K, Spets DS, Fisher P, Aroner S, et al
    Sex differences in the impact of genetic and clinical risk factors for Alzheimer's disease in midlife.
    J Alzheimers Dis. 2025 Aug 17:13872877251366701. doi: 10.1177/13872877251366701.
    PubMed     Abstract available
    
    
    
68. GHOSH D, Pal S, Lutz M, Luo S, et al
    Ensemble survival analysis for preclinical cognitive decline prediction in Alzheimer's disease using longitudinal biomarkers.
    J Alzheimers Dis. 2025 Aug 14:13872877251365621. doi: 10.1177/13872877251365621.
    PubMed     Abstract available
    
    
    
69. SHELTON M, Kerns KA, Shirali S, Castora FJ, et al
    Integrating mitochondrial gene expression data to model the effects of respirasome supercomplex formation on reactive oxygen species production in Alzheimer's disease models.
    J Alzheimers Dis. 2025 Aug 13:13872877251362889. doi: 10.1177/13872877251362889.
    PubMed     Abstract available
    
    
    
70. JIANG F, Wang N, Meng Q
    From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 13:13872877251360321. doi: 10.1177/13872877251360321.
    PubMed     Abstract available
    
    
    
71. PFLANZER H, Kerns KA, Knoble J, Gershon BS, et al
    Mitochondrial energy production genes affecting reactive oxygen species and ATP synthesis, inflammatory pathways, and neuron viability are differentially expressed in brains of Alzheimer's disease patients.
    J Alzheimers Dis. 2025 Aug 13:13872877251362884. doi: 10.1177/13872877251362884.
    PubMed     Abstract available
    
    
    
72. ZHANG X, Sun Z, Wu D, Shi X, et al
    Effects of cerebellar intermittent theta-burst stimulation on patients with Alzheimer's disease: A randomized controlled trial.
    J Alzheimers Dis. 2025 Aug 13:13872877251366656. doi: 10.1177/13872877251366656.
    PubMed     Abstract available
    
    
    
73. XIE F, Ye Y, Hao J, Liu H, et al
    Surgical advances in the treatment of Alzheimer's disease: A comprehensive review.
    J Alzheimers Dis. 2025 Aug 13:13872877251364397. doi: 10.1177/13872877251364397.
    PubMed     Abstract available
    
    
    
74. MERVOSH N, Bilici N, Wisniewski T, Devi G, et al
    Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab.
    J Alzheimers Dis. 2025 Aug 13:13872877251366657. doi: 10.1177/13872877251366657.
    PubMed     Abstract available
    
    
    
75. MOTAGHI M, Potvin O, Duchesne S
    Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 10:13872877251365671. doi: 10.1177/13872877251365671.
    PubMed     Abstract available
    
    
    
76. QI J, He M, Lian T, Wang S, et al
    Correlations of retinal morphology with clinical symptoms, blood-brain barrier, and brain structure in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 8:13872877251364736. doi: 10.1177/13872877251364736.
    PubMed     Abstract available
    
    
    
77. CABAN M, Tran E, Meng A, Wetmore JB, et al
    Planning for the future following receipt of Alzheimer's disease risk estimate among Latinos in New York City.
    J Alzheimers Dis. 2025 Aug 8:13872877251365571. doi: 10.1177/13872877251365571.
    PubMed     Abstract available
    
    
    
78. WANG H, Liu J, Tian YR, Zhu F, et al
    The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating SIRT3.
    J Alzheimers Dis. 2025 Aug 8:13872877251362185. doi: 10.1177/13872877251362185.
    PubMed     Abstract available
    
    
    
79. PRATT T, Lee A, Zheng J, Tavacoli F, et al
    Distinct glial functions are associated with Alzheimer's disease based on cell-type- and pathway-specific polygenic risk score analysis.
    J Alzheimers Dis. 2025 Aug 8:13872877251362258. doi: 10.1177/13872877251362258.
    PubMed     Abstract available
    
    
    
80. ZHAO R, Bai W, Tian Z, Li X, et al
    Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review.
    J Alzheimers Dis. 2025 Aug 8:13872877251361053. doi: 10.1177/13872877251361053.
    PubMed     Abstract available
    
    
    
81. ROBINSON JEYAPAUL S, Kombaiya S, Jeya Kumar AK, Stanley VJ, et al
    Ensemble deep learning model for early diagnosis and classification of Alzheimer's disease using MRI scans.
    J Alzheimers Dis. 2025 Aug 8:13872877251359950. doi: 10.1177/13872877251359950.
    PubMed     Abstract available
    
    
    
82. LV Y, Xiang Y, Fu W, Li B, et al
    Global burden trends of Alzheimer's disease and other dementias attributable to smoking from 1990 to 2021.
    J Alzheimers Dis. 2025 Aug 6:13872877251365284. doi: 10.1177/13872877251365284.
    PubMed     Abstract available
    
    
    
83. GUO X, Fu H, Qin M, Kan J, et al
    Multi-omics profiling reveals two distinct trajectories in the progression from mild cognitive impairment to Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 6:13872877251365210. doi: 10.1177/13872877251365210.
    PubMed     Abstract available
    
    
    
84. KITAGAWA K, Yoshizawa H, Toi S, Todo K, et al
    Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks.
    J Alzheimers Dis. 2025 Aug 6:13872877251365629. doi: 10.1177/13872877251365629.
    PubMed     Abstract available
    
    
    
85. YAO R, Ouyang Z, Xu T, Zhu Y, et al
    Immune system-associated genes in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 6:13872877251364396. doi: 10.1177/13872877251364396.
    PubMed     Abstract available
    
    
    
86. CHEN X, Zhou S, Wang W, Gao Z, et al
    Sex differences in white matter amplitude of low-frequency fluctuation associated with cognitive performance across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Aug 5:13872877251364722. doi: 10.1177/13872877251364722.
    PubMed     Abstract available
    
    
    
87. XIA Y, Sha L, Tao M, Peng A, et al
    Cognitive and spatial patterns of amyloid-beta burden in Alzheimer's disease with epilepsy.
    J Alzheimers Dis. 2025 Aug 4:13872877251360425. doi: 10.1177/13872877251360425.
    PubMed     Abstract available
    
    
    
88. CANOVAS R, Doecke JD, Fowler CJ, Fripp J, et al
    Association of plastic-associated chemicals with Alzheimer's disease amyloid-beta and cognitive status.
    J Alzheimers Dis. 2025 Aug 3:13872877251364559. doi: 10.1177/13872877251364559.
    PubMed     Abstract available
    
    
    
89. PANG R, Wang J, Kanekar S, Karunanayaka P, et al
    Linking genetics to MRI-DTI: HFE polymorphism delays Alzheimer's disease white matter degeneration in APOE4 carriers.
    J Alzheimers Dis. 2025 Aug 3:13872877251363211. doi: 10.1177/13872877251363211.
    PubMed     Abstract available
    
    
    
90. AYELE BA, Whitehead PL, Pascual J, Gu T, et al
    Exploring the stability of Alzheimer's disease plasma biomarkers stored for extended periods at -20 degrees C: Implications for resource-constrained environments.
    J Alzheimers Dis. 2025 Aug 3:13872877251364899. doi: 10.1177/13872877251364899.
    PubMed     Abstract available
    
    
    
91. BARBOUR AJ
    Screening antiseizure medications to break the cycle between neuronal hyperexcitability and Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 3:13872877251364556. doi: 10.1177/13872877251364556.
    PubMed     Abstract available
    
    
    
92. AKUSHEVICH I, Yashkin A, Tupler LA, Ouyang M, et al
    The absolute and relative concentration-response patterns of exposure to ambient air pollutants and the risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 1:13872877251362785. doi: 10.1177/13872877251362785.
    PubMed     Abstract available
    
    
    
93. ZANINI L, D'Antonio F, Di Vita A, Talarico G, et al
    Sensitivity and vagal reactivity to C-tactile-mediated affective touch in mild cognitive impairment due to Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 1:13872877251362249. doi: 10.1177/13872877251362249.
    PubMed     Abstract available
    
    
    
94. WOOD KA, Chen X, Ko YA, Wharton W, et al
    National Alzheimer's Coordinating Center cerebral neuropathology and cognitive function in atrial fibrillation.
    J Alzheimers Dis. 2025 Aug 1:13872877251364508. doi: 10.1177/13872877251364508.
    PubMed     Abstract available
    
    
    
95. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.
    J Alzheimers Dis. 2025 Aug 1:13872877251362212. doi: 10.1177/13872877251362212.
    PubMed     Abstract available
    
    
    
96. PARK J, Abner EL, Wang P, Liu C, et al
    Estimation of events in cohort studies based on probability of cognitive impairment.
    J Alzheimers Dis. 2025;106:1097-1107.
    PubMed     Abstract available
    
    
    
97. PARK YJ, Seo SW, Choi SH, Moon SY, et al
    Machine learning-based prediction of amyloid positivity using early-phase F-18 flutemetamol PET.
    J Alzheimers Dis. 2025;106:1198-1211.
    PubMed     Abstract available
    
    
    July 2025
98. PRAJAPAT M, Sarma P, Kaur G, Choudhary G, et al
    Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/beta-catenin pathway modulation for amyloid-beta-induced Alzheimer's disease model.
    J Alzheimers Dis. 2025 Jul 30:13872877251362787. doi: 10.1177/13872877251362787.
    PubMed     Abstract available
    
    
    
99. KUECK PJ, Honea RA, Kemna RE, Burns JM, et al
    Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 30:13872877251362487. doi: 10.1177/13872877251362487.
    PubMed     Abstract available
    
    
    
100. KIM J, Yang HJ, Park S, Kim BS, et al
     Gait speed and muscle mass as dual mediators in the link between white matter hyperintensities and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 30:13872877251362424. doi: 10.1177/13872877251362424.
     PubMed     Abstract available
     
     
     
101. MILES LA, Masters CL
     The structural foundations of anti-amyloid-beta immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment.
     J Alzheimers Dis. 2025 Jul 30:13872877251361049. doi: 10.1177/13872877251361049.
     PubMed     Abstract available
     
     
     
102. WANG H, Yang Q, Ge C, Liu J, et al
     Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 29:13872877251361042. doi: 10.1177/13872877251361042.
     PubMed     Abstract available
     
     
     
103. IKANGA J, Jean K, Medina P, Patel SS, et al
     Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo.
     J Alzheimers Dis. 2025 Jul 29:13872877251360697. doi: 10.1177/13872877251360697.
     PubMed     Abstract available
     
     
     
104. SHI L, Tian X, Lu X, Yih B, et al
     Frailty in Alzheimer's disease: A bibliometric analysis of research hotspots, emerging trends, and knowledge structure.
     J Alzheimers Dis. 2025 Jul 28:13872877251362665. doi: 10.1177/13872877251362665.
     PubMed     Abstract available
     
     
     
105. 
     Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award.
     J Alzheimers Dis. 2025 Jul 28:13872877251361092. doi: 10.1177/13872877251361092.
     PubMed    
     
     
     
106. XIONG C, Lu R, Bui Q, Popp B, et al
     Person-specific digital measurements of air pollutant exposure and biomarkers of Alzheimer's disease: Findings from a pilot study.
     J Alzheimers Dis. 2025 Jul 27:13872877251362667. doi: 10.1177/13872877251362667.
     PubMed     Abstract available
     
     
     
107. HSIAO CH, Wu CE, Wang CM, Lin TY, et al
     Intracerebral hemorrhage risk in Alzheimer's disease patients on anticoagulants: A nationwide cohort study.
     J Alzheimers Dis. 2025 Jul 27:13872877251362362. doi: 10.1177/13872877251362362.
     PubMed     Abstract available
     
     
     
108. ALABDULJABBAR A, Khan SU, Altherwy YN, Almarshad F, et al
     A novel multimodal medical image fusion model for Alzheimer's and glioma disease detection based on hybrid fusion strategies in non-subsampled shearlet transform domain.
     J Alzheimers Dis. 2025 Jul 27:13872877251362498. doi: 10.1177/13872877251362498.
     PubMed     Abstract available
     
     
     
109. PRABHU SS, Burrage EN, Coblentz T, Ball S, et al
     Mid-life exposure to chronic stress accelerates cerebrovascular dysfunction and upregulates oxidative stress in Alzheimer's disease mice.
     J Alzheimers Dis. 2025 Jul 27:13872877251362204. doi: 10.1177/13872877251362204.
     PubMed     Abstract available
     
     
     
110. RICH A, Oh H
     Distinctive volumetric associations between plasma p-tau181 and hippocampal formation structures across the Alzheimer's disease continuum.
     J Alzheimers Dis. 2025 Jul 27:13872877251361354. doi: 10.1177/13872877251361354.
     PubMed     Abstract available
     
     
     
111. CHONG JR, Hye A, Boada M, Svenningsson P, et al
     Cerebrospinal fluid biomarkers of Alzheimer's disease in Lewy body diseases: The performance of fully automated immunoassays.
     J Alzheimers Dis. 2025 Jul 27:13872877251360404. doi: 10.1177/13872877251360404.
     PubMed     Abstract available
     
     
     
112. MORYS F, Liu L, Senkevich K, Gan-Or Z, et al
     Obesity-related brain atrophy is independent of Alzheimer's disease protein pathways.
     J Alzheimers Dis. 2025 Jul 27:13872877251359680. doi: 10.1177/13872877251359680.
     PubMed     Abstract available
     
     
     
113. ARAI H, Aiba S, Arai R
     Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 24:13872877251361051. doi: 10.1177/13872877251361051.
     PubMed     Abstract available
     
     
     
114. BENGISU S, Savas M, Ustel DA, Begen SK, et al
     The discriminant ability of the Eating Assessment Tool-10 to detect dysphagia and aspiration according to the stage of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 23:13872877251362229. doi: 10.1177/13872877251362229.
     PubMed     Abstract available
     
     
     
115. WANG X, Wang M, Wang H, Yin G, et al
     Drug repurposing for Alzheimer's disease integrating transcriptome-wide association study and biological network analysis.
     J Alzheimers Dis. 2025 Jul 22:13872877251360009. doi: 10.1177/13872877251360009.
     PubMed     Abstract available
     
     
     
116. PEREIRA DA SILVA AM, Falcao L, Virgilio F, Rodrigues Menezes I, et al
     Efficacy and APOE epsilon4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.
     J Alzheimers Dis. 2025 Jul 21:13872877251361044. doi: 10.1177/13872877251361044.
     PubMed     Abstract available
     
     
     
117. YIN M, Ding S, Zhao M, Liu J, et al
     The global, regional, and national burden and attributable risk factors of Alzheimer's disease and other dementias, 1990-2021: A systematic analysis for the Global Burden of Disease Study.
     J Alzheimers Dis. 2025 Jul 21:13872877251360221. doi: 10.1177/13872877251360221.
     PubMed     Abstract available
     
     
     
118. ALZHRANI AJ, Stockfelt L, Xu Y, Harari F, et al
     Long-term exposure to air pollution and validated cases of Alzheimer's disease and vascular dementia in the Malmo diet and cancer cohort.
     J Alzheimers Dis. 2025 Jul 21:13872877251360225. doi: 10.1177/13872877251360225.
     PubMed     Abstract available
     
     
     
119. LUO X, Hong H, Wang S, Li K, et al
     Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 21:13872877251360416. doi: 10.1177/13872877251360416.
     PubMed     Abstract available
     
     
     
120. QIU Y, Bao J, Wang T, Shang L, et al
     Global and regional white matter hyperintensities in Alzheimer's disease: Exploring etiologies and cognitive correlates.
     J Alzheimers Dis. 2025 Jul 21:13872877251360239. doi: 10.1177/13872877251360239.
     PubMed     Abstract available
     
     
     
121. HUANG Y, Xu T, Wang L, Xiang R, et al
     Application of machine learning reveals diagnostic biomarkers related to pyroptosis in Alzheimer's disease and analysis of immune infiltration.
     J Alzheimers Dis. 2025 Jul 20:13872877251360033. doi: 10.1177/13872877251360033.
     PubMed     Abstract available
     
     
     
122. SENRA H, Costa MC, Pereira I, Agostinho D, et al
     Predicting diagnostic conversion from mild cognitive impairment to Alzheimer's disease: A Bayesian hierarchical model approach using ADNI patient data.
     J Alzheimers Dis. 2025 Jul 20:13872877251360228. doi: 10.1177/13872877251360228.
     PubMed     Abstract available
     
     
     
123. PASTERIS M, Cakir S, Bellizzi A, Sariyer IK, et al
     Alternative splicing in Alzheimer's disease: Mechanisms, therapeutic implications, and 3D modeling approaches.
     J Alzheimers Dis. 2025 Jul 20:13872877251359633. doi: 10.1177/13872877251359633.
     PubMed     Abstract available
     
     
     
124. LI Q, Koehler S, Koenig A, Dyrba M, et al
     Associations between digital speech features of automated cognitive tasks and trajectories of brain atrophy and cognitive decline in early Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 20:13872877251359967. doi: 10.1177/13872877251359967.
     PubMed     Abstract available
     
     
     
125. WEI C, Wang J, Xue Y, Jiang J, et al
     Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 17:13872877251360259. doi: 10.1177/13872877251360259.
     PubMed     Abstract available
     
     
     
126. VARANGIS E, Liu J, Miao Y, Zhu X, et al
     Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition.
     J Alzheimers Dis. 2025 Jul 17:13872877251360025. doi: 10.1177/13872877251360025.
     PubMed     Abstract available
     
     
     
127. GE L, Zhu L, Su C, Jin Z, et al
     Exploring causal gut-brain axes in Alzheimer's disease using mediation Mendelian randomization analysis.
     J Alzheimers Dis. 2025 Jul 15:13872877251360004. doi: 10.1177/13872877251360004.
     PubMed     Abstract available
     
     
     
128. ABBATE C, Gallucci A
     New Alzheimer's association workgroup criteria underestimate syndromes in Alzheimer's disease definition.
     J Alzheimers Dis. 2025 Jul 15:13872877251359642. doi: 10.1177/13872877251359642.
     PubMed     Abstract available
     
     
     
129. FU Y, Jiang L, Detre J, Wang Z, et al
     Alzheimer's disease classification using mutual information generated graph convolutional network for functional MRI.
     J Alzheimers Dis. 2025 Jul 15:13872877251350306. doi: 10.1177/13872877251350306.
     PubMed     Abstract available
     
     
     
130. TAHAMI MONFARED AA, Hummel N, Kopiec A, Chandak A, et al
     Integrating intangible costs into societal cost estimates of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 13:13872877251351591. doi: 10.1177/13872877251351591.
     PubMed     Abstract available
     
     
     
131. EDMUNDS KJ, Nelson AR, Brach TL, Glittenberg M, et al
     Depression modifies age-associated [(11)C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 10:13872877251353098. doi: 10.1177/13872877251353098.
     PubMed     Abstract available
     
     
     
132. GAMM S, Ummel D, Vasil N, Grenier S, et al
     The need to adapt after Alzheimer's disease diagnosis: Coping strategies used to maintain identity and quality of life.
     J Alzheimers Dis. 2025 Jul 7:13872877251351596. doi: 10.1177/13872877251351596.
     PubMed     Abstract available
     
     
     
133. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
     Is US residence a risk factor for Alzheimer's disease?
     J Alzheimers Dis. 2025 Jul 3:13872877251356682. doi: 10.1177/13872877251356682.
     PubMed     Abstract available
     
     
     
134. PALEY JL, Scheiffele GD, Li Y, Shaaban CE, et al
     Neighborhood deprivation and mortality among people with Alzheimer's disease and related dementia.
     J Alzheimers Dis. 2025 Jul 2:13872877251352120. doi: 10.1177/13872877251352120.
     PubMed     Abstract available
     
     
     
135. HSU YH, Huang SM, Kuo LW, Yang JJ, et al
     Diagnostic utility of the item-specific Encoding Deficit Index in relation to medial temporal lobe atrophy in early-stage Alzheimer's disease.
     J Alzheimers Dis. 2025 Jul 2:13872877251351612. doi: 10.1177/13872877251351612.
     PubMed     Abstract available
     
     
     
136. BOSE C, Hindle A, Smith SC, Strickland J, et al
     Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.
     J Alzheimers Dis. 2025 Jul 1:13872877251352107. doi: 10.1177/13872877251352107.
     PubMed     Abstract available
     
     
     
137. WALCZAK K, Kolodziejczyk W, Pszczolowska M, Kozlowska M, et al
     Klotho protein in Alzheimer's disease: Diet leading to immortality?
     J Alzheimers Dis. 2025 Jul 1:13872877251350125. doi: 10.1177/13872877251350125.
     PubMed     Abstract available
     
     
     
138. LIU SK, Cao H, Yang X, Zhou X, et al
     An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population.
     J Alzheimers Dis. 2025 Jul 1:13872877251350722. doi: 10.1177/13872877251350722.
     PubMed     Abstract available
     
     
     
139. RICCHI I, Griffa A, Corredor-Jerez R, Richiardi J, et al
     The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework.
     J Alzheimers Dis. 2025;106:245-258.
     PubMed     Abstract available
     
     
     
140. LOJO-RAMIREZ JA, Fernandez-Rodriguez P, Guerra-Gomez M, Marin-Cabanas AM, et al
     Evaluation of early-phase (18)F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with (18)F-FDG PET at group and single patient level.
     J Alzheimers Dis. 2025;106:304-316.
     PubMed     Abstract available
     
     
     
141. YIN A, Gui Y, Wan L, Cai Q, et al
     p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice.
     J Alzheimers Dis. 2025;106:352-362.
     PubMed     Abstract available
     
     
     
142. SEKIKAWA A, Higashiyama A, Lopresti BJ, Ihara M, et al
     An inverse association of cerebral amyloid-beta deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan.
     J Alzheimers Dis. 2025;106:378-386.
     PubMed     Abstract available
     
     
     
143. ANDERSEN LSN, Simonsen AH, Vogel A, McWilliam OH, et al
     Isolated elevation of 181p-tau in the cerebrospinal fluid is associated with distinct clinical features: Findings from a Danish memory clinic cohort.
     J Alzheimers Dis. 2025;106:111-119.
     PubMed     Abstract available
     
     
     
144. ZHAI A, Zou R, Lv T, Yang S, et al
     Genetic association of social participation with cognitive function: A bidirectional Mendelian randomization study.
     J Alzheimers Dis. 2025;106:259-270.
     PubMed     Abstract available
     
     
     
145. CAI Y, Wang X, Xiang Y, Wang Z, et al
     Codonopsis pilosula polysaccharides alleviate neuronal apoptosis induced by endoplasmic reticulum stress-activated PERK-ATF4-CHOP signaling in APP/PS1 mice.
     J Alzheimers Dis. 2025;106:317-330.
     PubMed     Abstract available
     
     
     
146. LIU J, Duangjan C, Phan NM, Curran SP, et al
     Loss of WDR23 slows the rate of age-related cognitive decline with elevated amyloid burden.
     J Alzheimers Dis. 2025;106:218-229.
     PubMed     Abstract available
     
     
     
147. SALVIONI CHIABOTTI P, Nasuti M, Rouaud O, Allali G, et al
     Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center.
     J Alzheimers Dis. 2025;106:512-517.
     PubMed     Abstract available
     
     
     
148. SINGHRAO SK
     Porphyromonas gingivalis-lipopolysaccharide and amyloid-beta: A dangerous liaison for impairing memory?
     J Alzheimers Dis. 2025;106:537-539.
     PubMed     Abstract available
     
     
     
149. SUZUMURA S, Sugioka J, Sakurai K, Osawa A, et al
     Finger motor skills and related brain regions in patients with cognitive disorder.
     J Alzheimers Dis. 2025;106:634-645.
     PubMed     Abstract available
     
     
     
150. ALISHAHI F, Beam CR, Gatz M, Schneider LS, et al
     High precision and cost-effective multiplex quantification of amyloid-beta40, amyloid-beta42, p181Tau, p217Tau, neurofilament light chain, and glial fibrillary acidic protein from plasma and serum.
     J Alzheimers Dis. 2025;106:739-755.
     PubMed     Abstract available
     
     
     June 2025
151. SARAIVA JA, Becker M, Dyrba M, Bolukbas B, et al
     Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhood.
     J Alzheimers Dis. 2025 Jun 30:13872877251352119. doi: 10.1177/13872877251352119.
     PubMed     Abstract available
     
     
     
152. SATO K, Niimi Y, Ihara R, Iwata A, et al
     Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease.
     J Alzheimers Dis. 2025 Jun 30:13872877251350718. doi: 10.1177/13872877251350718.
     PubMed     Abstract available
     
     
     
153. WANG G, Chen T, O'Gorman J, Li Y, et al
     Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials.
     J Alzheimers Dis. 2025 Jun 30:13872877251352189. doi: 10.1177/13872877251352189.
     PubMed     Abstract available
     
     
     
154. SHANG ZT, Huang XY, Xiong LL, Xu ZC, et al
     Methanol extract from miracle fruit seeds mitigates Alzheimer's disease and enhance autophagy via suppressing the AKT/mTOR signal pathway.
     J Alzheimers Dis. 2025 Jun 30:13872877251352545. doi: 10.1177/13872877251352545.
     PubMed     Abstract available
     
     
     
155. ESLICK S, Austin G, Ferguson JJ, Garg ML, et al
     Blood biomarkers of Alzheimer's disease in Australians habitually consuming various plant-based diets.
     J Alzheimers Dis. 2025 Jun 30:13872877251351549. doi: 10.1177/13872877251351549.
     PubMed     Abstract available
     
     
     
156. KIM S, Wang SM, Kang DW, Kim S, et al
     Impact of type 2 diabetes mellitus on differential cerebellar volume reduction in Alzheimer's disease trajectory.
     J Alzheimers Dis. 2025 Jun 27:13872877251352208. doi: 10.1177/13872877251352208.
     PubMed     Abstract available
     
     
     
157. JAMISON D, Kadamangudi S, Tumurbaatar B, Zhang WR, et al
     Comparative analysis of brain-derived tau oligomer interactomes in Alzheimer's disease, non-demented with Alzheimer's neuropathology, and primary age-related tauopathy: Implications for neurodegeneration and cognitive resilience.
     J Alzheimers Dis. 2025 Jun 27:13872877251352382. doi: 10.1177/13872877251352382.
     PubMed     Abstract available
     
     
     
158. ZHANG QN, Yu LK, Zhang XY, Wu Y, et al
     LCN2 of cerebrospinal fluid: A potential biomarker for diagnosis and disease progression in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jun 27:13872877251352411. doi: 10.1177/13872877251352411.
     PubMed     Abstract available
     
     
     
159. CHEN F, Deng H, Zhang Q, Liu Y, et al
     Utility of machine learning algorithms in classification of progressive cognitive impairment in Alzheimer's disease: A retrospective cohort based on China.
     J Alzheimers Dis. 2025 Jun 27:13872877251352510. doi: 10.1177/13872877251352510.
     PubMed     Abstract available
     
     
     
160. POPP ZT, Ang TFA, Hwang PH, Au R, et al
     Association between education and rate of cognitive decline among individuals with Alzheimer's disease: A multi-national European observational study.
     J Alzheimers Dis. 2025 Jun 26:13872877251352216. doi: 10.1177/13872877251352216.
     PubMed     Abstract available
     
     
     
161. WADLEY VG, Zhang Y, Bull T, Barba C, et al
     Daily function outcomes in adults with mild cognitive impairment due to Alzheimer's disease after two years of processing speed training versus a control training protocol.
     J Alzheimers Dis. 2025 Jun 26:13872877251351341. doi: 10.1177/13872877251351341.
     PubMed     Abstract available
     
     
     
162. XIA X, Duffner LA, Bintener C, Bradshaw A, et al
     Diagnostic and prognostic multimodal prediction models in Alzheimer's disease: A scoping review.
     J Alzheimers Dis. 2025 Jun 26:13872877251351630. doi: 10.1177/13872877251351630.
     PubMed     Abstract available
     
     
     
163. SIRIWARDHANA C, Carrazana E, Liow K
     Racial and socioeconomic influences on the interplay between Alzheimer's disease-related dementia and cardio-cerebrovascular disease in an aging population.
     J Alzheimers Dis. 2025 Jun 26:13872877251351216. doi: 10.1177/13872877251351216.
     PubMed     Abstract available
     
     
     
164. GARRAHY JP
     Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis.
     J Alzheimers Dis. 2025 Jun 26:13872877251350338. doi: 10.1177/13872877251350338.
     PubMed     Abstract available
     
     
     
165. KATABATHULA S, Gurney M, Perry G, Davis PB, et al
     Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.
     J Alzheimers Dis. 2025 Jun 25:13872877251351622. doi: 10.1177/13872877251351622.
     PubMed     Abstract available
     
     
     
166. WANG W, Davis PB, Qi X, Gurney M, et al
     Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study.
     J Alzheimers Dis. 2025 Jun 24:13872877251351329. doi: 10.1177/13872877251351329.
     PubMed     Abstract available
     
     
     
167. ASANTE J JR, Nagel CL, Barger SW
     Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study.
     J Alzheimers Dis. 2025 Jun 23:13872877251351629. doi: 10.1177/13872877251351629.
     PubMed     Abstract available
     
     
     
168. TIAN J, Meka SS, Wang T, Guo L, et al
     Vulnerability of mitochondrial OXPHOS complexes in the arcuate nucleus of the hypothalamus of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jun 22:13872877251352209. doi: 10.1177/13872877251352209.
     PubMed     Abstract available
     
     
     
169. GONG J, Li S, Han X, Wang P, et al
     Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons.
     J Alzheimers Dis. 2025 Jun 22:13872877251350292. doi: 10.1177/13872877251350292.
     PubMed     Abstract available
     
     
     
170. NAKAMURA K, Tagai K, Shinotoh H, Hirano S, et al
     Concurrent Alzheimer's disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study.
     J Alzheimers Dis. 2025 Jun 20:13872877251351220. doi: 10.1177/13872877251351220.
     PubMed     Abstract available
     
     
     
171. HOILUND-CARLSEN PF, Barrio JR
     History repeats itself: A new trivializing term for a potentially life-threatening side effect of antibody Alzheimer's disease therapy.
     J Alzheimers Dis. 2025 Jun 19:13872877251350295. doi: 10.1177/13872877251350295.
     PubMed     Abstract available
     
     
     
172. LIN PJ, Riley AG, Synnott PG, Frangiosa TL, et al
     Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States.
     J Alzheimers Dis. 2025 Jun 19:13872877251350381. doi: 10.1177/13872877251350381.
     PubMed     Abstract available
     
     
     
173. CHENG M, Wei YD, Zheng X, Gao XR, et al
     Bibliometric analysis of the interplay between Alzheimer's disease and type 2 diabetes mellitus: Trends, hotspots, and emerging research areas.
     J Alzheimers Dis. 2025 Jun 17:13872877251351042. doi: 10.1177/13872877251351042.
     PubMed     Abstract available
     
     
     
174. JOHNSON IP, Peterson TM, Gudsnuk K, Keene CD, et al
     Presence of Alzheimer's disease variants in circular RNA of PSEN1 and PSEN2.
     J Alzheimers Dis. 2025 Jun 16:13872877251350112. doi: 10.1177/13872877251350112.
     PubMed     Abstract available
     
     
     
175. MICHAEL GC
     Knowledge and attitudes about Alzheimer's disease in Nigerian geriatric outpatients: The role of primary care professionals.
     J Alzheimers Dis. 2025 Jun 16:13872877251350293. doi: 10.1177/13872877251350293.
     PubMed     Abstract available
     
     
     
176. ZAWAR I, Kapur J
     Seizing the link: Exploring the potential association between anti-seizure medications and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jun 16:13872877251350291. doi: 10.1177/13872877251350291.
     PubMed     Abstract available
     
     
     
177. VANNINI P, Zamboni G
     To know or to not know: The importance of assessing awareness of cognitive function in the early stages of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jun 16:13872877251350138. doi: 10.1177/13872877251350138.
     PubMed     Abstract available
     
     
     
178. MARIZZONI M, Coppola L, Festari C, Luongo D, et al
     Circulating short chain fatty acids in Alzheimer's disease: A cross-sectional observational study.
     J Alzheimers Dis. 2025 Jun 12:13872877251337773. doi: 10.1177/13872877251337773.
     PubMed     Abstract available
     
     
     
179. WANG DW, Qin XT, Wang G, Liu J, et al
     Effect of comprehensive geriatric assessment intervention on serum S100beta levels and clinical outcomes in patients with Alzheimer's disease.
     J Alzheimers Dis. 2025 Jun 10:13872877251344544. doi: 10.1177/13872877251344544.
     PubMed     Abstract available
     
     
     
180. KNOX KM, Davidson S, Lehmann LM, Skinner E, et al
     Alzheimer's disease-associated genotypes differentially influence chronic evoked seizure outcomes and antiseizure medicine efficacy in aged mice.
     J Alzheimers Dis. 2025 Jun 3:13872877251343321. doi: 10.1177/13872877251343321.
     PubMed     Abstract available
     
     
     
181. YU K, Jiang R, Zhou D, Zhao Z, et al
     Therapeutic targets for Alzheimer's disease: Proteome-wide Mendelian randomization and colocalization analyses.
     J Alzheimers Dis. 2025 Jun 2:13872877251344572. doi: 10.1177/13872877251344572.
     PubMed     Abstract available
     
     
     
182. KIM HN, Jang WH, Kang NS, Kim S, et al
     Pterosin D-activated protein kinase A mitigates Alzheimer's disease in 5xFAD mice.
     J Alzheimers Dis. 2025 Jun 2:13872877251344627. doi: 10.1177/13872877251344627.
     PubMed     Abstract available
     
     
     
183. YANG D, Hou N, Jia M
     Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective.
     J Alzheimers Dis. 2025 Jun 2:13872877251346989. doi: 10.1177/13872877251346989.
     PubMed     Abstract available
     
     
     
184. PEREIRA ME, de Souza JV, Gomar GG, Kruk IL, et al
     Glutathione peroxidase activity in Alzheimer's disease patients: A systematic review and meta-analysis.
     J Alzheimers Dis. 2025 Jun 2:13872877251346981. doi: 10.1177/13872877251346981.
     PubMed     Abstract available
     
     
     
185. LI L, Wang Y, Feng Q, Ma C, et al
     Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions.
     J Alzheimers Dis. 2025 Jun 2:13872877251335572. doi: 10.1177/13872877251335572.
     PubMed     Abstract available
     
     
     
186. ALKAM T, Tarshizi E, Van Benschoten AH
     Large language models for Alzheimer's disease drug discovery.
     J Alzheimers Dis. 2025 Jun 2:13872877251346890. doi: 10.1177/13872877251346890.
     PubMed     Abstract available
     
     
     
187. WANG Z, Wang Q, Fu C, Li X, et al
     The fall-dementia connection: Synergistic effects of falls with genetic and health risk factors.
     J Alzheimers Dis. 2025;105:990-999.
     PubMed     Abstract available
     
     
     
188. LI J, Zhang F, Eisel UL
     Adverse events associated with lecanemab: A disproportionality analysis of data from the FDA adverse event reporting system.
     J Alzheimers Dis. 2025;105:849-859.
     PubMed     Abstract available
     
     
     
189. SAEZ-CALVERAS N, Ishii M
     Hydrate to keep the amyloid away.
     J Alzheimers Dis. 2025;105:759-761.
     PubMed     Abstract available
     
     
     May 2025
190. LOFFREDO L, Alfano AR, Ettorre E, Desideri G, et al
     Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer's disease.
     J Alzheimers Dis. 2025 May 27:13872877251345157. doi: 10.1177/13872877251345157.
     PubMed     Abstract available
     
     
     
191. GUZMAN-VELEZ E, Aguillon D, Rivera-Hernandez A, Baena AY, et al
     Association among cardiorespiratory fitness, plasma biomarkers of pathology and astrocyte reactivity, and cognition in autosomal-dominant Alzheimer's disease.
     J Alzheimers Dis. 2025 May 27:13872877251344327. doi: 10.1177/13872877251344327.
     PubMed     Abstract available
     
     
     
192. LIANG J, Wang Q, Wang J, Shao Y, et al
     Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic stimulation treatment.
     J Alzheimers Dis. 2025 May 27:13872877251344599. doi: 10.1177/13872877251344599.
     PubMed     Abstract available
     
     
     
193. LU P, Chen M, Chen L, Lin F, et al
     Translational computerized clinical decision support systems for Alzheimer's disease: A systematic review.
     J Alzheimers Dis. 2025 May 25:13872877251343241. doi: 10.1177/13872877251343241.
     PubMed     Abstract available
     
     
     
194. SACU S, Slattery CF, Friston KJ, Paterson RW, et al
     Neural mechanisms of disease pathology and cognition in young-onset Alzheimer's disease variants.
     J Alzheimers Dis. 2025 May 22:13872877251344325. doi: 10.1177/13872877251344325.
     PubMed     Abstract available
     
     
     
195. PANDEY JP, Kimball C, Nietert PJ
     Epistatic effects of immunoglobulin KM (kappa marker) allotypes and APOE epsilon4 allele on the risk of Alzheimer's disease.
     J Alzheimers Dis. 2025 May 22:13872877251343315. doi: 10.1177/13872877251343315.
     PubMed     Abstract available
     
     
     
196. LIU H, Li Y, Sun Z, Xu X, et al
     Altered hemispheres lateralization of brain functional gradients in Alzheimer's disease.
     J Alzheimers Dis. 2025 May 22:13872877251339761. doi: 10.1177/13872877251339761.
     PubMed     Abstract available
     
     
     
197. MENG X, Gong Y, Xiao F, Cao Z, et al
     Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques.
     J Alzheimers Dis. 2025 May 21:13872877251344188. doi: 10.1177/13872877251344188.
     PubMed     Abstract available
     
     
     
198. ISHIMARU D, Satake Y, Kanemoto H, Taomoto D, et al
     Thieves in the delusions of theft in patients with Alzheimer's disease living alone: A case series.
     J Alzheimers Dis. 2025 May 21:13872877251343313. doi: 10.1177/13872877251343313.
     PubMed     Abstract available
     
     
     
199. LI Y, Yao YL, Wu Y
     Causal relationships between plasma proteins and Alzheimer's disease using bidirectional Mendelian randomization.
     J Alzheimers Dis. 2025 May 21:13872877251345151. doi: 10.1177/13872877251345151.
     PubMed     Abstract available
     
     
     
200. MIYASHITA A, Obinata A, Hara N, Mitsumori R, et al
     Association of rare APOE missense variants with Alzheimer's disease in the Japanese population.
     J Alzheimers Dis. 2025 May 21:13872877251340710. doi: 10.1177/13872877251340710.
     PubMed     Abstract available
     
     
     
201. LANDRY A, Elsliger S, Gaudet J, Al-Shamaa S, et al
     Psychological impact of biomarker-assisted diagnosis of Alzheimer's disease.
     J Alzheimers Dis. 2025 May 21:13872877251341587. doi: 10.1177/13872877251341587.
     PubMed     Abstract available
     
     
     
202. NONG Y, Kim JS, Jia L, Arancio O, et al
     The interaction between neurotransmitter receptor activity and amyloid-beta pathology in Alzheimer's disease.
     J Alzheimers Dis. 2025 May 19:13872877251342273. doi: 10.1177/13872877251342273.
     PubMed     Abstract available
     
     
     
203. GIAQUINTO F, Iaia M, Rizzi E, Macchitella L, et al
     Cognitive training for Alzheimer's disease and other forms of dementia: Insights from a systematic review and Bayesian meta-analysis.
     J Alzheimers Dis. 2025 May 13:13872877251334795. doi: 10.1177/13872877251334795.
     PubMed     Abstract available
     
     
     
204. QIN Q, Xia X, Qu J, Guan Z, et al
     Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early- and late-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 May 8:13872877251340955. doi: 10.1177/13872877251340955.
     PubMed     Abstract available
     
     
     
205. CUMBO E, Migliore D
     Differential effects of antidepressants on cognition in Alzheimer's disease with depression: A sub-group analysis of an open-label, observational study.
     J Alzheimers Dis. 2025 May 7:13872877251340084. doi: 10.1177/13872877251340084.
     PubMed     Abstract available
     
     
     
206. NYONGESA CA, Hogarth M, Pa J
     Artificial intelligence-driven natural language processing for identifying linguistic patterns in Alzheimer's disease and mild cognitive impairment: A study of lexical, syntactic, and cohesive features of speech through picture description tasks.
     J Alzheimers Dis. 2025 May 7:13872877251339756. doi: 10.1177/13872877251339756.
     PubMed     Abstract available
     
     
     
207. ZHANG J, Liu T, Wu H, Wei J, et al
     Identification of NDUFV2, NDUFS7, OPA1, and NDUFA1 as biomarkers for Alzheimer's disease: Insights from oxidative stress and mitochondrial dysfunction in the hippocampus.
     J Alzheimers Dis. 2025 May 7:13872877251339771. doi: 10.1177/13872877251339771.
     PubMed     Abstract available
     
     
     
208. VON GAL A, Papa D, D'Auria M, Piccardi L, et al
     Disruptive resting state networks characterizing depressive comorbidity in Alzheimer's disease and mild cognitive impairment.
     J Alzheimers Dis. 2025 May 6:13872877251337770. doi: 10.1177/13872877251337770.
     PubMed     Abstract available
     
     
     
209. WANG T, Jiang H, Zheng R, Zhang C, et al
     Trends and research focus on autophagy in Alzheimer's disease (2003-2023): A bibliometric study.
     J Alzheimers Dis. 2025 May 6:13872877251336442. doi: 10.1177/13872877251336442.
     PubMed     Abstract available
     
     
     
210. KORIATH CA, Perneczky R
     Obesity and Alzheimer's disease dementia: Examining inflammatory links to cognitive decline and neuropsychiatric symptoms.
     J Alzheimers Dis. 2025 May 6:13872877251338467. doi: 10.1177/13872877251338467.
     PubMed     Abstract available
     
     
     
211. WU R, Guo J, Liu Y, Huang S, et al
     Angiogenesis promotion of the transplantation of human amniotic mesenchymal stem cells via the Ang-1/Tie-2 signaling pathways in Alzheimer's disease model.
     J Alzheimers Dis. 2025 May 5:13872877251338687. doi: 10.1177/13872877251338687.
     PubMed     Abstract available
     
     
     
212. SANDBERG A, Puttagunta S, Duval N, Fleming H, et al
     Immunocal((R)), a cysteine-rich whey protein, rescues reelin and reduces amyloid plaque burden in a transgenic amyloid-beta protein precursor (hAbetaPP(SweInd)) mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2025 May 5:13872877251338323. doi: 10.1177/13872877251338323.
     PubMed     Abstract available
     
     
     
213. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
     Correlations between agitation and other neuropsychiatric symptoms in each stage of Alzheimer's disease: A re-analysis of CATIE-AD.
     J Alzheimers Dis. 2025 May 5:13872877251340402. doi: 10.1177/13872877251340402.
     PubMed     Abstract available
     
     
     
214. ITO K, Washimi Y, Kato T, Suzuki K, et al
     (18)F-FDG PET for the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration: A multicenter prospective study in Japan.
     J Alzheimers Dis. 2025 May 5:13872877251338691. doi: 10.1177/13872877251338691.
     PubMed     Abstract available
     
     
     
215. LI MJ, Lan MN, Du YX, Liu Y, et al
     EPRCN exerts neuroprotective function by regulating gut microbiota and restoring gut immune homeostasis in Alzheimer's disease model mice.
     J Alzheimers Dis. 2025 May 5:13872877251339762. doi: 10.1177/13872877251339762.
     PubMed     Abstract available
     
     
     
216. MO D, Li X, He J, Lin X, et al
     Chronic gingivitis increases the risk of early-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 May 4:13872877251336259. doi: 10.1177/13872877251336259.
     PubMed     Abstract available
     
     
     
217. VOGELS L, Mohammadi R, Schoonhoven M, Birbil SI, et al
     Modeling Alzheimer's disease: Bayesian copula graphical model from demographic, cognitive, and neuroimaging data.
     J Alzheimers Dis. 2025 May 4:13872877251337944. doi: 10.1177/13872877251337944.
     PubMed     Abstract available
     
     
     
218. YANG YH, Chang HW, Chien CF, Hour TC, et al
     Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-beta42 secretion, tau phosphorylation, phagocytosis, and autophagy.
     J Alzheimers Dis. 2025 May 4:13872877251339774. doi: 10.1177/13872877251339774.
     PubMed     Abstract available
     
     
     
219. BAO W, Bi H, Chao L, Jiang Y, et al
     Identifying the mediating role of brain atrophy on the relationship between DNA damage repair pathway and Alzheimer's disease: A Mendelian randomization analysis and mediation analysis.
     J Alzheimers Dis. 2025 May 2:13872877251333811. doi: 10.1177/13872877251333811.
     PubMed     Abstract available
     
     
     
220. URSO D, Introna A, Gnoni V, Giugno A, et al
     Donanemab eligibility in early Alzheimer's disease: A real-world study.
     J Alzheimers Dis. 2025 May 1:13872877251331243. doi: 10.1177/13872877251331243.
     PubMed     Abstract available
     
     
     
221. LOBUE C, Stopschinski BE, Calveras NS, Salter A, et al
     A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury.
     J Alzheimers Dis. 2025;105:49-55.
     PubMed     Abstract available
     
     
     
222. HOILUND-CARLSEN PF, Werner TJ, Alavi A
     The unsafe profile of lecanemab.
     J Alzheimers Dis. 2025;105:62-64.
     PubMed     Abstract available
     
     
     
223. LABONTE J, Sugarman MA, Pettway E, Zetterberg H, et al
     Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers.
     J Alzheimers Dis. 2025;105:443-452.
     PubMed     Abstract available
     
     
     
224. ZHAI Y, Lu K, Yuan Y, Zhang Z, et al
     Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-kappaB pathway.
     J Alzheimers Dis. 2025;105:416-432.
     PubMed     Abstract available
     
     
     
225. BARTOLINI E, Di Crosta A, La Malva P, Marin A, et al
     Gamma oscillation modulation for cognitive impairment: A systematic review.
     J Alzheimers Dis. 2025;105:331-350.
     PubMed     Abstract available
     
     
     
226. COOPER JK
     Differences between East and West may affect dementia studies: Thoughts from the KSA dementia prevalence study.
     J Alzheimers Dis. 2025;105:368-369.
     PubMed     Abstract available
     
     
     April 2025
227. HEINZE T, Tuchtenhagen M, Knuppel S, Weber D, et al
     EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset.
     J Alzheimers Dis. 2025 Apr 23:13872877251333726. doi: 10.1177/13872877251333726.
     PubMed     Abstract available
     
     
     
228. ZHANG W, Teng F, Lan X, Liu P, et al
     A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis.
     J Alzheimers Dis. 2025 Apr 23:13872877251336266. doi: 10.1177/13872877251336266.
     PubMed     Abstract available
     
     
     
229. JEONG H, Kim D, Na S, Kim B, et al
     Repeated neuromodulation with low-intensity focused ultrasound in patients with Alzheimer's disease.
     J Alzheimers Dis. 2025 Apr 23:13872877251333614. doi: 10.1177/13872877251333614.
     PubMed     Abstract available
     
     
     
230. WEI S, Li C, Li W, Yuan F, et al
     Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics.
     J Alzheimers Dis. 2025 Apr 23:13872877251330320. doi: 10.1177/13872877251330320.
     PubMed     Abstract available
     
     
     
231. HE F, Shi WJ, Liu W, Fan JX, et al
     A mass-producible macaque model displays a durable Alzheimer-like cognitive deficit and hallmark amyloid-beta/tau/neurofilament light chain pathologies.
     J Alzheimers Dis. 2025 Apr 23:13872877251334316. doi: 10.1177/13872877251334316.
     PubMed     Abstract available
     
     
     
232. SINGH-REILLY N, Graff-Radford J, Li D, Mielke MM, et al
     Abeta(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.
     J Alzheimers Dis. 2025 Apr 23:13872877251333450. doi: 10.1177/13872877251333450.
     PubMed     Abstract available
     
     
     
233. GHANBARIAN E, Khorsand B, Petersen KK, Nallapu BT, et al
     Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum.
     J Alzheimers Dis. 2025 Apr 22:13872877251335915. doi: 10.1177/13872877251335915.
     PubMed     Abstract available
     
     
     
234. KSHIRSAGAR S, Deshmukh H, Reddy AP, Reddy AP, et al
     Grounding as a complementary intervention for Alzheimer's disease: Mechanisms, evidence, and potential therapeutic applications.
     J Alzheimers Dis. 2025 Apr 22:13872877251334666. doi: 10.1177/13872877251334666.
     PubMed     Abstract available
     
     
     
235. CHEN HM, Shen K, Ji L, McGrath C, et al
     Patterns and trends in the burden of Alzheimer's disease and related dementias in China (1990-2021) and predictions to 2040.
     J Alzheimers Dis. 2025 Apr 22:13872877251333108. doi: 10.1177/13872877251333108.
     PubMed     Abstract available
     
     
     
236. STAMATELOS P, Beratis IN, Hatzaki P, Economou A, et al
     Mild cognitive impairment, Alzheimer's disease dementia, and predictors of driving cessation: A 7-year longitudinal prospective study.
     J Alzheimers Dis. 2025 Apr 22:13872877251333705. doi: 10.1177/13872877251333705.
     PubMed     Abstract available
     
     
     
237. WANG S, Ni J, Wei M, Li T, et al
     Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort.
     J Alzheimers Dis. 2025 Apr 22:13872877251331974. doi: 10.1177/13872877251331974.
     PubMed     Abstract available
     
     
     
238. JAMAL R, Shaikh MA, Taleuzzaman M, Haque Z, et al
     Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies.
     J Alzheimers Dis. 2025 Apr 21:13872877251330500. doi: 10.1177/13872877251330500.
     PubMed     Abstract available
     
     
     
239. MALEK J, Levchenko A, Robinson JO, Fong J, et al
     Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies.
     J Alzheimers Dis. 2025 Apr 21:13872877251331236. doi: 10.1177/13872877251331236.
     PubMed     Abstract available
     
     
     
240. KIM H, Kulshreshtha A, Alonso A, Goldstein FC, et al
     The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease.
     J Alzheimers Dis. 2025 Apr 21:13872877251331235. doi: 10.1177/13872877251331235.
     PubMed     Abstract available
     
     
     
241. SUN J, Teng F, Cao Y, Pei H, et al
     Peripheral blood immune cell phenotypes and Alzheimer's disease: A mediation Mendelian randomization study.
     J Alzheimers Dis. 2025 Apr 15:13872877251330503. doi: 10.1177/13872877251330503.
     PubMed     Abstract available
     
     
     
242. ASHMAWY RE, Okesanya OJ, Ukoaka BM, Daniel FM, et al
     Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence.
     J Alzheimers Dis. 2025 Apr 15:13872877251331640. doi: 10.1177/13872877251331640.
     PubMed     Abstract available
     
     
     
243. SEGIET N, Poczatek G, Drzazga J, Laskowska-Wronarowicz A, et al
     Effectiveness of structured cognitive intervention among patients diagnosed with late-onset Alzheimer's disease: Report from a pilot study.
     J Alzheimers Dis. 2025 Apr 15:13872877251331184. doi: 10.1177/13872877251331184.
     PubMed     Abstract available
     
     
     
244. SAAOUD F, Liu L, Xu K, Lu Y, et al
     Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model.
     J Alzheimers Dis. 2025 Apr 15:13872877251329583. doi: 10.1177/13872877251329583.
     PubMed     Abstract available
     
     
     
245. PARKS AL, Thacker A, Dohan D, Gomez LAR, et al
     A qualitative study of people with Alzheimer's disease in a memory clinic considering lecanemab treatment.
     J Alzheimers Dis. 2025 Apr 10:13872877251329519. doi: 10.1177/13872877251329519.
     PubMed     Abstract available
     
     
     
246. TONG H, Petyuk VA, Sendtner M, Sood A, et al
     Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.
     J Alzheimers Dis. 2025 Apr 4:13872877251319463. doi: 10.1177/13872877251319463.
     PubMed     Abstract available
     
     
     
247. KARKKAINEN V, Saari T, Hannonen S, Rusanen M, et al
     Altered tear fluid protein expression in persons with mild Alzheimer's disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism.
     J Alzheimers Dis. 2025 Apr 4:13872877251326868. doi: 10.1177/13872877251326868.
     PubMed     Abstract available
     
     
     
248. MARTINEZ JE, Bocanegra Y, Baena A, Langella S, et al
     Religious stress coping is associated with lower entorhinal tau pathology and better memory performance in autosomal dominant Alzheimer's disease.
     J Alzheimers Dis. 2025 Apr 3:13872877251331569. doi: 10.1177/13872877251331569.
     PubMed     Abstract available
     
     
     
249. CORDEIRO AMT, Singulani MP, Talib LL, Forlenza OV, et al
     Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.
     J Alzheimers Dis. 2025 Apr 3:13872877251326291. doi: 10.1177/13872877251326291.
     PubMed     Abstract available
     
     
     
250. DEVERKA PA, Arias JJ, Lin GA, Zwerling J, et al
     Alzheimer's disease blood-based biomarker testing: A stakeholder-informed assessment of coverage considerations.
     J Alzheimers Dis. 2025 Apr 1:13872877251329394. doi: 10.1177/13872877251329394.
     PubMed     Abstract available
     
     
     
251. WANG Y, Wu Z, Zheng Y, Wang H, et al
     Unraveling the genetic underpinnings of mitochondrial traits and associated circulating inflammatory proteins in Alzheimer's disease: Mitochondrial HtrA2-T cell CD5 negative axis.
     J Alzheimers Dis. 2025 Apr 1:13872877251329517. doi: 10.1177/13872877251329517.
     PubMed     Abstract available
     
     
     
252. ASADA T, Kakuma T, Tanaka M, Araki W, et al
     A statistical method for predicting amyloid-beta deposits from severity, extend, and ratio indices of the (99m)Tc-ECD SPECT.
     J Alzheimers Dis. 2025;104:1281-1289.
     PubMed     Abstract available
     
     
     
253. WANG J, Wang DZ, Li BH, Yang S, et al
     Elevated circulating cathepsin S levels are associated with cognitive decline and neurodegeneration in a cohort of patients reporting memory complaints.
     J Alzheimers Dis. 2025;104:1147-1153.
     PubMed     Abstract available
     
     
     
254. BECKER C, Herschung L, Gomm W, Haenisch B, et al
     Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016).
     J Alzheimers Dis. 2025;104:698-708.
     PubMed     Abstract available
     
     
     
255. XU S, Fan Y, Mao C, Hu Z, et al
     Multimodal magnetic resonance imaging analysis of early mild cognitive impairment.
     J Alzheimers Dis. 2025;104:1013-1027.
     PubMed     Abstract available
     
     
     
256. FURUYA Y, Sato K, Niimi Y, Ihara R, et al
     Cognitive function instrument-based anosognosia to predict amyloid status.
     J Alzheimers Dis. 2025;104:995-1000.
     PubMed     Abstract available
     
     
     March 2025
257. GONG C, Song W, Zhu Z, Yang D, et al
     APOE epsilon4 influences the dynamic functional connectivity variability and cognitive performance in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 28:13872877251322687. doi: 10.1177/13872877251322687.
     PubMed     Abstract available
     
     
     
258. VANNINEN A, Erkkila L, Kokkola T, Selander T, et al
     Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.
     J Alzheimers Dis. 2025 Mar 28:13872877251329081. doi: 10.1177/13872877251329081.
     PubMed     Abstract available
     
     
     
259. BELFORT T, Nogueira ML, Gaigher J, Rangel R, et al
     Comparing patterns of impairment in social cognition between young-onset and late-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 28:13872877251323046. doi: 10.1177/13872877251323046.
     PubMed     Abstract available
     
     
     
260. RUAN T, Ling Y, Wu C, Niu Y, et al
     Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 28:13872877251322955. doi: 10.1177/13872877251322955.
     PubMed     Abstract available
     
     
     
261. SHEN Y, Nie Q, Xiang W, Chen S, et al
     The relationship between Alzheimer's disease and intracerebral hemorrhage based on Mendelian randomization.
     J Alzheimers Dis. 2025 Mar 28:13872877251323294. doi: 10.1177/13872877251323294.
     PubMed     Abstract available
     
     
     
262. XUE RJ, Gao PY, Chen YM, Liu Y, et al
     Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.
     J Alzheimers Dis. 2025 Mar 26:13872877251322808. doi: 10.1177/13872877251322808.
     PubMed     Abstract available
     
     
     
263. WANG S, Luo G, Sun G, Zhang M, et al
     A polymorphism in the BIN1 gene influences its expression and is associated with the risk of Alzheimer's disease: An integrated analysis.
     J Alzheimers Dis. 2025 Mar 26:13872877251326273. doi: 10.1177/13872877251326273.
     PubMed     Abstract available
     
     
     
264. HOWARD KA, Massimo LM, Witrick B, Zhang L, et al
     Investigation of risk of Alzheimer's disease diagnosis and survival based on variation to life experiences used to operationalize cognitive reserve.
     J Alzheimers Dis. 2025 Mar 26:13872877251326818. doi: 10.1177/13872877251326818.
     PubMed     Abstract available
     
     
     
265. ROBERTS H, Fang Y, Quinn K, Hill T, et al
     Lifespan of male and female APP/PS1 and APP(NL-F/NL-F) mouse models of Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 26:13872877251325878. doi: 10.1177/13872877251325878.
     PubMed     Abstract available
     
     
     
266. JEONG S, Lin L, Leone AP, Hsu YH, et al
     Type 2 diabetes and late-onset Alzheimer's disease and related dementia: A longitudinal cohort study integrating polygenic risk score.
     J Alzheimers Dis. 2025 Mar 25:13872877251326107. doi: 10.1177/13872877251326107.
     PubMed     Abstract available
     
     
     
267. SCHAEFER SY, Reed AM, Duff K
     Validating a brief performance-based measure of cognition and daily functioning in amnestic mild cognitive impairment and mild Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 25:13872877251320379. doi: 10.1177/13872877251320379.
     PubMed     Abstract available
     
     
     
268. SLADE B, Williams B, Engelbrecht R, Ciorciari J, et al
     Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms.
     J Alzheimers Dis. 2025 Mar 24:13872877251327762. doi: 10.1177/13872877251327762.
     PubMed     Abstract available
     
     
     
269. DE RIJKE TJ, Vasseur D, van der Flier WM, Minkman MM, et al
     Exploring interdisciplinary perspectives on the implementation of personalized medicine and patient-orchestrated care in Alzheimer's disease: A qualitative study within the ABOARD research project.
     J Alzheimers Dis. 2025 Mar 21:13872877251326166. doi: 10.1177/13872877251326166.
     PubMed     Abstract available
     
     
     
270. SORDU P, Alaylioglu M, Samanci B, Bulu E, et al
     Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.
     J Alzheimers Dis. 2025 Mar 21:13872877251329540. doi: 10.1177/13872877251329540.
     PubMed     Abstract available
     
     
     
271. KRAAKE S, Luppa M, Saur D, Dietzel J, et al
     Social functioning in individuals with Alzheimer's disease and the situation of caregivers.
     J Alzheimers Dis. 2025 Mar 21:13872877251326029. doi: 10.1177/13872877251326029.
     PubMed     Abstract available
     
     
     
272. WILLIAMS JP, Zhu Y, Singh RK, Beyene K, et al
     The effect of anti-seizure medications on Alzheimer's disease (AD) risk and AD-related symptoms: A scoping review.
     J Alzheimers Dis. 2025 Mar 21:13872877251324663. doi: 10.1177/13872877251324663.
     PubMed     Abstract available
     
     
     
273. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Marin-Cabanas AM, et al
     TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers.
     J Alzheimers Dis. 2025 Mar 21:13872877251325759. doi: 10.1177/13872877251325759.
     PubMed     Abstract available
     
     
     
274. MACIVER MB, Pearce RA
     Reduced GABA(A, slow) synaptic inhibition in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 21:13872877251328940. doi: 10.1177/13872877251328940.
     PubMed     Abstract available
     
     
     
275. YANG B, Teymur A, Tang C, Wu T, et al
     V-set and immunoglobulin domain containing 4 as a potential predictor of Alzheimer's disease and advanced aging.
     J Alzheimers Dis. 2025 Mar 21:13872877251329463. doi: 10.1177/13872877251329463.
     PubMed     Abstract available
     
     
     
276. RICHTER N, Breidenbach L, Schmieschek MH, Heiss WD, et al
     Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes.
     J Alzheimers Dis. 2025 Mar 21:13872877251324080. doi: 10.1177/13872877251324080.
     PubMed     Abstract available
     
     
     
277. LI F, Zheng M, Jia J
     Validate association of gene loci and establish genetic risk prediction models for late-onset Alzheimer's disease in Chinese populations.
     J Alzheimers Dis. 2025 Mar 21:13872877251326283. doi: 10.1177/13872877251326283.
     PubMed     Abstract available
     
     
     
278. XU X, Mo X, Zhang W, Liu D, et al
     Local and distant atrophy mediate the relationship between tau pathology and cognition in temporoparietal region in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 21:13872877251322539. doi: 10.1177/13872877251322539.
     PubMed     Abstract available
     
     
     
279. ABDULLAH L, Zhou Z, Hall J, Petersen M, et al
     Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.
     J Alzheimers Dis. 2025 Mar 21:13872877251322966. doi: 10.1177/13872877251322966.
     PubMed     Abstract available
     
     
     
280. VASILEVA-METODIEV SZ, Spargo D, Klein EG, Quevenco FC, et al
     Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey.
     J Alzheimers Dis. 2025 Mar 20:13872877251322978. doi: 10.1177/13872877251322978.
     PubMed     Abstract available
     
     
     
281. AYAZ G, Sordu P, Kucuksezer UC, Hanagasi H, et al
     Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 20:13872877251326204. doi: 10.1177/13872877251326204.
     PubMed     Abstract available
     
     
     
282. HU D, Chen M, Li X, Daley S, et al
     ApoE epsilon4-dependent Alteration of CXCR3 (+) CD127(+) CD4(+) T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 20:13872877251320123. doi: 10.1177/13872877251320123.
     PubMed     Abstract available
     
     
     
283. KATONOVA A, Andel R, Jurasova V, Veverova K, et al
     Associations of KLOTHO-VS heterozygosity and alpha-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkers.
     J Alzheimers Dis. 2025 Mar 20:13872877251326199. doi: 10.1177/13872877251326199.
     PubMed     Abstract available
     
     
     
284. FUSEYA K, Mimura Y, Nakajima S, Mimura M, et al
     A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 20:13872877251325887. doi: 10.1177/13872877251325887.
     PubMed     Abstract available
     
     
     
285. WIMO A, Handels R, Blennow K, Kirsebom KB, et al
     Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.
     J Alzheimers Dis. 2025 Mar 20:13872877251323231. doi: 10.1177/13872877251323231.
     PubMed     Abstract available
     
     
     
286. ALAMI M, Zerif E, Khalil A, Hajji N, et al
     Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Abeta(1-42)-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 20:13872877251329474. doi: 10.1177/13872877251329474.
     PubMed     Abstract available
     
     
     
287. GUI S, Zeng F, Wu Z, Nonaka S, et al
     Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3beta-dependent synaptic defects and cause cognitive decline in a low-amyloid-beta-concentration environment in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 20:13872877251326879. doi: 10.1177/13872877251326879.
     PubMed     Abstract available
     
     
     
288. LALIVE HM, Griffa A, Pini L, Rouaud O, et al
     Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis.
     J Alzheimers Dis. 2025 Mar 20:13872877251328953. doi: 10.1177/13872877251328953.
     PubMed     Abstract available
     
     
     
289. MEWS MA, Naj AC, Griswold AJ, Below JE, et al
     Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 20:13872877251326288. doi: 10.1177/13872877251326288.
     PubMed     Abstract available
     
     
     
290. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
     Cerebrospinal fluid LMO4 as a synaptic biomarker linked to Alzheimer's disease pathology and cognitive decline.
     J Alzheimers Dis. 2025 Mar 19:13872877251326286. doi: 10.1177/13872877251326286.
     PubMed     Abstract available
     
     
     
291. LEI S, Liu Y
     Identifying microglia-derived NFKBIA as a potential contributor to the pathogenesis of Alzheimer's disease and age-related macular degeneration.
     J Alzheimers Dis. 2025 Mar 19:13872877251326267. doi: 10.1177/13872877251326267.
     PubMed     Abstract available
     
     
     
292. SIMMATIS LE, Russo EE, Steininger T, Riddell H, et al
     EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.
     J Alzheimers Dis. 2025 Mar 18:13872877251327754. doi: 10.1177/13872877251327754.
     PubMed     Abstract available
     
     
     
293. DZIANOK P, Wojciechowski J, Wolak T, Kublik E, et al
     Alzheimer's disease-like features in resting state EEG/fMRI of cognitively intact and healthy middle-aged APOE/PICALM risk carriers.
     J Alzheimers Dis. 2025 Mar 17:13872877251317489. doi: 10.1177/13872877251317489.
     PubMed     Abstract available
     
     
     
294. ZHANG Z, Cui L, Huang L, Guan YH, et al
     Development and validation of the Chinese Naming Test (CNT): Diagnostic efficacy and correlation with Alzheimer's disease biomarkers.
     J Alzheimers Dis. 2025 Mar 17:13872877251324100. doi: 10.1177/13872877251324100.
     PubMed     Abstract available
     
     
     
295. LU Y, Li D, Yu Y, Wang Q, et al
     Cerebrospinal fluid VGF is associated with the onset and progression of Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 17:13872877251323002. doi: 10.1177/13872877251323002.
     PubMed     Abstract available
     
     
     
296. ZEISS CJ, Huttner A, Nairn AC, Arnsten A, et al
     The neuropathologic basis for translational biomarker development in the macaque model of late-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 17:13872877251323787. doi: 10.1177/13872877251323787.
     PubMed     Abstract available
     
     
     
297. YANG Y, Li Y, Chen Y
     Changes in transcriptional regulation in the temporal lobe in patients with Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 17:13872877251322536. doi: 10.1177/13872877251322536.
     PubMed     Abstract available
     
     
     
298. ZHANG C, Tai Y, Kong M, Jia P, et al
     Synergistic associations of amyloid-beta and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 17:13872877251322196. doi: 10.1177/13872877251322196.
     PubMed     Abstract available
     
     
     
299. LIN YJ, Liu Y, Sheng ZH, Fu Y, et al
     The associations of cerebrospinal fluid ApoE and C1q with Alzheimer's disease biomarkers.
     J Alzheimers Dis. 2025 Mar 17:13872877251320419. doi: 10.1177/13872877251320419.
     PubMed     Abstract available
     
     
     
300. ISHIKAWA-TAKATA K, Fujiwara K, Tanaka T, Nakamura K, et al
     Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people.
     J Alzheimers Dis. 2025 Mar 14:13872877251319535. doi: 10.1177/13872877251319535.
     PubMed     Abstract available
     
     
     
301. PIERCE ME, Logue M, Sherva R, Miller M, et al
     Association of Alzheimer's disease genetic risk with age-dependent changes in plasma amyloid-beta(42:40) in Veterans.
     J Alzheimers Dis. 2025 Mar 14:13872877251321183. doi: 10.1177/13872877251321183.
     PubMed     Abstract available
     
     
     
302. WANG D, Scalici A, Wang Y, Lin H, et al
     Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project.
     J Alzheimers Dis. 2025 Mar 14:13872877251320375. doi: 10.1177/13872877251320375.
     PubMed     Abstract available
     
     
     
303. TREMBLAY C, Shakir N, Zhang N, Adler CH, et al
     Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies.
     J Alzheimers Dis. 2025 Mar 14:13872877251320670. doi: 10.1177/13872877251320670.
     PubMed     Abstract available
     
     
     
304. ALVES L, Hashiguchi D, Loss CM, van Praag H, et al
     Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies.
     J Alzheimers Dis. 2025 Mar 13:13872877251321118. doi: 10.1177/13872877251321118.
     PubMed     Abstract available
     
     
     
305. BARRETT-YOUNG A, Reuben A, Caspi A, Cheyne K, et al
     Measures of retinal health successfully capture risk for Alzheimer's disease and related dementias at midlife.
     J Alzheimers Dis. 2025 Mar 3:13872877251321114. doi: 10.1177/13872877251321114.
     PubMed     Abstract available
     
     
     
306. SHARDELL M, Chen C
     Genetic geroscience and Alzheimer's disease: The pleiotropy is the point!
     J Alzheimers Dis. 2025 Mar 3:13872877251321182. doi: 10.1177/13872877251321182.
     PubMed     Abstract available
     
     
     
307. ZEGARRA-VALDIVIA JA, Shany-Ur T, Rijpma MG, Callahan P, et al
     Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration.
     J Alzheimers Dis. 2025 Mar 3:13872877251317683. doi: 10.1177/13872877251317683.
     PubMed     Abstract available
     
     
     
308. MORITO T, Watamura N, Sasaguri H, Tomita T, et al
     Experimental basis for generating nonhuman primate models of frontotemporal dementia and Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 2:13872877251321116. doi: 10.1177/13872877251321116.
     PubMed     Abstract available
     
     
     
309. WANG SY, Huang ZH, Duan R, Fu XX, et al
     IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease.
     J Alzheimers Dis. 2025 Mar 2:13872877251320418. doi: 10.1177/13872877251320418.
     PubMed     Abstract available
     
     
     
310. YANG J, Ding H, Li Y, Ang TFA, et al
     Association of mid-age Life's Essential 8 score with digital cognitive performance and incident Alzheimer's disease: The Framingham Heart Study.
     J Alzheimers Dis. 2025 Mar 2:13872877251317734. doi: 10.1177/13872877251317734.
     PubMed     Abstract available
     
     
     
311. BOHN L, Zheng Y, McFall GP, Andrew MK, et al
     Frailty in motion: Amnestic mild cognitive impairment and Alzheimer's disease cohorts display heterogeneity in multimorbidity classification and longitudinal transitions.
     J Alzheimers Dis. 2025 Mar 2:13872877251319547. doi: 10.1177/13872877251319547.
     PubMed     Abstract available
     
     
     
312. KIM JW, Byun MS, Yi D, Jung JH, et al
     Daily fluid intake and brain amyloid deposition: A cohort study.
     J Alzheimers Dis. 2025;104:138-149.
     PubMed     Abstract available
     
     
     
313. YANG Q, Yang H, Long W, Zuo S, et al
     Rapid cognitive assessment: Accuracy and discriminant validity of Mini-Cog and process-based Clock Drawing Test.
     J Alzheimers Dis. 2025;104:200-208.
     PubMed     Abstract available
     
     
     
314. SALMAN Y, Huyghe L, Quenon L, Ghysens O, et al
     Autopsy-proven patient with corticobasal degeneration presenting with visuo-constructive disorders as initial symptoms: How advanced MRI sequences can help clinical practice.
     J Alzheimers Dis. 2025;104:158-172.
     PubMed     Abstract available
     
     
     
315. PARK SA, An YS, Park YJ, Lee JY, et al
     Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers.
     J Alzheimers Dis. 2025;104:232-244.
     PubMed     Abstract available
     
     
     
316. KUMAR WS, Bhutare SR, Sinha N, Issac TG, et al
     Bayesian network modeling of statistical dependency within cognitive domains and clinical dementia severity ratings for Western and Indian cohorts.
     J Alzheimers Dis. 2025;104:221-231.
     PubMed     Abstract available
     
     
     
317. LIGUORI C
     Obstructive sleep apnea is a common diagnosis in patients admitted at the memory clinic: Please screen for it!
     J Alzheimers Dis. 2025;104:40-42.
     PubMed     Abstract available
     
     
     
318. D'ANTONIO F, Vivacqua G, Serrentino M, Nalepa M, et al
     Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies.
     J Alzheimers Dis. 2025;104:452-462.
     PubMed     Abstract available
     
     
     
319. HAJJAR SH, Alsaad SM, AlFouzan MA, Rohaiem SN, et al
     Dementia prevalence within the Kingdom of Saudi Arabia National Guard Health System (2015-2023): An exploratory epidemiological study.
     J Alzheimers Dis. 2025;104:488-497.
     PubMed     Abstract available
     
     
     
320. ZHU S, Ni J, Long S, Teng Y, et al
     Androgen deprivation therapy and dementia risk: An updated and dose-response meta-analysis.
     J Alzheimers Dis. 2025;104:547-562.
     PubMed     Abstract available
     
     
     
321. JANG JW, Lee SH, Kim T, Lee E, et al
     Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort.
     J Alzheimers Dis. 2025;104:364-373.
     PubMed     Abstract available
     
     
     
322. MAYAN I, Roth H, Ghosh D, Whitson HE, et al
     Genetic and biomarker disclosure process in a memory and aging study.
     J Alzheimers Dis. 2025;104:312-318.
     PubMed     Abstract available
     
     
     February 2025
323. CHRISTIMANN G, Rocha G, Sattler JAG
     Bioactive compounds and dietary patterns in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 26:13872877251319048. doi: 10.1177/13872877251319048.
     PubMed     Abstract available
     
     
     
324. RENTOUMI V, Vassiliou E, Pittaras N, Demiraj A, et al
     Linguistic cues for automatic assessment of Alzheimer's disease across languages.
     J Alzheimers Dis. 2025 Feb 25:13872877251319401. doi: 10.1177/13872877251319401.
     PubMed     Abstract available
     
     
     
325. BRADEN-KUHLE PN, Lacy VA, Brice KN, Bertrand ME, et al
     A Mediterranean-style diet protects against cognitive and behavioral deficits, adiposity, and Alzheimer's disease-related markers, compared to a macronutrient-matched typical American diet in C57BL/6J mice.
     J Alzheimers Dis. 2025 Feb 25:13872877251319467. doi: 10.1177/13872877251319467.
     PubMed     Abstract available
     
     
     
326. STOJANOVIC M, Millar PR, McKay NS, Aschenbrenner AJ, et al
     The associations between attentional control, episodic memory, and Alzheimer's disease biomarkers of tau and neurodegeneration.
     J Alzheimers Dis. 2025 Feb 24:13872877251316801. doi: 10.1177/13872877251316801.
     PubMed     Abstract available
     
     
     
327. ALHARBI AA, Alatwi HE, Albulaihe H, Algarzae NK, et al
     Alzheimer's disease in the Kingdom of Saudi Arabia: Current perspectives and genetic insights.
     J Alzheimers Dis. 2025 Feb 24:13872877251316122. doi: 10.1177/13872877251316122.
     PubMed     Abstract available
     
     
     
328. RANDLOVA K, Pazitny P, Kandilaki D
     Institutionalization of persons with Alzheimer's disease in the Czech and Slovak Republics.
     J Alzheimers Dis. 2025 Feb 24:13872877251317987. doi: 10.1177/13872877251317987.
     PubMed     Abstract available
     
     
     
329. WANG H, Qin N, Maimaitiaili D, Wu J, et al
     Transcranial electrical stimulation as a therapeutic strategy for Alzheimer's disease: Current uses and challenges.
     J Alzheimers Dis. 2025 Feb 24:13872877251315777. doi: 10.1177/13872877251315777.
     PubMed     Abstract available
     
     
     
330. GAO X, Sun Z, Hu J, Li Y, et al
     Identification of the enzymatic cleavage relationship between anti-aging protein alpha-Klotho and Alzheimer's disease biomarker BACE1.
     J Alzheimers Dis. 2025 Feb 24:13872877251317730. doi: 10.1177/13872877251317730.
     PubMed     Abstract available
     
     
     
331. LIN SW, Hsu YH, Yang JJ, Tu MC, et al
     A higher vertebrobasilar pulsatility index is associated with lower parietal perfusion in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 24:13872877251314140. doi: 10.1177/13872877251314140.
     PubMed     Abstract available
     
     
     
332. DONG YT, Luo X, Zhang LL, Gong YM, et al
     Genetic colocalization of cathepsins H, D, and L1 with Alzheimer's disease: Implications for biomarker and therapeutic target discovery.
     J Alzheimers Dis. 2025 Feb 21:13872877251314058. doi: 10.1177/13872877251314058.
     PubMed     Abstract available
     
     
     
333. FIALA M, Hammock BD, Hwang SH, Whitelegge J, et al
     Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-beta clearance underlying vascular complications of Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 17:13872877241305965. doi: 10.1177/13872877241305965.
     PubMed     Abstract available
     
     
     
334. WEISS JN, Eber D
     Earlier diagnosis of Alzheimer's disease by dynamic light scattering spectroscopy.
     J Alzheimers Dis. 2025 Feb 16:13872877251319352. doi: 10.1177/13872877251319352.
     PubMed     Abstract available
     
     
     
335. CHEN ZQ, Wang MT, Tan CR, Huang S, et al
     Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251317659. doi: 10.1177/13872877251317659.
     PubMed     Abstract available
     
     
     
336. MICHELUTTI M, Urso D, Tafuri B, Gnoni V, et al
     Structural covariance network patterns linked to neuropsychiatric symptoms in biologically defined Alzheimer's disease: Insights from the mild behavioral impairment checklist.
     J Alzheimers Dis. 2025 Feb 16:13872877251316794. doi: 10.1177/13872877251316794.
     PubMed     Abstract available
     
     
     
337. CLAUS JJ, Rosbergen MT, Roshchupkin GV, Ikram MA, et al
     Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study.
     J Alzheimers Dis. 2025 Feb 16:13872877251315044. doi: 10.1177/13872877251315044.
     PubMed     Abstract available
     
     
     
338. KASAHARA H, Ikeda M, Makioka K, Nakamura T, et al
     White matter lesions rather than amyloid-beta burden are associated with cognitive decline in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251316516. doi: 10.1177/13872877251316516.
     PubMed     Abstract available
     
     
     
339. PAN N, Liu S, Ge X, Zheng Y, et al
     Association of hippocampal atrophy with tau pathology of temporal regions in preclinical Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251314785. doi: 10.1177/13872877251314785.
     PubMed     Abstract available
     
     
     
340. XAVIER C, Pinto N
     Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics.
     J Alzheimers Dis. 2025 Feb 16:13872877251317543. doi: 10.1177/13872877251317543.
     PubMed     Abstract available
     
     
     
341. ONIFADE IA, Umar HI, Aborode AT, Awaji AA, et al
     In silico study of selected alkaloids as dual inhibitors of beta- and gamma-secretases for Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877241313049. doi: 10.1177/13872877241313049.
     PubMed     Abstract available
     
     
     
342. NETSYK O, Korol SV, Li JP, Birnir B, et al
     GABA-activated slow spontaneous inhibitory postsynaptic currents are decreased in dorsal hippocampal dentate gyrus granule cells in an aged mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877251317608. doi: 10.1177/13872877251317608.
     PubMed     Abstract available
     
     
     
343. SHENG ZH, Liu JY, Ma JY, Mi YC, et al
     Frailty increases the risk of Alzheimer's disease in non-demented individuals: A longitudinal cohort study.
     J Alzheimers Dis. 2025 Feb 16:13872877241309081. doi: 10.1177/13872877241309081.
     PubMed     Abstract available
     
     
     
344. CAI C, Kato T, Arahata Y, Takeda A, et al
     Altered functional connectivity between primary visual cortex and cerebellum in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 16:13872877241303849. doi: 10.1177/13872877241303849.
     PubMed     Abstract available
     
     
     
345. WILLIAMS LA, Terhorst L, Williams IC, Skidmore E, et al
     Perceived risk of Alzheimer's disease: Insights into the Black and African American male perspective.
     J Alzheimers Dis. 2025 Feb 9:13872877251317151. doi: 10.1177/13872877251317151.
     PubMed     Abstract available
     
     
     
346. WEN C, Gan JH, Liu S, Lu H, et al
     Enlarged perivascular spaces correlate with blood-brain barrier leakage and cognitive impairment in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 9:13872877251317220. doi: 10.1177/13872877251317220.
     PubMed     Abstract available
     
     
     
347. SILVA RPDS, Barbosa BJAP
     Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward.
     J Alzheimers Dis. 2025 Feb 9:13872877251316572. doi: 10.1177/13872877251316572.
     PubMed     Abstract available
     
     
     
348. TAWEEPHOL T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, et al
     Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand.
     J Alzheimers Dis. 2025 Feb 9:13872877251316546. doi: 10.1177/13872877251316546.
     PubMed     Abstract available
     
     
     
349. LU C, Zhou J
     Analysis of the causal relationship between five chosen factors and early-onset Alzheimer's disease: A Mendelian randomization study.
     J Alzheimers Dis. 2025 Feb 9:13872877241310248. doi: 10.1177/13872877241310248.
     PubMed     Abstract available
     
     
     
350. NDUKWE K, Serrano PA, Rockwell P, Xie L, et al
     Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.
     J Alzheimers Dis. 2025 Feb 9:13872877251314777. doi: 10.1177/13872877251314777.
     PubMed     Abstract available
     
     
     
351. TIAN Q, Dong Q, Su Z, Liu Y, et al
     Association of body weight and serum uric acid with Alzheimer's disease biomarkers and cognitive impairment.
     J Alzheimers Dis. 2025 Feb 9:13872877251315011. doi: 10.1177/13872877251315011.
     PubMed     Abstract available
     
     
     
352. PRIGATANO GP, Braga LW, McElvogue M, Coddaire K, et al
     Motor correlates of finger tapping variability in subjective memory complaints, mild cognitive impairment and probable Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 7:13872877241312984. doi: 10.1177/13872877241312984.
     PubMed     Abstract available
     
     
     
353. GUO R, Li D, Li F, Ji L, et al
     Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study.
     J Alzheimers Dis. 2025 Feb 5:13872877251313819. doi: 10.1177/13872877251313819.
     PubMed     Abstract available
     
     
     
354. RAMIREZ-GOMEZ J, Dalal S, Devara D, Sharma B, et al
     MicroRNA-based recent research developments in Alzheimer's disease.
     J Alzheimers Dis. 2025 Feb 2:13872877241313397. doi: 10.1177/13872877241313397.
     PubMed     Abstract available
     
     
     
355. KHALED M, Al-Jamal H, Matar D, Ibrahim A, et al
     Unveiling the link between APOE epsilon4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control study.
     J Alzheimers Dis. 2025 Feb 2:13872877241307307. doi: 10.1177/13872877241307307.
     PubMed     Abstract available
     
     
     
356. YANG X, Wang J, Jia X, Yang Y, et al
     Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities.
     J Alzheimers Dis. 2025 Feb 2:13872877241313223. doi: 10.1177/13872877241313223.
     PubMed     Abstract available
     
     
     
357. S M, Roy D, Menon AJ, G S, et al
     Exploring predementia: Understanding the characteristics of subjective cognitive decline plus from India.
     J Alzheimers Dis. 2025;103:966-973.
     PubMed     Abstract available
     
     
     
358. GE W, Yan Y, Hu Y, Lin S, et al
     Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data.
     J Alzheimers Dis. 2025;103:844-855.
     PubMed     Abstract available
     
     
     
359. LI D, An B, Men L, Glittenberg M, et al
     The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC).
     J Alzheimers Dis. 2025;103:724-734.
     PubMed     Abstract available
     
     
     
360. WANG Y, Zhu L, He K, Cui L, et al
     Urinary formic acid is associated with cerebral amyloid deposition and glucose metabolism in memory clinic patients.
     J Alzheimers Dis. 2025;103:1102-1111.
     PubMed     Abstract available
     
     
     January 2025
361. ZHANG E, Dai F, Tao L, Chen Y, et al
     Immune cells: Mediators in the metabolites and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 29:13872877241313140. doi: 10.1177/13872877241313140.
     PubMed     Abstract available
     
     
     
362. ZHANG L, An H, Zhen R, Zhang T, et al
     Di Huang Yi Zhi Fang improves cognitive function in APP/PS1 mice by inducing neuronal mitochondrial autophagy through the PINK1-parkin pathway.
     J Alzheimers Dis. 2025 Jan 28:13872877241299832. doi: 10.1177/13872877241299832.
     PubMed     Abstract available
     
     
     
363. ROVETA F, Rubino E, Marcinno A, Grassini A, et al
     Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.
     J Alzheimers Dis. 2025 Jan 26:13872877241313145. doi: 10.1177/13872877241313145.
     PubMed     Abstract available
     
     
     
364. ASHFORD JW
     The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 26:13872877241313398. doi: 10.1177/13872877241313398.
     PubMed     Abstract available
     
     
     
365. SIRIWARDHANA C, Carrazana E, Liow K
     Survival disparities among Alzheimer's disease patients in Hawaii.
     J Alzheimers Dis. 2025 Jan 26:13872877251314144. doi: 10.1177/13872877251314144.
     PubMed     Abstract available
     
     
     
366. GALVIN JE, Kleiman MJ, Estes PW, Harris HM, et al
     Cognivue Clarity((R)) characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study.
     J Alzheimers Dis. 2025 Jan 26:13872877251314117. doi: 10.1177/13872877251314117.
     PubMed     Abstract available
     
     
     
367. GILLMAN A, Bourgeat P, Cox T, Villemagne VL, et al
     Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.
     J Alzheimers Dis. 2025 Jan 26:13872877241313063. doi: 10.1177/13872877241313063.
     PubMed     Abstract available
     
     
     
368. TOLEA MI, Rosenfeld A, Roy SV, Besser LM, et al
     Gait, balance, and physical performance as markers of early Alzheimer's disease and related dementia risk.
     J Alzheimers Dis. 2025 Jan 26:13872877241313144. doi: 10.1177/13872877241313144.
     PubMed     Abstract available
     
     
     
369. SHAO J, Youngblood H, Yang L
     Targeting SPI1 to mitigate amyloid-beta pathology in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 26:13872877251316593. doi: 10.1177/13872877251316593.
     PubMed     Abstract available
     
     
     
370. CROOKE PS 3RD, Tossberg JT, Aune TM
     Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.
     J Alzheimers Dis. 2025 Jan 26:13872877241313054. doi: 10.1177/13872877241313054.
     PubMed     Abstract available
     
     
     
371. PETKUS AJ, Sonti AN, Montoya L, Rowe B, et al
     Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 26:13872877241312934. doi: 10.1177/13872877241312934.
     PubMed     Abstract available
     
     
     
372. FU XX, Wei B, Huang ZH, Duan R, et al
     Modulation of mitochondrial functions contributes to the protection of lamotrigine against Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 21:13872877251314847. doi: 10.1177/13872877251314847.
     PubMed     Abstract available
     
     
     
373. YANG H, Ning Y, Chen M, Jia J, et al
     SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: A Mendelian randomization study.
     J Alzheimers Dis. 2025 Jan 21:13872877241309674. doi: 10.1177/13872877241309674.
     PubMed     Abstract available
     
     
     
374. WANG Z, Liang Q, Lin Z, Li H, et al
     Potential role of formononetin as a novel natural agent in Alzheimer's disease and osteoporosis comorbidity.
     J Alzheimers Dis. 2025 Jan 19:13872877241299104. doi: 10.1177/13872877241299104.
     PubMed     Abstract available
     
     
     
375. KJAERGAARD D, Simonsen AH, Waldemar G, Nielsen TR, et al
     Ethnic and racial influences on blood biomarkers for Alzheimer's disease: A systematic review.
     J Alzheimers Dis. 2025 Jan 15:13872877241299047. doi: 10.1177/13872877241299047.
     PubMed     Abstract available
     
     
     
376. DAVID S, Costa AS, Hohenfeld C, Romanzetti S, et al
     Modulating effects of fitness and physical activity on Alzheimer's disease: Implications from a six-month randomized controlled sports intervention.
     J Alzheimers Dis. 2025 Jan 15:13872877241303764. doi: 10.1177/13872877241303764.
     PubMed     Abstract available
     
     
     
377. TAUFEEQ M, Choudhury A, Hussain A, Alajmi MF, et al
     Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 15:13872877241309592. doi: 10.1177/13872877241309592.
     PubMed     Abstract available
     
     
     
378. YANG W, Yu W, Lv Y
     Neuroprotective effects of chitinase-1 and calcitonin gene-related peptide on Alzheimer's disease by promoting lysosomal function.
     J Alzheimers Dis. 2025 Jan 15:13872877241307257. doi: 10.1177/13872877241307257.
     PubMed     Abstract available
     
     
     
379. LI Y, Sanjay AB, Manchella M, Mishra A, et al
     Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 12:13872877241307321. doi: 10.1177/13872877241307321.
     PubMed     Abstract available
     
     
     
380. RUIZ-URIBE NE, Manser P, Butcher B, Li Y, et al
     Cross-sectional and prognostic associations of baseline [(18)F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 12:13872877241302497. doi: 10.1177/13872877241302497.
     PubMed     Abstract available
     
     
     
381. XING H, Kant S, Kanuparthy M, Harris D, et al
     Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241309120. doi: 10.1177/13872877241309120.
     PubMed     Abstract available
     
     
     
382. HAN X, Li Y, Wang J, Liu X, et al
     Associations between lifelong cognitive reserve, Alzheimer's disease-related plasma biomarkers, and cognitive function in dementia-free older adults: A population-based study.
     J Alzheimers Dis. 2025 Jan 10:13872877241306448. doi: 10.1177/13872877241306448.
     PubMed     Abstract available
     
     
     
383. XU F, Shi J
     Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241307404. doi: 10.1177/13872877241307404.
     PubMed     Abstract available
     
     
     
384. SHAH J, Krell-Roesch J, Forzani E, Knopman DS, et al
     Predicting cognitive decline from neuropsychiatric symptoms and Alzheimer's disease biomarkers: A machine learning approach to a population-based data.
     J Alzheimers Dis. 2025 Jan 10:13872877241306654. doi: 10.1177/13872877241306654.
     PubMed     Abstract available
     
     
     
385. WAN T, Wang C
     SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241307337. doi: 10.1177/13872877241307337.
     PubMed     Abstract available
     
     
     
386. MATSUNAGA M, Tanihara S, He Y, Yatsuya H, et al
     Sex-specific association of comorbid heart failure on mortality after Alzheimer's disease diagnosis in older adults aged 75 years and above: A health insurance claims data analysis in Japan.
     J Alzheimers Dis. 2025 Jan 10:13872877241305813. doi: 10.1177/13872877241305813.
     PubMed     Abstract available
     
     
     
387. DA SILVA PINTO GM, de Souza Crepalde LO, Scalli ACAM, de Oliveira MPB, et al
     Body composition differences in older adults with and without Alzheimer's disease: A systematic review and meta-analysis of observational studies.
     J Alzheimers Dis. 2025 Jan 10:13872877241304603. doi: 10.1177/13872877241304603.
     PubMed     Abstract available
     
     
     
388. ALGHAMDI A, de Vos S, Bos JH, Schuiling-Veninga CC, et al
     A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 10:13872877241305799. doi: 10.1177/13872877241305799.
     PubMed     Abstract available
     
     
     
389. LI S, Wang Y, Liang X, Li Y, et al
     Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 9:13872877241307403. doi: 10.1177/13872877241307403.
     PubMed     Abstract available
     
     
     
390. BARKER-HALISKI M
     Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 9:13872877241305740. doi: 10.1177/13872877241305740.
     PubMed     Abstract available
     
     
     
391. SU S, Huang R, Liu Y
     The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis.
     J Alzheimers Dis. 2025 Jan 9:13872877241298303. doi: 10.1177/13872877241298303.
     PubMed     Abstract available
     
     
     
392. WANG X, Chen L, Li W, He Z, et al
     Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect.
     J Alzheimers Dis. 2025 Jan 8:13872877241304673. doi: 10.1177/13872877241304673.
     PubMed     Abstract available
     
     
     
393. GRAU-JURADO P, Mostafaei S, Xu H, Mo M, et al
     Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.
     J Alzheimers Dis. 2025 Jan 8:13872877241307870. doi: 10.1177/13872877241307870.
     PubMed     Abstract available
     
     
     
394. GOODING DC, Van Hulle CA, Zuelsdorff M, Lewis JP, et al
     Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study.
     J Alzheimers Dis. 2025 Jan 8:13872877241307255. doi: 10.1177/13872877241307255.
     PubMed     Abstract available
     
     
     
395. WANG P, Dong YL, Li SS, Jin Y, et al
     Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer's disease.
     J Alzheimers Dis. 2025 Jan 8:13872877241305744. doi: 10.1177/13872877241305744.
     PubMed     Abstract available
     
     
     
396. MERRITT VC, Zhang R, Sherva R, Ly MT, et al
     Curation and validation of electronic medical record-based dementia diagnoses in the VA Million Veteran Program.
     J Alzheimers Dis. 2025;103:180-193.
     PubMed     Abstract available
     
     
     
397. IMPERIALE D, Atzori C, Angeloro DP, Murgioni A, et al
     Real-life reliability of plasma pTau181, Abeta(42)/Abeta(40), and pTau181/Abeta(42) measured by Lumipulse G600II in predicting cerebrospinal fluid amyloid status.
     J Alzheimers Dis. 2025;103:305-315.
     PubMed     Abstract available
     
     
     
398. ENGEL MG, Narayan S, Cui MH, Branch CA, et al
     Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.
     J Alzheimers Dis. 2025;103:113-126.
     PubMed     Abstract available
     
     
     
399. CHEN X, Lin C, He C, Li K, et al
     Icariin improves learning and memory function by enhancing HRD1-mediated ubiquitination of amyloid precursor protein in APP/PS1 mice.
     J Alzheimers Dis. 2025;103:616-626.
     PubMed     Abstract available
     
     
     
400. WITBRACHT M, Xu Y, Morgan OB, Salazar CR, et al
     Research Attitudes Questionnaire scores and retention in a recruitment registry.
     J Alzheimers Dis. 2025;103:406-418.
     PubMed     Abstract available
     
     
     
401. HEDDERICH DM, Opfer R, Kruger J, Spies L, et al
     Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database.
     J Alzheimers Dis. 2025;103:542-551.
     PubMed     Abstract available
     
     
     
402. WEINSTEIN AM, Fang F, Chang CH, Cohen A, et al
     Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.
     J Alzheimers Dis. 2025;103:570-581.
     PubMed     Abstract available
     
     
     
403. LIM YY, Mills A, Norfolk M, Rosenich E, et al
     Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults.
     J Alzheimers Dis. 2025;103:441-451.
     PubMed     Abstract available
     
     
     
404. JAHANI I, Jahani A, Delrobaei M, Khadem A, et al
     Classifying cognitive impairment based on FDG-PET and combined T1-MRI and rs-fMRI: An ADNI study.
     J Alzheimers Dis. 2025;103:452-464.
     PubMed     Abstract available
     
     
     
405. WEINSTEIN AM, Gogniat MA, Butters MA
     The importance of cognitive correlates of plasma amyloid-beta 42/40.
     J Alzheimers Dis. 2025;103:353-355.
     PubMed     Abstract available
     
     
     December 2024
406. BENNETT CG, Guttmann RP, Hackney ME, Amin R, et al
     Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease.
     J Alzheimers Dis. 2024 Dec 23:13872877241298529. doi: 10.1177/13872877241298529.
     PubMed     Abstract available
     
     
     
407. HORSTKOTTER D
     Alzheimer's disease prediction and prevention in a public health perspective: Ethical considerations and collaborations beyond the biomedical paradigm.
     J Alzheimers Dis. 2024 Dec 23:13872877241308299. doi: 10.1177/13872877241308299.
     PubMed     Abstract available
     
     
     
408. VIGNOLO J, Jacus JP, Darnaud T, Cuervo-Lombard CV, et al
     Exploratory study of French healthcare workers' experiences of anosognosia in Alzheimer's disease and related disorders.
     J Alzheimers Dis. 2024 Dec 19:13872877241307045. doi: 10.1177/13872877241307045.
     PubMed     Abstract available
     
     
     
409. BOADA M, Neve A, Das B, Wojtowicz J, et al
     Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
     J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644.
     PubMed     Abstract available
     
     
     
410. GARCIA-LLUCH G, Marseglia A, Royo LM, Albiach JP, et al
     Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
     J Alzheimers Dis. 2024 Dec 16:13872877241304995. doi: 10.1177/13872877241304995.
     PubMed     Abstract available
     
     
     
411. PLUTA R, Kocki J, Bogucki J, Bogucka-Kocka A, et al
     Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years.
     J Alzheimers Dis. 2024 Dec 16:13872877241303950. doi: 10.1177/13872877241303950.
     PubMed     Abstract available
     
     
     
412. NAZARETH CCG, Scalli ACAM, de Oliveira MPB, Gomes AFS, et al
     Differences in lean mass and sarcopenia between individuals with Alzheimer's disease and those without dementia: A systematic review and meta-analysis of observational studies.
     J Alzheimers Dis. 2024 Dec 16:13872877241299051. doi: 10.1177/13872877241299051.
     PubMed     Abstract available
     
     
     
413. LI D, Liu X, Yu J, Zhang Y, et al
     Item response theory for the color-picture version of Boston naming test in a Chinese sample with neurodegenerative diseases.
     J Alzheimers Dis. 2024 Dec 16:13872877241305820. doi: 10.1177/13872877241305820.
     PubMed     Abstract available
     
     
     
414. OKAFOR M, Yang Z, Vickers KL, Sanders K, et al
     Technology literacy and access to digital resources for remote assessment among adults enrolled in Alzheimer's disease research.
     J Alzheimers Dis. 2024 Dec 11:13872877241297496. doi: 10.1177/13872877241297496.
     PubMed     Abstract available
     
     
     
415. MAKI Y, Ubuka T, Yamane Y
     The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease.
     J Alzheimers Dis. 2024 Dec 5:13872877241301806. doi: 10.1177/13872877241301806.
     PubMed     Abstract available
     
     
     
416. SMITH ML, Wilson AD, Knebl J, Hilsabeck RC, et al
     Utilization and perceived usefulness of monitoring technology for family caregivers of people living with Alzheimer's disease and related dementias.
     J Alzheimers Dis. 2024 Dec 5:13872877241300078. doi: 10.1177/13872877241300078.
     PubMed     Abstract available
     
     
     
417. ZENG J, Gao Z, Xiong X, Hou X, et al
     The effects of two Alzheimer's disease related genes APOE and MAPT in healthy young adults: An attentional blink study.
     J Alzheimers Dis. 2024 Dec 5:13872877241299124. doi: 10.1177/13872877241299124.
     PubMed     Abstract available
     
     
     
418. ANGELOPOULOU E, Papageorgiou SG
     Telemedicine in Alzheimer's disease and other dementias: Where we are?
     J Alzheimers Dis. 2024 Dec 5:13872877241298295. doi: 10.1177/13872877241298295.
     PubMed     Abstract available
     
     
     
419. ZHANG P, Liu Y, Jin X, Hu Z, et al
     Alzheimer's disease-like pathology induced by Porphyromonas gingivalis in middle-aged mice is mediated by NLRP3 inflammasome via the microbiota-gut-brain axis.
     J Alzheimers Dis. 2024 Dec 5:13872877241302498. doi: 10.1177/13872877241302498.
     PubMed     Abstract available
     
     
     
420. XU L, Chen K, Mueller KD, Liss J, et al
     Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer's disease risk-enriched cohorts.
     J Alzheimers Dis. 2024 Dec 5:13872877241300149. doi: 10.1177/13872877241300149.
     PubMed     Abstract available
     
     
     
421. BARNES DE, Balderson BH, Shulman L, Rosenberg DE, et al
     The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction.
     J Alzheimers Dis. 2024 Dec 3:13872877241296161. doi: 10.1177/13872877241296161.
     PubMed     Abstract available
     
     
     
422. TAO M, Cui L, Du Y, Liu X, et al
     Analysis of eye movement features in patients with Alzheimer's disease based on intelligent eye movement analysis and evaluation system.
     J Alzheimers Dis. 2024 Dec 1:13872877241297416. doi: 10.1177/13872877241297416.
     PubMed     Abstract available
     
     
     
423. SHIR D, Shiner T, Bregman N
     Anti-amyloid treatments for Alzheimer's disease: A study on physicians' perspectives.
     J Alzheimers Dis. 2024;102:627-632.
     PubMed     Abstract available
     
     
     
424. CANEVELLI M, Ancidoni A, Valletta M, Toccaceli Blasi M, et al
     Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review.
     J Alzheimers Dis. 2024;102:587-596.
     PubMed     Abstract available
     
     
     
425. KISELICA AM, Atkinas KJ, Han SD, Diaz-Orueta U, et al
     Reactions of clinical neuropsychologists to the Alzheimer's Association workgroup's draft diagnostic and staging criteria for Alzheimer's disease.
     J Alzheimers Dis. 2024;102:877-884.
     PubMed     Abstract available
     
     
     
426. OLIVER A, Wildschut T, Redhead ES, Parker MO, et al
     Benefits of nostalgic landmarks for people living with Alzheimer's disease.
     J Alzheimers Dis. 2024;102:683-702.
     PubMed     Abstract available
     
     
     
427. ANDRES P, Flores-Vazquez JF, Enriquez-Geppert S
     Associating faces with names and meals as a biomarker of early AD in cognitively healthy individuals.
     J Alzheimers Dis. 2024;102:639-641.
     PubMed     Abstract available
     
     
     
428. SOINIEMI L, Solje E, Suominen AL, Kanninen KM, et al
     The association between oral diseases and neurodegenerative disorders.
     J Alzheimers Dis. 2024;102:577-586.
     PubMed     Abstract available
     
     
     
429. PEETHAMBARAN MALLIKA A
     Tri-culture modeling of neuroinflammation, neurodegeneration, and neuroprotection.
     J Alzheimers Dis. 2024;102:742-744.
     PubMed     Abstract available
     
     
     
430. GAN J, Zeng Y, Huang G, Wang XD, et al
     The updated prevalence and risk factors of dementia in old adults in China: A cross-sectional study.
     J Alzheimers Dis. 2024;102:1209-1223.
     PubMed     Abstract available
     
     
     November 2024
431. BENKE T, Karagiannis G
     Memory anosognosia in early Alzheimer's disease: A memory clinic study.
     J Alzheimers Dis. 2024 Nov 29:13872877241302423. doi: 10.1177/13872877241302423.
     PubMed     Abstract available
     
     
     
432. CASTELLANI RJ
     Biomarker-only diagnosis of Alzheimer's disease: Not ready for prime time.
     J Alzheimers Dis. 2024 Nov 29:13872877241301805. doi: 10.1177/13872877241301805.
     PubMed     Abstract available
     
     
     
433. JUDAY TR, Holub A, Mattke S, Betts KA, et al
     Real-world diagnostic, referral, and treatment patterns in early Alzheimer's disease among community-based practices in the United States.
     J Alzheimers Dis. 2024 Nov 29:13872877241297128. doi: 10.1177/13872877241297128.
     PubMed     Abstract available
     
     
     
434. BECHI GABRIELLI G, D'Antonio F, Di Vita A, Margiotta R, et al
     Mind's eye in the Alzheimer's disease spectrum continuum.
     J Alzheimers Dis. 2024 Nov 29:13872877241299134. doi: 10.1177/13872877241299134.
     PubMed     Abstract available
     
     
     
435. UNERI A, McArdle CJ, Deng Z, Barth SH, et al
     DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related protein networks.
     J Alzheimers Dis. 2024 Nov 29:13872877241291175. doi: 10.1177/13872877241291175.
     PubMed     Abstract available
     
     
     
436. MALIK R, Beaton D, Ahmed J, Nho K, et al
     A DAT1 gene and APOE epsilon4 interaction is associated with apathy and structural brain changes in mild cognitive impairment and Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 29:13872877241299785. doi: 10.1177/13872877241299785.
     PubMed     Abstract available
     
     
     
437. AKHTAR SN, Tran TD, Chen YH, Lu Q, et al
     Spatial and planar profiling of Rac1/Cdc42 signaling in Alzheimer's disease brain.
     J Alzheimers Dis. 2024 Nov 29:13872877241291076. doi: 10.1177/13872877241291076.
     PubMed     Abstract available
     
     
     
438. RAO S, Forns J, Danysh HE, Calingaert B, et al
     Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.
     J Alzheimers Dis. 2024 Nov 27:13872877241297361. doi: 10.1177/13872877241297361.
     PubMed     Abstract available
     
     
     
439. BERNARD MA, Boutajangout A, Debure L, Ahmed W, et al
     The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers.
     J Alzheimers Dis. 2024 Nov 27:13872877241295324. doi: 10.1177/13872877241295324.
     PubMed     Abstract available
     
     
     
440. PRABHA S, Sajad M, Anjum F, Hassan MI, et al
     Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers.
     J Alzheimers Dis. 2024 Nov 27:13872877241297335. doi: 10.1177/13872877241297335.
     PubMed     Abstract available
     
     
     
441. ORJUELA AL, Pecchio M, Cruz-Mora J, Emani LS, et al
     The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-beta monomers in Alzheimer's disease: Computational analysis and ADMET prediction.
     J Alzheimers Dis. 2024 Nov 26:13872877241291172. doi: 10.1177/13872877241291172.
     PubMed     Abstract available
     
     
     
442. BAGHERI S, Rashno M, Salehi I, Karimi SA, et al
     Protective effects of geraniol in a male rat model of Alzheimer's disease: A behavioral, biochemical, and histological study.
     J Alzheimers Dis. 2024 Nov 25:13872877241290695. doi: 10.1177/13872877241290695.
     PubMed     Abstract available
     
     
     
443. FERRARO PM, Filippi L, Ponzano M, Signori A, et al
     Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241299843. doi: 10.1177/13872877241299843.
     PubMed     Abstract available
     
     
     
444. LIU W, Chen S, Rao X, Chen X, et al
     Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology.
     J Alzheimers Dis. 2024 Nov 25:13872877241297178. doi: 10.1177/13872877241297178.
     PubMed     Abstract available
     
     
     
445. GAO Z, Zhu W, Li Y, Ye W, et al
     Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes.
     J Alzheimers Dis. 2024 Nov 25:13872877241296130. doi: 10.1177/13872877241296130.
     PubMed     Abstract available
     
     
     
446. PAN H, Wang G, Bi Z, Lai C, et al
     Identification of key neutrophil extracellular trap genes in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241295374. doi: 10.1177/13872877241295374.
     PubMed     Abstract available
     
     
     
447. WEISS JN
     Dynamic light scattering of the eye in the diagnosis of Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241301802. doi: 10.1177/13872877241301802.
     PubMed     Abstract available
     
     
     
448. SHIBATA H, Uchida Y, Kan H, Sakurai K, et al
     Deep-learning assessment of hippocampal magnetic susceptibility in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241300278. doi: 10.1177/13872877241300278.
     PubMed     Abstract available
     
     
     
449. SANTOS VD, Costa AC, Junior NC, Delaere FJ, et al
     Virtual reality interventions and their effects on the cognition of individuals with Alzheimer's disease: A systematic review and meta-analysis.
     J Alzheimers Dis. 2024 Nov 25:13872877241299037. doi: 10.1177/13872877241299037.
     PubMed     Abstract available
     
     
     
450. KOLLING LJ, Chimenti MS, Marcinkiewcz CA
     Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241299119. doi: 10.1177/13872877241299119.
     PubMed     Abstract available
     
     
     
451. XIYANG Y, Gao J, Ding M, Ren X, et al
     Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 25:13872877241295403. doi: 10.1177/13872877241295403.
     PubMed     Abstract available
     
     
     
452. BUONGIORNO M, Sanchez-Benavides G, Marzal-Espi C, Giraldo DM, et al
     Blood-brain barrier permeable beta-blockers association with Alzheimer's disease cerebrospinal fluid biomarkers levels in non-demented individuals.
     J Alzheimers Dis. 2024 Nov 25:13872877241293812. doi: 10.1177/13872877241293812.
     PubMed     Abstract available
     
     
     
453. MARTINEZ-LOPEZ S, Tabone M, Clemente-Velasco S, Gonzalez-Soltero MDR, et al
     A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.
     J Alzheimers Dis. 2024 Nov 25:13872877241292829. doi: 10.1177/13872877241292829.
     PubMed     Abstract available
     
     
     
454. PAJAVAND AM, Grothe MJ, De Schotten MT, Giorgi FS, et al
     Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-based statistics.
     J Alzheimers Dis. 2024 Nov 22:13872877241288710. doi: 10.1177/13872877241288710.
     PubMed     Abstract available
     
     
     
455. WANG LY, Hu H, Sheng ZH, Hu HY, et al
     Associations among healthy lifestyle characteristics, neuroinflammation, and cerebrospinal fluid core biomarkers of Alzheimer's disease in cognitively intact adults: The CABLE study.
     J Alzheimers Dis. 2024 Nov 19:13872877241291969. doi: 10.1177/13872877241291969.
     PubMed     Abstract available
     
     
     
456. KARKKAINEN V, Hannonen S, Rusanen M, Lehtola JM, et al
     Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton.
     J Alzheimers Dis. 2024 Nov 18:13872877241295315. doi: 10.1177/13872877241295315.
     PubMed     Abstract available
     
     
     
457. RIGHI D, Manco C, Pardini M, Stufano A, et al
     Investigating interleukin-8 in Alzheimer's disease: A comprehensive review.
     J Alzheimers Dis. 2024 Nov 18:13872877241298973. doi: 10.1177/13872877241298973.
     PubMed     Abstract available
     
     
     
458. SHAO K, Chen X, Yu X, Yang J, et al
     Functional connectivity changes in two cortico-hippocampal networks of Alzheimer's disease continuum and their correlations with cognition: A SILCODE study.
     J Alzheimers Dis. 2024 Nov 15:13872877241291236. doi: 10.1177/13872877241291236.
     PubMed     Abstract available
     
     
     
459. KE C, Shan S, Yu J, Wei X, et al
     Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis.
     J Alzheimers Dis. 2024 Nov 14:13872877241295400. doi: 10.1177/13872877241295400.
     PubMed     Abstract available
     
     
     
460. AGBOJI A, Freeman S, Banner D, Armstrong J, et al
     The prevalence and risk factors of apathy among the Canadian long-term care residents with Alzheimer's disease and related dementias.
     J Alzheimers Dis. 2024 Nov 14:JAD240370. doi: 10.3233/JAD-240370.
     PubMed     Abstract available
     
     
     
461. SCHEINMAN SB, Dong H
     The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms.
     J Alzheimers Dis. 2024 Nov 14:13872877241288709. doi: 10.1177/13872877241288709.
     PubMed     Abstract available
     
     
     
462. CHAO SP, Lin WC, Lu CH, Wu HC, et al
     Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays.
     J Alzheimers Dis. 2024 Nov 13:JAD240690. doi: 10.3233/JAD-240690.
     PubMed     Abstract available
     
     
     
463. SCHROEDER KM, Afonso AS, Wang H, Grace S, et al
     Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data.
     J Alzheimers Dis. 2024 Nov 13:JAD231488. doi: 10.3233/JAD-231488.
     PubMed     Abstract available
     
     
     
464. BEHL S, Slomkowski M, Chen D, Chang D, et al
     Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial.
     J Alzheimers Dis. 2024 Nov 13:JAD240491. doi: 10.3233/JAD-240491.
     PubMed     Abstract available
     
     
     
465. LEWIS JM, Harris DA, Kosmatka J, Mikrut E, et al
     Single step capture and assessment of multiple plasma extracellular vesicle biomarkers in Alzheimer's disease detection.
     J Alzheimers Dis. 2024 Nov 13:13872877241291964. doi: 10.1177/13872877241291964.
     PubMed     Abstract available
     
     
     
466. MOSS DE, Perez RG
     The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors.
     J Alzheimers Dis. 2024 Nov 12:13872877241289602. doi: 10.1177/13872877241289602.
     PubMed     Abstract available
     
     
     
467. SUZUKI H, Tagai K, Ono M, Shimizu H, et al
     Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomography.
     J Alzheimers Dis. 2024 Nov 11:13872877241297382. doi: 10.1177/13872877241297382.
     PubMed     Abstract available
     
     
     
468. MAYR E, Rotter J, Kuhrt H, Winter K, et al
     Detection of molecular markers of ferroptosis in human Alzheimer's disease brains.
     J Alzheimers Dis. 2024 Nov 11:13872877241296563. doi: 10.1177/13872877241296563.
     PubMed     Abstract available
     
     
     
469. PAN M, Lai D, Unverzagt F, Apostolova L, et al
     Genetic variants for Alzheimer's disease and comorbid conditions.
     J Alzheimers Dis. 2024 Nov 10:13872877241289054. doi: 10.1177/13872877241289054.
     PubMed     Abstract available
     
     
     
470. MAHAJAN K, Sharma S, Gautam RK, Goyal R, et al
     Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective.
     J Alzheimers Dis. 2024 Nov 10:13872877241296557. doi: 10.1177/13872877241296557.
     PubMed     Abstract available
     
     
     
471. AAZAD AA, Choudhury A, Hussain A, AlAjmi MF, et al
     Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 10:13872877241289620. doi: 10.1177/13872877241289620.
     PubMed     Abstract available
     
     
     
472. REN C, Wang WQ, Li HH, Li BY, et al
     Valuing the importance of sex differences in prodromal Alzheimer's disease based on structural magnetic resonance imaging.
     J Alzheimers Dis. 2024 Nov 8:13872877241289790. doi: 10.1177/13872877241289790.
     PubMed     Abstract available
     
     
     
473. GARCIA-ALBERCA JM, De La Guia P, Gris E, Mendoza S, et al
     Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 5:13872877241292018. doi: 10.1177/13872877241292018.
     PubMed     Abstract available
     
     
     
474. DEJAKAISAYA H, Lin R, Harutyunyan A, Chan J, et al
     Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2024 Nov 3:13872877241289053. doi: 10.1177/13872877241289053.
     PubMed     Abstract available
     
     
     
475. CHEN X, Hu F, Chi Q, Rao C, et al
     The study of Alzheimer's disease risk diagnosis based on natural killer cell marker genes in the multi-omics data.
     J Alzheimers Dis. 2024 Nov 3:13872877241295316. doi: 10.1177/13872877241295316.
     PubMed     Abstract available
     
     
     
476. GESSI S, Mirandola P, Merighi S
     Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective.
     J Alzheimers Dis. 2024 Nov 3:13872877241290693. doi: 10.1177/13872877241290693.
     PubMed     Abstract available
     
     
     
477. ABDELRAOUF K, Farrag HS, El-Ganzuri MA, El-Sayed WM, et al
     A new bithiophene inhibited amyloid-beta accumulation and enhanced cognitive function in the hippocampus of aluminum-induced Alzheimer's disease in adult rats.
     J Alzheimers Dis. 2024 Nov 3:13872877241295405. doi: 10.1177/13872877241295405.
     PubMed     Abstract available
     
     
     
478. ZHAO Y, Villasante-Tezanos A, Miranda-Morales EG, Pappolla MA, et al
     Discovery of novel metabolic biomarkers in blood serum for diagnosis of Alzheimer's disease.
     J Alzheimers Dis. 2024;102:237-253.
     PubMed     Abstract available
     
     
     
479. MATIAS-GUIU JA, Alvarez-Sabin J, Botia E, Casado-Naranjo I, et al
     Perceptions of key informant neurologists before implementing anti-amyloid drugs in the Spanish departments of neurology.
     J Alzheimers Dis. 2024;102:207-217.
     PubMed     Abstract available
     
     
     
480. PAPOTTI B, Palumbo M, Adorni MP, Elviri L, et al
     Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum.
     J Alzheimers Dis. 2024;102:162-172.
     PubMed     Abstract available
     
     
     
481. JURASOVA V, Andel R, Katonova A, Nolan R, et al
     Is KIBRA polymorphism associated with memory performance and cognitive impairment in Alzheimer's disease?
     J Alzheimers Dis. 2024;102:218-227.
     PubMed     Abstract available
     
     
     
482. KHAN SU, Albanyan A, Bilal M, Ullah S, et al
     A genetic programming Rician noise reduction and explainable deep learning model for Alzheimer's diseases severity prediction.
     J Alzheimers Dis. 2024;102:129-142.
     PubMed     Abstract available
     
     
     
483. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
     Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.
     J Alzheimers Dis. 2024;102:228-236.
     PubMed     Abstract available
     
     
     
484. ZHANG Z, Sheng Z, Liu J, Zhang D, et al
     The association of the triglyceride-glucose index with Alzheimer's disease and its potential mechanisms.
     J Alzheimers Dis. 2024;102:77-88.
     PubMed     Abstract available
     
     
     
485. GAO Z, Dorney I, Davis PB, Kaelber DC, et al
     Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease.
     J Alzheimers Dis. 2024;102:99-109.
     PubMed     Abstract available
     
     
     
486. SERRA L, Bonarota S, Di Domenico C, Caruso G, et al
     The funnel effect of reserves prompted by leisure activities across the Alzheimer's disease continuum.
     J Alzheimers Dis. 2024;102:181-194.
     PubMed     Abstract available
     
     
     
487. KANG L, Zhang X, Guan J, Huang K, et al
     Early Alzheimer's disease diagnosis via handwriting with self-attention mechanisms.
     J Alzheimers Dis. 2024;102:173-180.
     PubMed     Abstract available
     
     
     
488. BEDER N, Belkhelfa M, Leklou H
     Involvement of inflammasomes in the pathogenesis of Alzheimer's disease.
     J Alzheimers Dis. 2024;102:11-29.
     PubMed     Abstract available
     
     
     
489. BESSER LM, Fuentes AJ, Zhang JN, O'Shea DM, et al
     Intersectionality of gender with social determinants of health and asymptomatic Alzheimer's disease neuropathology.
     J Alzheimers Dis. 2024;102:110-118.
     PubMed     Abstract available
     
     
     
490. CALVO N, McFall GP, Ramana S, Galper M, et al
     Associated risk and resilience factors of Alzheimer's disease in women with early bilateral oophorectomy: Data from the UK Biobank.
     J Alzheimers Dis. 2024;102:119-128.
     PubMed     Abstract available
     
     
     
491. LECLERC H, Lee AK, Kunicki ZJ, Alber J, et al
     Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease.
     J Alzheimers Dis. 2024;102:89-98.
     PubMed     Abstract available
     
     
     
492. ABDULLAH L, Zhang F, Hall J, O'Bryant S, et al
     Neurofilament light and cognition in community-dwelling non-Hispanic Blacks.
     J Alzheimers Dis. 2024;102:60-66.
     PubMed     Abstract available
     
     
     
493. LIN Y, Kuo SH
     The emerging role of the cerebellum in neurodegeneration linked to cognitive impairment.
     J Alzheimers Dis. 2024;102:30-32.
     PubMed     Abstract available
     
     
     
494. LIU Z, Hu B, Tang J, Liu X, et al
     Frontiers and hotspots evolution between air pollution and Alzheimer's disease: A bibliometric analysis from 2013 to 2023.
     J Alzheimers Dis. 2024;102:257-274.
     PubMed     Abstract available
     
     
     
495. CHEN H, Wang L, Chen F, Sun W, et al
     Performance of the Benton Judgment of Line Orientation test across patients with different types of dementia.
     J Alzheimers Dis. 2024;102:437-448.
     PubMed     Abstract available
     
     
     
496. DOS SANTOS JR, Catalao CHR, Vulczak A, Azzolini AECS, et al
     Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.
     J Alzheimers Dis. 2024;102:424-436.
     PubMed     Abstract available
     
     
     
497. TANG M, Guo JJ, Guo RX, Xu SJ, et al
     Progress of research and application of non-pharmacologic intervention in Alzheimer's disease.
     J Alzheimers Dis. 2024;102:275-294.
     PubMed     Abstract available
     
     
     
498. ZHANG X, Lv R, Sun Y, Liu TC, et al
     The safety and effectiveness of 40 Hz gamma-tACS in Alzheimer's disease: A meta-analysis.
     J Alzheimers Dis. 2024;102:295-307.
     PubMed     Abstract available
     
     
     
499. FINDLEY CA, McFadden SA, Hill T, Peck MR, et al
     Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice.
     J Alzheimers Dis. 2024;102:491-505.
     PubMed     Abstract available
     
     
     
500. CIESLA M, Toro-Serey C, Jannati A, Banks RE, et al
     Detecting functional impairment with the Digital Clock and Recall.
     J Alzheimers Dis. 2024;102:329-337.
     PubMed     Abstract available
     
     
     
501. COOK N, Driscoll I, Gaitan JM, Glittenberg M, et al
     Amyloid-beta positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes.
     J Alzheimers Dis. 2024;102:480-490.
     PubMed     Abstract available
     
     
     September 2024
502. CHAN CK, Lane KA, Gao S, Adeoye-Olatunde OA, et al
     Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers.
     J Alzheimers Dis. 2024 Sep 30. doi: 10.3233/JAD-240485.
     PubMed     Abstract available
     
     
     
503. WANG N, Tai HC, Tzeng IS
     Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 20. doi: 10.3233/JAD-240418.
     PubMed     Abstract available
     
     
     
504. DEL TREDICI K, Schon M, Feldengut S, Ghebremedhin E, et al
     Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 18. doi: 10.3233/JAD-240483.
     PubMed     Abstract available
     
     
     
505. MATTKE S, Tang Y, Hanson M, von Arnim CAF, et al
     Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times.
     J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240728.
     PubMed     Abstract available
     
     
     
506. LIU XL, Yeerlan J, Liu Z, Bai Y, et al
     Past, Present, and Future of Liver-Brain Axis in Alzheimer's Disease: A Bibliometric Review.
     J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240688.
     PubMed     Abstract available
     
     
     
507. NOWELL J, Raza S, Livingston NR, Sivanathan S, et al
     Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
     J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240434.
     PubMed     Abstract available
     
     
     
508. BABULAL GM, Zha W, Trani JF, Guerra JL, et al
     Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240650.
     PubMed     Abstract available
     
     
     
509. UTYRO O, Wloczkowska-Lapinska O, Jakubowski H
     Association of GLOD4 with Alzheimer's Disease in Humans and Mice.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240512.
     PubMed     Abstract available
     
     
     
510. RAJAMAKI B, Braithwaite B, Hartikainen S, Tolppanen AM, et al
     Identifying Comorbidity Patterns in People with and without Alzheimer's Disease Using Latent Dirichlet Allocation.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240490.
     PubMed     Abstract available
     
     
     
511. ABI-GHANEM C, Salinero AE, Smith RM, Kelly RD, et al
     Effects of Menopause and High Fat Diet on Metabolic Outcomes in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-231332.
     PubMed     Abstract available
     
     
     
512. MENDEZ-BARRIO C, Medina-Rodriguez M, Mendoza-Vazquez G, Garcia-Roldan E, et al
     Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia.
     J Alzheimers Dis. 2024 Sep 14. doi: 10.3233/JAD-240689.
     PubMed     Abstract available
     
     
     
513. PARK J, Oh JP, Ku K, Jin Y, et al
     Preventing Donepezil-Induced Adverse Effects Through N-acetylcysteine Co-Administration.
     J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240709.
     PubMed     Abstract available
     
     
     
514. MANAKKADAN A, Krishnan D, Rui Xia Ang S, Sajikumar S, et al
     Slow Release of Hydrogen Sulfide in CA1 Hippocampal Neurons Rescues Long-Term Synaptic Plasticity and Associativity in an Amyloid-beta Induced Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240456.
     PubMed     Abstract available
     
     
     
515. SCHICKTANZ S, Alpinar-Segawa Z, Ulitsa N, Perry J, et al
     Moving Towards Ethical-Practical Recommendations for Alzheimer's Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects.
     J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-231137.
     PubMed     Abstract available
     
     
     
516. VYHNALEK M, Laczo M, Laczo J
     Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240660.
     PubMed     Abstract available
     
     
     
517. WANG T, Yan S, Shan Y, Xing Y, et al
     Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240400.
     PubMed     Abstract available
     
     
     
518. SPENCER FSE, Elsworthy RJ, Breen L, Bishop J, et al
     The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study.
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240269.
     PubMed     Abstract available
     
     
     
519. WANG Q, Fu M, Gao L, Yuan X, et al
     A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240235.
     PubMed     Abstract available
     
     
     
520. SELIGMANN B, Camiolo S, Hernandez M, Yeakley JM, et al
     Molecular Gene Expression Testing to Identify Alzheimer's Disease with High Accuracy from Fingerstick Blood.
     J Alzheimers Dis. 2024 Sep 11. doi: 10.3233/JAD-240174.
     PubMed     Abstract available
     
     
     
521. BOLSHAKOV AP, Gerasimov K, Dobryakova YV
     Alzheimer's Disease: An Attempt of Total Recall.
     J Alzheimers Dis. 2024 Sep 7. doi: 10.3233/JAD-240620.
     PubMed     Abstract available
     
     
     
522. LIU S, Maruff P, Fedyashov V, Masters CL, et al
     A Data-Driven Cognitive Composite Sensitive to Amyloid-beta for Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 6. doi: 10.3233/JAD-231319.
     PubMed     Abstract available
     
     
     
523. BUTLER T, Tey SR, Galvin JE, Perry G, et al
     Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 4. doi: 10.3233/JAD-240334.
     PubMed     Abstract available
     
     
     
524. GUO H, Sun S, Yang Y, Ma R, et al
     A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.
     J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240532.
     PubMed     Abstract available
     
     
     
525. GUO F, Tan MS, Hu H, Ou YN, et al
     sTREM2 Mediates the Correlation Between BIN1 Gene Polymorphism and Tau Pathology in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240372.
     PubMed     Abstract available
     
     
     
526. CARDOSO R, Teunissen CE, Oliveira CR
     Enhancing Alzheimer's Disease Diagnosis and Care by Focusing on Plasma Biomarkers for Identifying Mild Cognitive Impairment.
     J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-240724.
     PubMed     Abstract available
     
     
     
527. ZHANG X, You J, Qao Q, Qi X, et al
     Correlation Between the Fractional Amplitude of Low-Frequency Fluctuation and Cognitive Defects in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-231040.
     PubMed     Abstract available
     
     
     August 2024
528. KRESHPA W, Raffa S, Girtler N, Brugnolo A, et al
     Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis.
     J Alzheimers Dis. 2024 Aug 31. doi: 10.3233/JAD-240430.
     PubMed     Abstract available
     
     
     
529. ZHAO H, Yuan H, Wang E
     Causal Effects of Kidney Function and Chronic Kidney Disease on Alzheimer's Disease by Analyzing Large-Scale Genome-Wide Association Study Datasets.
     J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240807.
     PubMed     Abstract available
     
     
     
530. GIUDICESSI A, McDowell CP, Martinez JE, Baena A, et al
     Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.
     J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240360.
     PubMed     Abstract available
     
     
     
531. HANYU H, Koyama Y, Umekida K, Watanabe S, et al
     Path Integration Detects Prodromal Alzheimer's Disease and Predicts Cognitive Decline.
     J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240347.
     PubMed     Abstract available
     
     
     
532. CHEN Y, Ji X, Bao Z
     Identification of the Shared Gene Signatures Between Alzheimer's Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment.
     J Alzheimers Dis. 2024 Aug 29. doi: 10.3233/JAD-240353.
     PubMed     Abstract available
     
     
     
533. MACCIONI RB, Prieto R
     Understanding the Human Being from a Quantum Perspective: Lessons to Elucidate Alzheimer's Disease Pathogenesis.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240864.
     PubMed    
     
     
     
534. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
     The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240702.
     PubMed     Abstract available
     
     
     
535. GUTIERREZ J, Kurz C, Sandoval C, Edmonds R, et al
     Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240287.
     PubMed     Abstract available
     
     
     
536. HUYNH ALH, Wang Y, Ma L, Low YLC, et al
     A Comparison of an Australian Observational Longitudinal Alzheimer's Disease Cohort to Community-Based Australian Data.
     J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240241.
     PubMed     Abstract available
     
     
     
537. SOUZA NAP, Simoes Neto JP, Dourado MCN
     The Relationship Between Decision-Making Capacity and Awareness in People with Young-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 26. doi: 10.3233/JAD-231324.
     PubMed     Abstract available
     
     
     
538. GIAQUINTO F, Lorenzini P, Salvi E, Carnevale G, et al
     The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240594.
     PubMed     Abstract available
     
     
     
539. SUN W, Chen Y, Yang Y, Wang P, et al
     Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240299.
     PubMed     Abstract available
     
     
     
540. SILVA-RUDBERG JA, Mecca AP
     Diffusion Imaging of Gray Matter Microstructure in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240673.
     PubMed     Abstract available
     
     
     
541. PERREIRA KM, Hotz VJ, Duke NN, Aiello AE, et al
     The Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
     J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240201.
     PubMed     Abstract available
     
     
     
542. WEI W, Jiang Y, Hu G, He Y, et al
     Recent Advances of Mitochondrial Alterations in Alzheimer's Disease: A Perspective of Mitochondrial Basic Events.
     J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240092.
     PubMed     Abstract available
     
     
     
543. CHEN J, Yang J, Shen D, Wang X, et al
     A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces.
     J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240523.
     PubMed     Abstract available
     
     
     
544. JANN K, Cen S, Santos M, Aksman L, et al
     Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240459.
     PubMed     Abstract available
     
     
     
545. NATARAJ A, Kala A, Pena SLP, Jezek K, et al
     Impaired Dynamics of Positional and Contextual Neural Coding in an Alzheimer's Disease Rat Model.
     J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-231386.
     PubMed     Abstract available
     
     
     
546. UH K, Monarch K, Reese ED, Rodriguez K, et al
     Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 21. doi: 10.3233/JAD-231297.
     PubMed     Abstract available
     
     
     
547. QI H, Zhu X, Ren Y, Zhang X, et al
     A Study of Assisted Screening for Alzheimer's Disease Based on Handwriting and Gait Analysis.
     J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240362.
     PubMed     Abstract available
     
     
     
548. NEVE A, Das B, Wojtowicz J, Huang Z, et al
     Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).
     J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240221.
     PubMed     Abstract available
     
     
     
549. AVELAR-PEREIRA B, Phillips CM, Hosseini SMH
     Convergence of Accelerated Brain Volume Decline in Normal Aging and Alzheimer's Disease Pathology.
     J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-231458.
     PubMed     Abstract available
     
     
     
550. ILARDI CR, Menichelli A, Michelutti M, Cattaruzza T, et al
     On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 12. doi: 10.3233/JAD-240339.
     PubMed     Abstract available
     
     
     
551. KOHLER K, Macheda T, Hobbs MM, Maisel MT, et al
     Exposure to Lead in Drinking Water Causes Cognitive Impairment via an Alzheimer's Disease Gene-Dependent Mechanism in Adult Mice.
     J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240640.
     PubMed     Abstract available
     
     
     
552. DUITS FH, Nilsson J, Zetterberg H, Blennow K, et al
     Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240610.
     PubMed     Abstract available
     
     
     
553. KALTSA M, Tsolaki A, Lazarou I, Mittas I, et al
     Assessing the Linguistic Capacity Across Alzheimer's Disease and Its Preclinical Stages: Evidence from Narrative Macrostructure in Elderly Speakers of Greek.
     J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240496.
     PubMed     Abstract available
     
     
     
554. L'ESPERANCE OJ, McGhee J, Davidson G, Niraula S, et al
     Functional Connectivity Favors Aberrant Visual Network c-Fos Expression Accompanied by Cortical Synapse Loss in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240776.
     PubMed     Abstract available
     
     
     
555. WING JJ, Rajczyk JI, Burke JF
     Geographic Variation of Prevalence of Alzheimer's Disease and Related Dementias in Central Appalachia.
     J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240528.
     PubMed     Abstract available
     
     
     
556. GRANT WB
     A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240658.
     PubMed     Abstract available
     
     
     
557. BUCHMAN AS, Yu L, Oveisgharan S, Zammit AR, et al
     Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults.
     J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240593.
     PubMed     Abstract available
     
     
     
558. RUSTAMZADEH A, Tafakhori A, Ariaei A, Heydari M, et al
     Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 5. doi: 10.3233/JAD-240413.
     PubMed     Abstract available
     
     
     
559. ORIA RB, Smith CJ, Ashford JW, Vitek MP, et al
     Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer's Disease, and Alzheimer's Prevention.
     J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-240888.
     PubMed     Abstract available
     
     
     
560. HAN BL, Ma LZ, Han SL, Mi YC, et al
     Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-231489.
     PubMed     Abstract available
     
     
     July 2024
561. IBAN-ARIAS R, Wang SH, Soares Dias Portela A, Yang EJ, et al
     Exposure to the World Center Particulate Matter Alters the Gut-Brain Axis in Early Onset Alzheimer's Disease Mice.
     J Alzheimers Dis. 2024 Jul 30. doi: 10.3233/JAD-240635.
     PubMed     Abstract available
     
     
     
562. WANG H, Li J, Tu W, Wang Z, et al
     Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts.
     J Alzheimers Dis. 2024 Jul 29. doi: 10.3233/JAD-240301.
     PubMed     Abstract available
     
     
     
563. KASHIBAYASHI T, Kanemoto H, Takahashi R, Fujito R, et al
     Neural Basis of Agitated Behaviors in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 27. doi: 10.3233/JAD-240256.
     PubMed     Abstract available
     
     
     
564. BOCCARDI V, Ruggiero C, Cecchetti R, Mecocci P, et al
     Geroscience and the Fight Against Alzheimer's Disease: Between Myth and Reality.
     J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240582.
     PubMed     Abstract available
     
     
     
565. WANG W, Zhao F, Torres S, Harris PLR, et al
     Space-Like Irradiation Exacerbated Cognitive Deficits and Amyloid Pathology in CRND8 Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240570.
     PubMed     Abstract available
     
     
     
566. LEE JH, Jia J, Ji Y, Kandiah N, et al
     A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia.
     J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240684.
     PubMed     Abstract available
     
     
     
567. LIU Y, Xu W, Yang P, Liu X, et al
     Revealing Molecular Patterns of Alzheimer's Disease Risk Gene Expression Signatures in COVID-19 Brains.
     J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240609.
     PubMed     Abstract available
     
     
     
568. AVILA J
     Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer's Disease: In Memoriam of Mark A. Smith.
     J Alzheimers Dis. 2024 Jul 20. doi: 10.3233/JAD-240500.
     PubMed     Abstract available
     
     
     
569. LIU Y, He B, Du K, Zheng J, et al
     Periphery Biomarkers Predicting Conversion of Type 2 Diabetes to Pre-Alzheimer-Like Cognitive Decline: A Multicenter Follow-Up Study.
     J Alzheimers Dis. 2024 Jul 19. doi: 10.3233/JAD-240455.
     PubMed     Abstract available
     
     
     
570. BUTTERFIELD DA
     Activation of the Neuronal Cell Cycle in Brains in Amnestic Mild Cognitive Impairment: Early Involvement in the Progression of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240615.
     PubMed     Abstract available
     
     
     
571. MANDAL PK, Maroon JC, Samkaria A, Arora Y, et al
     Iron Chelators and Alzheimer's Disease Clinical Trials.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240605.
     PubMed     Abstract available
     
     
     
572. AMARAL-CARVALHO V, Bento Lima-Silva T, Inacio Mariano L, Cruz de Souza L, et al
     Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240554.
     PubMed     Abstract available
     
     
     
573. WANG RT, Sun Z, Tan CC, Tan L, et al
     Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240292.
     PubMed     Abstract available
     
     
     
574. BOCTI C
     Is Simpler Always Better? The Case for Going Beyond the Amyloid Hypothesis in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 9. doi: 10.3233/JAD-240488.
     PubMed     Abstract available
     
     
     
575. ELMAN JA, Schork NJ, Rangan AV
     Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes.
     J Alzheimers Dis. 2024 Jul 8. doi: 10.3233/JAD-231252.
     PubMed     Abstract available
     
     
     
576. REIVE BS, Lau V, Sanchez-Lafuente CL, Henri-Bhargava A, et al
     The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 5. doi: 10.3233/JAD-240088.
     PubMed     Abstract available
     
     
     
577. PORTAL B, Sodergren M, Pares I Borrell T, Giraud R, et al
     Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jul 4. doi: 10.3233/JAD-231461.
     PubMed     Abstract available
     
     
     
578. 
     Erratum to: Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice.
     J Alzheimers Dis. 2024 Jul 2. doi: 10.3233/JAD-249014.
     PubMed    
     
     
     June 2024
579. JIN H, Yang Q, Chen G, Zhang W, et al
     Effects of Hepatorenal Function on Urinary Alzheimer-Associated Neuronal Thread Protein: A Laboratory-Based Cross-Sectional Study Among the Older Chinese Population.
     J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-240148.
     PubMed     Abstract available
     
     
     
580. ZHANG YH, Zhao P, Gao HL, Zhong ML, et al
     Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking.
     J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-231389.
     PubMed     Abstract available
     
     
     
581. 
     Erratum to: Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-249011.
     PubMed    
     
     
     
582. GARCIA-MARTINEZ M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, et al
     LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-240067.
     PubMed     Abstract available
     
     
     
583. ZHUANG X, Cordes D, Bender AR, Nandy R, et al
     Classifying Alzheimer's Disease Neuropathology Using Clinical and MRI Measurements.
     J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-231321.
     PubMed     Abstract available
     
     
     
584. PUZZO D
     Beyond Amyloid-beta: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 27. doi: 10.3233/JAD-240406.
     PubMed     Abstract available
     
     
     
585. COIMBRA JRM, Resende R, Custodio JBA, Salvador JAR, et al
     BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.
     J Alzheimers Dis. 2024 Jun 22. doi: 10.3233/JAD-240146.
     PubMed     Abstract available
     
     
     
586. SAKHAROVA T, Mao S, Osadchuk M
     Updated Models of Alzheimer's Disease with Deep Neural Networks.
     J Alzheimers Dis. 2024 Jun 21. doi: 10.3233/JAD-240183.
     PubMed     Abstract available
     
     
     
587. PERRY G, Castellani R
     Alzheimer's Disease: Are We There Yet?
     J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-249012.
     PubMed    
     
     
     
588. LOBUE C, McClintock SM, Chiang HS, Helphrey J, et al
     A Critical Review of Noninvasive Brain Stimulation Technologies in Alzheimer's Dementia and Primary Progressive Aphasia.
     J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240230.
     PubMed     Abstract available
     
     
     
589. HU Y, Wang X, Zhao Z, Liu M, et al
     The Downregulation of ITGAX Exacerbates Amyloid-beta Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia.
     J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240118.
     PubMed     Abstract available
     
     
     
590. GARERI P, Cotroneo AM, Montella R, Gaglianone M, et al
     Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 15. doi: 10.3233/JAD-240497.
     PubMed     Abstract available
     
     
     
591. DESAI S, Chen IY, Hom C, Doran E, et al
     Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
     PubMed     Abstract available
     
     
     
592. CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
     Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
     J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
     PubMed     Abstract available
     
     
     
593. CHEN X, Walton K, Brodaty H, Chalton K, et al
     Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials.
     J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
     PubMed     Abstract available
     
     
     
594. CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
     The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
     J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
     PubMed     Abstract available
     
     
     
595. SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
     Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
     PubMed     Abstract available
     
     
     
596. CHANDLER JM, Ye W, Mi X, Doty EG, et al
     Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
     J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
     PubMed     Abstract available
     
     
     
597. LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
     Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
     PubMed     Abstract available
     
     
     
598. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
     Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
     PubMed     Abstract available
     
     
     
599. LI D, Xie Q, Xie J, Ni M, et al
     Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
     PubMed     Abstract available
     
     
     
600. LI JG, Mutreja Y, Servili M, Leone A, et al
     The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple Transgenic Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
     PubMed     Abstract available
     
     
     
601. 
     Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
     J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.
     PubMed    
     
     
     
602. SUN CK, Guo F, Ou YN, Zhang MZ, et al
     Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
     J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
     PubMed     Abstract available
     
     
     
603. LIANG X, Wang Y, Li S, Fan J, et al
     Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.
     J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
     PubMed     Abstract available
     
     
     
604. FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
     A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
     J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
     PubMed     Abstract available
     
     
     May 2024
605. TAYLOR J, Jaros M, Chen C, Harrison J, et al
     Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
     PubMed     Abstract available
     
     
     
606. CANTERO-FORTIZ Y, Cano A, Boada M
     Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
     PubMed     Abstract available
     
     
     
607. ZHAO A, Balcer LJ, Himali JJ, O'Donnell A, et al
     Association of Loneliness with Functional Connectivity MRI, Amyloid-beta PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 28. doi: 10.3233/JAD-231425.
     PubMed     Abstract available
     
     
     
608. ILBOUDO Y, Yoshiji S, Lu T, Butler-Laporte G, et al
     Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies.
     J Alzheimers Dis. 2024 May 27. doi: 10.3233/JAD-221223.
     PubMed     Abstract available
     
     
     
609. DUCHESNE S, Rousseau LS, Belzile-Marsolais F, Welch LA, et al
     A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.
     J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-230772.
     PubMed     Abstract available
     
     
     
610. GENG Z, Wu Y, Liu J, Zhan Y, et al
     A Study on the Effect of Executive Control Network Functional Connection on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-231449.
     PubMed     Abstract available
     
     
     
611. AGUILAR BJ, Jasuja GK, Li X, Shishova E, et al
     Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
     J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-240027.
     PubMed     Abstract available
     
     
     
612. HERMES S, Cady J, Armentrout S, O'Connor J, et al
     Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
     J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-230236.
     PubMed     Abstract available
     
     
     
613. STARMANS NLP, Kappelle LJ, Muller M, Staals J, et al
     Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis.
     J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-240119.
     PubMed     Abstract available
     
     
     
614. CHAI YL, Strohm L, Zhu Y, Chia RSL, et al
     Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
     J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-230572.
     PubMed     Abstract available
     
     
     
615. NING M, An L, Dong L, Zhu R, et al
     Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study.
     J Alzheimers Dis. 2024 May 20. doi: 10.3233/JAD-240082.
     PubMed     Abstract available
     
     
     
616. PRZYBYSZEWSKI AW, Chudzik A
     How to Cure Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-240231.
     PubMed     Abstract available
     
     
     
617. GAMM S, Ummel D, Vasil N, Grenier S, et al
     Getting Insight to the Lived Emotional Experience of People with Alzheimer's Disease Shortly After Diagnosis: A Phenomenological Approach.
     J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-231403.
     PubMed     Abstract available
     
     
     
618. ZENG B, Tang C, Wang J, Yang Q, et al
     Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
     J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
     PubMed     Abstract available
     
     
     
619. PLUTA R, Bogucka-Kocka A, Bogucki J, Kocki J, et al
     Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.
     J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
     PubMed     Abstract available
     
     
     
620. COSTANTINI E, Carrarini C, Calisi D, De Rosa M, et al
     Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
     PubMed     Abstract available
     
     
     
621. KURIHARA M, Kondo S, Ohse K, Nojima H, et al
     Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
     PubMed     Abstract available
     
     
     
622. WEGNER P, Balabin H, Ay MC, Bauermeister S, et al
     Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
     PubMed     Abstract available
     
     
     
623. NAKAYA M, Sato N, Matsuda H, Maikusa N, et al
     Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
     PubMed     Abstract available
     
     
     
624. STAM CJ, de Haan W
     Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
     J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
     PubMed     Abstract available
     
     
     
625. MCINTIRE LB
     Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
     J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
     PubMed     Abstract available
     
     
     
626. IRFAN B, Ankouni G, Reader J, Seraji-Bozorgzad N, et al
     Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for Culturally Sensitive Care.
     J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
     PubMed     Abstract available
     
     
     
627. ZAKRZEWSKI JJ, Davis JD, Gemelli ZT, Korthauer LE, et al
     Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
     PubMed     Abstract available
     
     
     
628. SATO K, Niimi Y, Ihara R, Suzuki K, et al
     Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
     J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
     PubMed     Abstract available
     
     
     
629. CHONG JSX, Tan YJ, Koh AJ, Ting SKS, et al
     Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia.
     J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
     PubMed     Abstract available
     
     
     
630. GUO ZX, Liu F, Wang FY, Ou YN, et al
     CAIDE Score, Alzheimer's Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study.
     J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240005.
     PubMed     Abstract available
     
     
     
631. MCLAREN AMR, Kawaja MD
     Olfactory Dysfunction and Alzheimer's Disease: A Review.
     J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-231377.
     PubMed     Abstract available
     
     
     
632. WU C, Ruan T, Yuan Y, Xu C, et al
     Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.
     J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
     PubMed     Abstract available
     
     
     
633. ZUPANIC E, Emersic A, Wimo A, Winblad B, et al
     Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment.
     J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240190.
     PubMed     Abstract available
     
     
     
634. XIE L, Raj Y, Varathan P, He B, et al
     Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240098.
     PubMed     Abstract available
     
     
     
635. ZHU M, Liu Y, Chen C, Chen H, et al
     TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease.
     J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-240012.
     PubMed     Abstract available
     
     
     
636. GIRALDO-BERRIO D, Jimenez-Del-Rio M, Velez-Pardo C
     Sildenafil Reverses the Neuropathological Alzheimer's Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation.
     J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-231169.
     PubMed     Abstract available
     
     
     April 2024
637. XU J, Chen Y, Shi Y, Sun A, et al
     Associations Between Neuroinflammation-Related Conditions and Alzheimer's Disease: A Study of US Insurance Claims Data.
     J Alzheimers Dis. 2024 Apr 30. doi: 10.3233/JAD-231286.
     PubMed     Abstract available
     
     
     
638. WU B, Chen M, Meng L, Tian Q, et al
     Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-240096.
     PubMed     Abstract available
     
     
     
639. LI Y, Yang Z, Zhang Y, Liu F, et al
     Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
     J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-231361.
     PubMed     Abstract available
     
     
     
640. GALE SA
     Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
     J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-240195.
     PubMed     Abstract available
     
     
     
641. OHNO M
     A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231451.
     PubMed     Abstract available
     
     
     
642. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
     The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231026.
     PubMed     Abstract available
     
     
     
643. 
     Erratum to: Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-249008.
     PubMed    
     
     
     
644. UM YH, Wang SM, Kang DW, Kim S, et al
     Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240065.
     PubMed     Abstract available
     
     
     
645. ELGHANAM Y, Purja S, Kim EY
     Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240008.
     PubMed     Abstract available
     
     
     
646. DURAN T, Gaussoin SA, Latham LA, Rundle MM, et al
     Examining a Preclinical Alzheimer's Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231435.
     PubMed     Abstract available
     
     
     
647. GARCIA-CARLOS CA, Basurto-Islas G, Perry G, Mondragon-Rodriguez S, et al
     Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-beta and Phosphorylated Tau Proteins.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231365.
     PubMed     Abstract available
     
     
     
648. MEMON A, Moore JA, Kang C, Ismail Z, et al
     Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231084.
     PubMed     Abstract available
     
     
     
649. LIU M, Ma N, Yang X, Sun M, et al
     The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 25. doi: 10.3233/JAD-240001.
     PubMed     Abstract available
     
     
     
650. NGO S, Jackson AJ, Manivannan M, Young JC, et al
     Real World Financial Mismanagement in Alzheimer's Disease, Frontotemporal Dementia, and Primary Progressive Aphasia.
     J Alzheimers Dis. 2024 Apr 24. doi: 10.3233/JAD-231021.
     PubMed     Abstract available
     
     
     
651. HUANG Z
     Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
     J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-240042.
     PubMed     Abstract available
     
     
     
652. DUFF K, Hammers DB, Koppelmans V, King JB, et al
     Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231392.
     PubMed     Abstract available
     
     
     
653. CHU Y, Xie Q, Meng R, Leng B, et al
     Evaluation of the Quality and Readability of Online Information about Alzheimer's Disease in China.
     J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231339.
     PubMed     Abstract available
     
     
     
654. CETINSOY O, Anyanwu I, Krishnanand H, Natarajan G, et al
     Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-231383.
     PubMed     Abstract available
     
     
     
655. KIM D, Jamrasi P, Li X, Ahn S, et al
     Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial.
     J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-230946.
     PubMed     Abstract available
     
     
     
656. BUTLER T, Wang X, Chiang G, Xi K, et al
     Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231312.
     PubMed     Abstract available
     
     
     
657. KIM M, Song YS, Han K, Bae YJ, et al
     Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
     J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231131.
     PubMed     Abstract available
     
     
     
658. CAI J, Xie D, Kong F, Zhai Z, et al
     Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.
     J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231249.
     PubMed     Abstract available
     
     
     
659. SIGHINOLFI G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, et al
     Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231192.
     PubMed     Abstract available
     
     
     
660. CHANDRASEKARAN G, Xie SX
     Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231047.
     PubMed     Abstract available
     
     
     
661. DAS S
     Omics Approaches in Alzheimer's Disease Research.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-240272.
     PubMed    
     
     
     
662. TAHAMI MONFARED AA, Khachatryan A, Hummel N, Kopiec A, et al
     Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231259.
     PubMed     Abstract available
     
     
     
663. CHOI YY, Lee JJ, Te Nijenhuis J, Choi KY, et al
     Multi-Ethnic Norms for Volumes of Subcortical and Lobar Brain Structures Measured by Neuro I: Ethnicity May Improve the Diagnosis of Alzheimer's Disease1.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231182.
     PubMed     Abstract available
     
     
     
664. YOO HS, Kim HK, Lee JH, Chun JH, et al
     Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-230975.
     PubMed     Abstract available
     
     
     
665. KHALED M, Al-Jamal H, Tajer L, El-Mir R, et al
     Alzheimer's Disease in Lebanon: Exploring Genetic and Environmental Risk Factors-A Comprehensive Review.
     J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231432.
     PubMed     Abstract available
     
     
     
666. ETEKOCHAY MO, Amaravadhi AR, Gonzalez GV, Atanasov AG, et al
     Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231135.
     PubMed     Abstract available
     
     
     
667. DORADO-MARTINEZ C, Montiel-Flores E, Ordonez-Librado JL, Gutierrez-Valdez AL, et al
     Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation.
     J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-230818.
     PubMed     Abstract available
     
     
     
668. BINI J
     The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231463.
     PubMed     Abstract available
     
     
     
669. BECKERS E, Riphagen JM, Van Egroo M, Bennett DA, et al
     Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231328.
     PubMed     Abstract available
     
     
     
670. SACHDEVA P, Narayanan KB, Sinha JK, Gupta S, et al
     Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 6. doi: 10.3233/JAD-231181.
     PubMed     Abstract available
     
     
     
671. WIDJAYA MA, Lee SD, Cheng WC, Wu BT, et al
     Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2024 Apr 5. doi: 10.3233/JAD-230803.
     PubMed     Abstract available
     
     
     
672. ACQUARONE E, Argyrousi EK, Arancio O, Watterson DM, et al
     The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
     J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-240063.
     PubMed     Abstract available
     
     
     
673. AREA-GOMEZ E, Schon EA
     Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.
     J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231318.
     PubMed     Abstract available
     
     
     
674. DAUAR MT, Picard C, Labonte A, Breitner J, et al
     Contactin 5 and Apolipoproteins Interplay in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231003.
     PubMed     Abstract available
     
     
     March 2024
675. BRAGAZZI NL, Boulares A, Garbarino S
     Could the Historical Transition from Segmented to Monophasic Sleep Explain the Modern Insurgence of Alzheimer's Disease and Related Dementias?
     J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-240154.
     PubMed     Abstract available
     
     
     
676. MORENO-RODRIGUEZ M, Perez SE, Martinez-Gardeazabal J, Manuel I, et al
     Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-231485.
     PubMed     Abstract available
     
     
     
677. MUELLER SG
     Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life.
     J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231183.
     PubMed     Abstract available
     
     
     
678. MATTSSON P, Cselenyi Z, Forsberg Moren A, Freund-Levi Y, et al
     High Contrast PET Imaging of Subcortical and Allocortical Amyloid-beta in Early Alzheimer's Disease Using [11C]AZD2184.
     J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231013.
     PubMed     Abstract available
     
     
     
679. ROBINSON AC, Bin Rizwan T, Davidson YS, Minshull J, et al
     Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231429.
     PubMed     Abstract available
     
     
     
680. VIJAYAN M, Reddy PH
     Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231281.
     PubMed     Abstract available
     
     
     
681. GELFO F, Petrosini L, Mandolesi L, Landolfo E, et al
     Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231279.
     PubMed     Abstract available
     
     
     
682. LOVE RWB
     Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-beta Plaques in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231247.
     PubMed     Abstract available
     
     
     
683. LI Y, Xu X, Wang P, Chen X, et al
     Association of Cancer History with Lifetime Risk of Dementia and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231223.
     PubMed     Abstract available
     
     
     
684. MATTKE S, Jun H, Chu S, Hanson M, et al
     Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
     J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231134.
     PubMed     Abstract available
     
     
     
685. ZHANG M, Qu Y, Li Q, Gu C, et al
     Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
     J Alzheimers Dis. 2024 Mar 21. doi: 10.3233/JAD-230648.
     PubMed     Abstract available
     
     
     
686. CUMMINGS J
     "Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.
     J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-240145.
     PubMed     Abstract available
     
     
     
687. SHUI L, Shibata D, Chan KCG, Zhang W, et al
     Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization.
     J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-231149.
     PubMed     Abstract available
     
     
     
688. POLIS B, Samson AO
     Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.
     J Alzheimers Dis. 2024 Mar 19. doi: 10.3233/JAD-240058.
     PubMed     Abstract available
     
     
     
689. ZHONG P, Cao Q, Yan Z
     Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
     PubMed     Abstract available
     
     
     
690. SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
     FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
     PubMed     Abstract available
     
     
     
691. ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
     Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
     PubMed     Abstract available
     
     
     
692. ZHANG X, Gomez L, Below JE, Naj AC, et al
     An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
     PubMed     Abstract available
     
     
     
693. SHEN Z, Yang X, Lan Y, Chen G, et al
     The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
     PubMed     Abstract available
     
     
     
694. RAMADAN FA, Arani G, Jafri A, Thompson T, et al
     Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
     PubMed     Abstract available
     
     
     
695. BROOKS WH
     Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
     PubMed     Abstract available
     
     
     
696. CAO J, Tang Y, Chen S, Yu S, et al
     The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
     PubMed     Abstract available
     
     
     
697. TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
     Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
     PubMed     Abstract available
     
     
     
698. ZHAI M, Zhang Y, Yan D, Wang Y, et al
     Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
     PubMed     Abstract available
     
     
     
699. CESANA BM, Bergh S, Ciccone A, Cognat E, et al
     Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.
     J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
     PubMed     Abstract available
     
     
     
700. CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
     Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
     J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
     PubMed     Abstract available
     
     
     
701. TERAO I, Kodama W
     Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Networ
     J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
     PubMed     Abstract available
     
     
     
702. MANDAL PK
     Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
     PubMed    
     
     
     
703. 
     Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle.
     J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-239016.
     PubMed    
     
     
     
704. GOHEL D, Zhang P, Gupta AK, Li Y, et al
     Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
     J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-231391.
     PubMed     Abstract available
     
     
     
705. YANG J, Liu X, Oveisgharan S, Zammit AR, et al
     Inferring Alzheimer's Disease Pathologic Traits from Clinical Measures in Living Adults.
     J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-230639.
     PubMed     Abstract available
     
     
     February 2024
706. WANG CS, Chen PS, Tsai TY, Hou NT, et al
     Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study.
     J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-240002.
     PubMed     Abstract available
     
     
     
707. LI S, Lan X, Liu Y, Zhou J, et al
     Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
     J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-231031.
     PubMed     Abstract available
     
     
     
708. LU TV, Grill JD, Gillen DL
     Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231283.
     PubMed     Abstract available
     
     
     
709. SIGURDSSON EM
     Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231238.
     PubMed     Abstract available
     
     
     
710. GARCIA-ALBERCA JM, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, et al
     An Insertion Within SIRPbeta1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231150.
     PubMed     Abstract available
     
     
     
711. CHI HC, Ma LZ, Wang ZB, Sheng ZH, et al
     Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231111.
     PubMed     Abstract available
     
     
     
712. ROSSI E, Marrosu F, Saba L
     Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230852.
     PubMed     Abstract available
     
     
     
713. NJOMBORO P, Lekhutlile T
     The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230426.
     PubMed     Abstract available
     
     
     
714. VERWAERDE P, Estrella C, Burlet S, Barrier M, et al
     First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.
     J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-220883.
     PubMed     Abstract available
     
     
     
715. KUMARI S, Kaur P, Singh AK, Ashar MS, et al
     Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-231445.
     PubMed     Abstract available
     
     
     
716. KAVOOSI S, Shahraki A, Sheervalilou R
     Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230966.
     PubMed     Abstract available
     
     
     
717. SABBIR MG
     Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230883.
     PubMed     Abstract available
     
     
     
718. CULIBRK RA, Ebbert KA, Yeisley DJ, Chen R, et al
     Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
     J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230600.
     PubMed     Abstract available
     
     
     
719. KAMEYAMA H, Tagai K, Takasaki E, Kashibayashi T, et al
     Examining Frontal Lobe Asymmetry and Its Potential Role in Aggressive Behaviors in Early Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-231306.
     PubMed     Abstract available
     
     
     
720. VAISHNAV N, Gonzalez R, Karunungan K, Tyler A, et al
     Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-230067.
     PubMed     Abstract available
     
     
     
721. ADAMS JA, Uryash A, Lopez JR
     Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention.
     J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-231010.
     PubMed     Abstract available
     
     
     
722. RAPOS PEREIRA F, George N, Dalla Barba G, Dubois B, et al
     The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
     J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-230921.
     PubMed     Abstract available
     
     
     
723. COGRAM P, Garduno BM, Ren B, Xu X, et al
     First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
     J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-249004.
     PubMed     Abstract available
     
     
     
724. ACHARYA NK, Grossman HC, Clifford PM, Levin EC, et al
     A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
     J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-231028.
     PubMed     Abstract available
     
     
     
725. CZUCZWAR SAJ, Kocki J, Miziak B, Bogucki J, et al
     Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231333.
     PubMed     Abstract available
     
     
     
726. RAJABLI F, Seixas AA, Akgun B, Adams LD, et al
     African Ancestry Individuals with Higher Educational Attainment are Resilient to Alzheimer's Disease Measured by pTau181.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231116.
     PubMed     Abstract available
     
     
     
727. SUN H, Li P, Gao L, Yang J, et al
     Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230928.
     PubMed     Abstract available
     
     
     
728. NELSON D, Thompson KJ, Wang L, Wang Z, et al
     Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230907.
     PubMed     Abstract available
     
     
     
729. GILLS JL, Bubu OM
     Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?
     J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-231385.
     PubMed     Abstract available
     
     
     
730. KIM SA, Maeda M, Murata F, Fujii T, et al
     Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study.
     J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806.
     PubMed     Abstract available
     
     
     
731. JU IG, Lee S, Kim SH, Im H, et al
     Trichosanthis Semen Exerts Neuroprotective Effects in Alzheimer's Disease Models by Inhibiting Amyloid-beta Accumulation and Regulating the Akt and ERK Signaling Pathways.
     J Alzheimers Dis. 2024 Feb 13. doi: 10.3233/JAD-231124.
     PubMed     Abstract available
     
     
     
732. LI Z, Fan Z, Zhang Q
     The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024 Feb 7. doi: 10.3233/JAD-230799.
     PubMed     Abstract available
     
     
     
733. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
     Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
     J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
     PubMed     Abstract available
     
     
     
734. DE LA MONTE SM, Tong M
     Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
     J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
     PubMed     Abstract available
     
     
     
735. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
     Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
     J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
     PubMed     Abstract available
     
     
     January 2024
736. MONE P, De Luca A, Kansakar U, Santulli G, et al
     Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
     PubMed     Abstract available
     
     
     
737. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
     Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
     PubMed     Abstract available
     
     
     
738. SIBLE IJ, Nation DA
     Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
     PubMed     Abstract available
     
     
     
739. NOORI A, Jayakumar R, Moturi V, Li Z, et al
     Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
     PubMed     Abstract available
     
     
     
740. WHEELER KV, Irimia A, Braskie MN
     Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
     PubMed     Abstract available
     
     
     
741. JIAO L, Jing Z, Zhang W, Su X, et al
     Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
     J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
     PubMed     Abstract available
     
     
     
742. NG PY, Zhang C, Li H, Baker DJ, et al
     Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
     J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
     PubMed     Abstract available
     
     
     
743. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
     Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
     J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
     PubMed     Abstract available
     
     
     
744. BELKHELFA M, Bekrar S, Rezaig L, Beder N, et al
     Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
     J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230910.
     PubMed     Abstract available
     
     
     
745. WEI G, Tian X, Yang H, Luo Y, et al
     Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials.
     J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230822.
     PubMed     Abstract available
     
     
     
746. TAKASE H, Hamanaka G, Hoshino T, Ohtomo R, et al
     Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-231049.
     PubMed     Abstract available
     
     
     
747. OKINAKA Y, Shinagawa Y, Claussen C, Gul S, et al
     RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230874.
     PubMed     Abstract available
     
     
     
748. SAEED A, Alharazi T, Alshaghdali K, Rezgui R, et al
     Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects.
     J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230821.
     PubMed     Abstract available
     
     
     
749. VILLEMAGNE VL, Dore V, Chong L, Kassiou M, et al
     Brain 11beta-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
     J Alzheimers Dis. 2024 Jan 19. doi: 10.3233/JAD-220542.
     PubMed     Abstract available
     
     
     
750. ZHOU J, Zhao M, Yang Z, Chen L, et al
     Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
     J Alzheimers Dis. 2024 Jan 18. doi: 10.3233/JAD-230733.
     PubMed     Abstract available
     
     
     
751. GORHAM IK, Reid DM, Sun J, Zhou Z, et al
     Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.
     J Alzheimers Dis. 2024 Jan 16. doi: 10.3233/JAD-230880.
     PubMed     Abstract available
     
     
     
752. KURANO M, Saito Y, Yatomi Y
     Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 13. doi: 10.3233/JAD-230942.
     PubMed     Abstract available
     
     
     
753. CHEN M, Wang F, Lei H, Yang Z, et al
     In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
     PubMed     Abstract available
     
     
     
754. FORT-AZNAR L, Molina-Porcel L, Ramos-Campoy O, Esteller D, et al
     Misfolded alpha-Synuclein in Autosomal Dominant Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230919.
     PubMed     Abstract available
     
     
     
755. SMITH HS, Robinson JO, Levchenko A, Pereira S, et al
     Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230609.
     PubMed     Abstract available
     
     
     
756. HAN Y, Huang C, Pan Y, Gu X, et al
     Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
     PubMed     Abstract available
     
     
     
757. WU LY, Chong JR, Chong JPC, Hilal S, et al
     Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
     PubMed     Abstract available
     
     
     
758. ZHANG C, Lei X, Ma W, Long J, et al
     Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
     J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
     PubMed     Abstract available
     
     
     
759. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
     The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
     PubMed     Abstract available
     
     
     
760. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
     The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
     PubMed     Abstract available
     
     
     
761. FAN X, Cai Y, Zhao L, Liu W, et al
     Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
     J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
     PubMed     Abstract available
     
     
     
762. VALENTIN-ESCALERA J, Leclerc M, Calon F
     High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
     J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
     PubMed     Abstract available
     
     
     
763. SELLES MC, Oliveira MM
     The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
     J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
     PubMed     Abstract available
     
     
     
764. LI J, Yang M, Wei R, Cao Y, et al
     The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
     PubMed     Abstract available
     
     
     
765. NADEAU PA, Jobin B, Boller B
     Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024;97:521.
     PubMed    
     
     
     
766. 
     The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
     J Alzheimers Dis. 2024;97:1.
     PubMed    
     
     
     
767. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
     Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
     J Alzheimers Dis. 2024;97:309-325.
     PubMed     Abstract available
     
     
     
768. ZENG Y, Cao S, Pang K, Tang J, et al
     Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
     J Alzheimers Dis. 2024;97:229-237.
     PubMed     Abstract available
     
     
     
769. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
     The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
     J Alzheimers Dis. 2024;97:507-519.
     PubMed     Abstract available
     
     
     
770. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
     Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
     J Alzheimers Dis. 2024;97:219-228.
     PubMed     Abstract available
     
     
     
771. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
     Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
     J Alzheimers Dis. 2024;97:345-358.
     PubMed     Abstract available
     
     
     
772. GUO Y, Sun Y, Li M, Qi WY, et al
     Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
     J Alzheimers Dis. 2024;97:471-484.
     PubMed     Abstract available
     
     
     
773. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
     Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
     J Alzheimers Dis. 2024;97:171-178.
     PubMed     Abstract available
     
     
     
774. MARTIN J, Reid N, Ward DD, King S, et al
     Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
     J Alzheimers Dis. 2024;97:101-119.
     PubMed     Abstract available
     
     
     
775. YANG M, Gan J, Liu S, Yang Y, et al
     Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
     J Alzheimers Dis. 2024;97:409-419.
     PubMed     Abstract available
     
     
     
776. KIM REY, Lee M, Kang DW, Wang SM, et al
     Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
     J Alzheimers Dis. 2024;97:259-271.
     PubMed     Abstract available
     
     
     
777. NA S, Lee C, Ho S, Hong YJ, et al
     A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
     J Alzheimers Dis. 2024;97:193-204.
     PubMed     Abstract available
     
     
     
778. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
     The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
     J Alzheimers Dis. 2024;97:179-191.
     PubMed     Abstract available
     
     
     
779. BRUNO JL, Shaw JS, Hosseini SMH
     Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
     J Alzheimers Dis. 2024;97:327-343.
     PubMed     Abstract available
     
     
     
780. DE LA PERRELLE L
     Health Care Is Not Enough to Prevent Dementia.
     J Alzheimers Dis. 2024;97:951-952.
     PubMed     Abstract available
     
     
     
781. DIGMA LA, Winer JR, Greicius MD
     Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
     J Alzheimers Dis. 2024;97:567-572.
     PubMed     Abstract available
     
     
     
782. FRENTZ I, van Arendonk J, Leeuwis AE, Vernooij MW, et al
     Interaction Between Arteriosclerosis and Amyloid-beta on Cognitive Function.
     J Alzheimers Dis. 2024;97:953-961.
     PubMed     Abstract available
     
     
     
783. MATERS J, van der Steen JT, de Vugt ME, Bakker C, et al
     Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.
     J Alzheimers Dis. 2024;97:573-586.
     PubMed     Abstract available
     
     
     
784. SCHRODER VE, Skrozic A, Erz D, Kaysen A, et al
     Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
     J Alzheimers Dis. 2024;97:791-804.
     PubMed     Abstract available
     
     
     
785. DINGLE SE, Milte CM, Daly RM, Torres SJ, et al
     Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study.
     J Alzheimers Dis. 2024;97:939-949.
     PubMed     Abstract available
     
     
     
786. KOSEL F, Hartley MR, Franklin TB
     Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli.
     J Alzheimers Dis. 2024;97:659-677.
     PubMed     Abstract available
     
     
     
787. REHMAN H, Ang TFA, Tao Q, Espenilla AL, et al
     Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.
     J Alzheimers Dis. 2024;97:621-633.
     PubMed     Abstract available
     
     
     
788. REN J, Yu Y, Wang Y, Dong Y, et al
     Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.
     J Alzheimers Dis. 2024;97:609-620.
     PubMed     Abstract available
     
     
     
789. MAZZOLA P, Zanetti M, Ferraguzzi G, Villa ML, et al
     Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2.
     J Alzheimers Dis. 2024;97:741-752.
     PubMed     Abstract available
     
     
     
790. BRITZ J, Ojo E, Haque N, Dhukhwa A, et al
     Sex-Dependent Effects of Chronic Circadian Disruption in AbetaPP/PS1 Mice.
     J Alzheimers Dis. 2024;97:855-870.
     PubMed     Abstract available
     
     
     
791. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
     Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
     J Alzheimers Dis. 2024;97:1111-1123.
     PubMed     Abstract available
     
     
     
792. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
     The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
     J Alzheimers Dis. 2024;97:1353-1363.
     PubMed     Abstract available
     
     
     
793. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
     The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
     J Alzheimers Dis. 2024;97:1007-1031.
     PubMed     Abstract available
     
     
     
794. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
     Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
     J Alzheimers Dis. 2024;97:1161-1171.
     PubMed     Abstract available
     
     
     
795. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
     The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
     J Alzheimers Dis. 2024;97:1083-1090.
     PubMed     Abstract available
     
     
     
796. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
     Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
     J Alzheimers Dis. 2024;97:1249-1260.
     PubMed     Abstract available
     
     
     
797. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
     Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
     J Alzheimers Dis. 2024;97:1435-1448.
     PubMed     Abstract available
     
     
     
798. DU P, Zhang X, Lian X, Holscher C, et al
     O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
     J Alzheimers Dis. 2024;97:1051-1068.
     PubMed     Abstract available
     
     
     
799. SHANG L, Dong L, Huang X, Chu S, et al
     Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
     J Alzheimers Dis. 2024;97:1313-1322.
     PubMed     Abstract available
     
     
     
800. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
     FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
     J Alzheimers Dis. 2024;97:1173-1187.
     PubMed     Abstract available
     
     
     
801. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
     Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;97:1341-1351.
     PubMed     Abstract available
     
     
     
802. TSENG YT, Chang YL, Chiu YS
     Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
     J Alzheimers Dis. 2024;97:1189-1209.
     PubMed     Abstract available
     
     
     
803. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
     Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
     J Alzheimers Dis. 2024;97:1223-1233.
     PubMed     Abstract available
     
     
     
804. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
     Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;97:1235-1247.
     PubMed     Abstract available
     
     
     
805. FERINI-STRAMBI L
     Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?
     J Alzheimers Dis. 2024;97:1641-1643.
     PubMed     Abstract available
     
     
     
806. KANG J, Park M, Kim T
     Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2024;97:1939-1950.
     PubMed     Abstract available
     
     
     
807. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
     Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
     J Alzheimers Dis. 2024;97:1901-1911.
     PubMed     Abstract available
     
     
     
808. BACHAND AM, Dell LD
     Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
     J Alzheimers Dis. 2024;97:1931-1937.
     PubMed     Abstract available
     
     
     
809. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
     Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
     J Alzheimers Dis. 2024;97:1829-1840.
     PubMed     Abstract available
     
     
     
810. HARRIS JL, Wang X, Christian SK, Novikova L, et al
     Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
     J Alzheimers Dis. 2024;97:1793-1806.
     PubMed     Abstract available
     
     
     
811. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
     APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
     J Alzheimers Dis. 2024;97:1629-1639.
     PubMed     Abstract available
     
     
     
812. ZHANG S, Ai H, Wang J, Liu T, et al
     Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
     J Alzheimers Dis. 2024;97:1737-1749.
     PubMed     Abstract available
     
     
     
813. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
     Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
     J Alzheimers Dis. 2024;97:1807-1827.
     PubMed     Abstract available
     
     
     
814. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
     Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
     J Alzheimers Dis. 2024;97:1765-1776.
     PubMed     Abstract available
     
     
     
815. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
     Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
     J Alzheimers Dis. 2024;97:1841-1850.
     PubMed     Abstract available
     
     
     
816. ARMSTRONG MJ, Barnes LL
     Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
     J Alzheimers Dis. 2024;97:1571-1580.
     PubMed     Abstract available
     
     
     
817. CUI X, Wang J, Wu B, Zhao Q, et al
     Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
     J Alzheimers Dis. 2024;97:1519-1531.
     PubMed     Abstract available
     
     
     
818. FINCH CE, Burstein SM
     Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
     J Alzheimers Dis. 2024;97:1581-1588.
     PubMed     Abstract available
     
     
     
819. SIAFARIKAS N
     Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
     J Alzheimers Dis. 2024;98:75-78.
     PubMed     Abstract available
     
     
     
820. MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
     Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study.
     J Alzheimers Dis. 2024;98:275-285.
     PubMed     Abstract available
     
     
     
821. NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
     Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;98:231-246.
     PubMed     Abstract available
     
     
     
822. PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
     Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.
     J Alzheimers Dis. 2024;98:83-94.
     PubMed     Abstract available
     
     
     
823. ROSS JP, Post SG, Scheinfeld L
     Lucidity in the Deeply Forgetful: A Scoping Review.
     J Alzheimers Dis. 2024;98:3-11.
     PubMed     Abstract available
     
     
     
824. PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
     Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study.
     J Alzheimers Dis. 2024;98:145-150.
     PubMed     Abstract available
     
     
     
825. BALLENGER J, George DR, Whitehouse PJ
     Digging Deeper: What Can We Really Learn about Dementia from History?
     J Alzheimers Dis. 2024;98:417-419.
     PubMed     Abstract available
     
     
     
826. ORR ME
     A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain.
     J Alzheimers Dis. 2024;98:411-415.
     PubMed     Abstract available
     
     
     
827. SHIMADA H, Doi T, Tsutsumimoto K, Makino K, et al
     Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.
     J Alzheimers Dis. 2024;98:659-669.
     PubMed     Abstract available
     
     
     
828. ZHANG XX, Wang HR, Meng-Wei, Hu YZ, et al
     Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.
     J Alzheimers Dis. 2024;98:373-385.
     PubMed     Abstract available
     
     
     
829. WANG J, Leong IT, Johnson MK, Pei Y, et al
     What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives.
     J Alzheimers Dis. 2024;98:519-538.
     PubMed     Abstract available
     
     
     
830. VERA R, Hong N, Jiang B, Liang G, et al
     Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
     J Alzheimers Dis. 2024;98:549-562.
     PubMed     Abstract available
     
     
     
831. GREENBLATT CL, Lathe R
     Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.
     J Alzheimers Dis. 2024;98:361-372.
     PubMed     Abstract available
     
     
     
832. WANG Y, Wang S, Wu J, Liu X, et al
     Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
     J Alzheimers Dis. 2024;98:505-517.
     PubMed     Abstract available
     
     
     
833. PARKER DC, Whitson HE, Smith PJ, Kraus VB, et al
     Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-beta Accumulation.
     J Alzheimers Dis. 2024;98:593-600.
     PubMed     Abstract available
     
     
     
834. HAN SL, Ou YN, Han BL, Guo HH, et al
     Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline.
     J Alzheimers Dis. 2024;98:1133-1143.
     PubMed     Abstract available
     
     
     
835. COGUT V, McNeely TL, Bussian TJ, Graves SI, et al
     Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
     J Alzheimers Dis. 2024;98:925-940.
     PubMed     Abstract available
     
     
     
836. TSENG WI, Hsu YC, Huang LK, Hong CT, et al
     Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;98:1095-1106.
     PubMed     Abstract available
     
     
     
837. MARTINEZ-DUBARBIE F, Lopez-Garcia S, Lage C, Di Molfetta G, et al
     Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
     J Alzheimers Dis. 2024;98:1029-1042.
     PubMed     Abstract available
     
     
     
838. O'SHEA DM, Camacho S, Ezzeddine R, Besser L, et al
     The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.
     J Alzheimers Dis. 2024;98:1017-1027.
     PubMed     Abstract available
     
     
     
839. PODGER L, Stewart WF, Serrano D, Lipton RB, et al
     Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.
     J Alzheimers Dis. 2024;98:1079-1094.
     PubMed     Abstract available
     
     
     
840. CEYZERIAT K, Jaques E, Gloria Y, Badina A, et al
     Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.
     J Alzheimers Dis. 2024;98:1001-1016.
     PubMed     Abstract available
     
     
     
841. PAPADIMITRIOU A, Dawson AZ, Thorgerson A, Bhandari S, et al
     Understanding the Relationship Between Wealth and Cognitive Function by Race/Ethnicity Among Older United States Adults with Diabetes.
     J Alzheimers Dis. 2024;98:1145-1155.
     PubMed     Abstract available
     
     
     
842. SANCHEZ-SOBLECHERO A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al
     Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?
     J Alzheimers Dis. 2024;98:957-967.
     PubMed     Abstract available
     
     
     
843. BERGAMINO M, Keeling E, McElvogue M, Schaefer SY, et al
     White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI.
     J Alzheimers Dis. 2024;98:863-884.
     PubMed     Abstract available
     
     
     
844. 
     Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
     J Alzheimers Dis. 2024;98:1543-1546.
     PubMed    
     
     
     
845. JANBEK J, Laursen TM, Frimodt-Moller N, Magyari M, et al
     Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases.
     J Alzheimers Dis. 2024;98:1503-1514.
     PubMed     Abstract available
     
     
     
846. CHEN Y, Su Y, Wu J, Chen K, et al
     Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.
     J Alzheimers Dis. 2024;98:1415-1426.
     PubMed     Abstract available
     
     
     
847. GALANKIN TL, Bespalov AY, Moebius HY
     Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.
     J Alzheimers Dis. 2024;98:1483-1491.
     PubMed     Abstract available
     
     
     
848. HOJJATI SH, Chiang GC, Butler TA, de Leon M, et al
     Remote Associations Between Tau and Cortical Amyloid-beta Are Stage-Dependent.
     J Alzheimers Dis. 2024;98:1467-1482.
     PubMed     Abstract available
     
     
     
849. CALDERON-GARCIDUENAS L, Ayala A, Mukherjee PS
     2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?
     J Alzheimers Dis. 2024;98:1277-1282.
     PubMed     Abstract available
     
     
     
850. SYED RA, Hayat M, Qaiser H, Uzair M, et al
     Aging-Related Protein Alterations in the Brain.
     J Alzheimers Dis. 2024;99.
     PubMed     Abstract available
     
     
     
851. ALROUJI M, Yasmin S, Furkan M, Alhumaydhi FA, et al
     Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics.
     J Alzheimers Dis. 2024;99:333-343.
     PubMed     Abstract available
     
     
     
852. MORROW CB, Pontone GM
     Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
     J Alzheimers Dis. 2024;99:101-103.
     PubMed     Abstract available
     
     
     
853. CRESSOT C, Vrillon A, Lilamand M, Francisque H, et al
     Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
     J Alzheimers Dis. 2024;99:85-99.
     PubMed     Abstract available
     
     
     
854. ESPAY AJ, Herrup K, Imbimbo BP, Kepp KP, et al
     Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-beta42.
     J Alzheimers Dis. 2024;99:877-881.
     PubMed     Abstract available
     
     
     
855. TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
     The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed.
     J Alzheimers Dis. 2024;99:1159-1171.
     PubMed     Abstract available
     
     
     
856. SUGANUMA T, Hatori S, Chen CK, Hori S, et al
     Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-beta Plaque Burden.
     J Alzheimers Dis. 2024;99:1285-1301.
     PubMed     Abstract available
     
     
     
857. WANG T, Zhang W, Maclin JMA, Xu H, et al
     Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
     J Alzheimers Dis. 2024;99:1385-1396.
     PubMed     Abstract available
     
     
     
858. XIONG R, Li B, Yu H, Fan T, et al
     Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1 Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
     J Alzheimers Dis. 2024;99:1303-1316.
     PubMed     Abstract available
     
     
     
859. LEE CS, Ferguson AN, Gibbons LE, Walker R, et al
     Eye Adult Changes in Thought (Eye ACT) Study: Design and Report on the Inaugural Cohort.
     J Alzheimers Dis. 2024;100:309-320.
     PubMed     Abstract available
     
     
     
860. MENG H, Lv X, Zhang R, Feng Y, et al
     Occurrence and Risk Factors for Cognitive Decline Shared by Couples: A Systematic Review and Meta-Analysis.
     J Alzheimers Dis. 2024;100:29-40.
     PubMed     Abstract available
     
     
     
861. GIBBONS LE, Mobley T, Mayeda ER, Lee CS, et al
     How Generalizable Are Findings from a Community-Based Prospective Cohort Study? Extending Estimates from the Adult Changes in Thought Study to Its Source Population.
     J Alzheimers Dis. 2024;100:163-174.
     PubMed     Abstract available
     
     
     
862. SHI Q, Liu WS, Liu F, Zeng YX, et al
     The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.
     J Alzheimers Dis. 2024;100:77-85.
     PubMed     Abstract available
     
     
     
863. SANNEMANN L, Bartels C, Brosseron F, Buerger K, et al
     Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
     J Alzheimers Dis. 2024;100:193-205.
     PubMed     Abstract available
     
     
     
864. ZUKOWSKI LA, Brinkerhoff SA, Levin I, Herter TM, et al
     Amyloid-beta Deposition Predicts Grocery Shopping Performance in Older Adults Without Cognitive Impairment.
     J Alzheimers Dis. 2024;100:53-75.
     PubMed     Abstract available
     
     
     
865. 
     Robert Rissman, PhD, is the recipient of the 2024 Alzheimer Award.
     J Alzheimers Dis. 2024;100:377-378.
     PubMed    
     
     
     
866. KRIZANOVIC N, Jokisch M, Jockel KH, Schmidt B, et al
     Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
     J Alzheimers Dis. 2024;100:495-507.
     PubMed     Abstract available
     
     
     
867. HOWARD E, Moody JN, Prieto S, Hayes JP, et al
     Higher Cerebrospinal Fluid Levels of Amyloid-beta40 Following Traumatic Brain Injury Relate to Confrontation Naming Performance.
     J Alzheimers Dis. 2024;100:539-550.
     PubMed     Abstract available
     
     
     
868. HE Q, Wang W, Xiong Y, Tao C, et al
     Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia.
     J Alzheimers Dis. 2024;100:603-611.
     PubMed     Abstract available
     
     
     
869. LOEFFLER DA
     Approaches for Increasing Cerebral Efflux of Amyloid-beta in Experimental Systems.
     J Alzheimers Dis. 2024;100:379-411.
     PubMed     Abstract available
     
     
     
870. LENG F, Hinz R, Gentleman S, Dani M, et al
     Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
     J Alzheimers Dis. 2024;100:973-986.
     PubMed     Abstract available
     
     
     
871. FRANK B, Walsh M, Hurley L, Groh J, et al
     Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
     J Alzheimers Dis. 2024;100:1055-1073.
     PubMed     Abstract available
     
     
     
872. FU J, Wei Q, Chen X, Lai X, et al
     Analysis of the Association Between Pathogen Exposure and the Risk of Dementia.
     J Alzheimers Dis. 2024;100:961-972.
     PubMed     Abstract available
     
     
     
873. SCHWERTHOFFER D, Haselwarter T, Grimmer T
     Obstructive Sleep Apnea Among Patients with Mild Cognitive Impairment.
     J Alzheimers Dis. 2024;100:809-823.
     PubMed     Abstract available
     
     
     
874. YU W, Zhuang S, Zhan M, Chen Y, et al
     Deubiquitinating Enzyme USP19 Regulates Ferroptosis and Mitochondrial Damage in SH-SY5Y Cells by Targeting the NOX4 Protein.
     J Alzheimers Dis. 2024;100:799-808.
     PubMed     Abstract available
     
     
     
875. DENG C, Cai Q, Zhang J, Chang K, et al
     Generation and Characterization of a Novel Knockin Mouse Model Expressing PSEN1 D385A: Implications for Investigating Herbal Drug Effects in gamma-Secretase Activity.
     J Alzheimers Dis. 2024;100:825-841.
     PubMed     Abstract available
     
     
     
876. MACE RA, Lyons C, Cohen JE, Ritchie C, et al
     Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.
     J Alzheimers Dis. 2024;100:1237-1259.
     PubMed     Abstract available
     
     
     
877. LEPPING RJ, Hess BJ, Taylor JM, Hanson-Abromeit D, et al
     Inconsistent Music-Based Intervention Reporting in Dementia Studies: A Systematic Mapping Review.
     J Alzheimers Dis. 2024;100:1145-1159.
     PubMed     Abstract available
     
     
     
878. MARIN A, Turk KW, Schiloski K, Vives-Rodriguez A, et al
     The Use of Event Related Potentials to Predict Amyloid PET Status Among Patients from a Memory Disorders Clinic.
     J Alzheimers Dis. 2024;100:1195-1208.
     PubMed     Abstract available
     
     
     
879. FROMM D, Dalton SG, Brick A, Olaiya G, et al
     The Case of the Cookie Jar: Differences in Typical Language Use in Dementia.
     J Alzheimers Dis. 2024;100:1417-1434.
     PubMed     Abstract available
     
     
     
880. CORREIA SC, Perry G, Moreira PI
     Fueling Alzheimer's Disease: Where Does Immunometabolism Stand?
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
881. PETERSEN ME, Zhang F, Hall JR, Julovich D, et al
     Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
882. ARENDASH GW, Lin X, Cao C
     Enhanced Brain Clearance of Tau and Amyloid-beta in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF).
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
883. POUDEL P, Frost SM, Eslick S, Sohrabi HR, et al
     Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
884. GOGOLA A, Cohen AD, Snitz B, Minhas D, et al
     Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
885. LEINENGA G, Padmanabhan P, Gotz J
     Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
886. PERRY G
     JAD's Glorious 100 Volumes.
     J Alzheimers Dis. 2024;100.
     PubMed    
     
     
     
887. ALLDRED MJ, Pidikiti H, Ibrahim KW, Lee SH, et al
     Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
     J Alzheimers Dis. 2024;100.
     PubMed     Abstract available
     
     
     
888. ZHANG J, Zhang Y, Zhang Y, Yao J, et al
     The Association of Brain Insulin Resistance with Anesthesia/Surgery-Induced Cognitive Deterioration Is Female-Specific in 5XFAD Transgenic Mice.
     J Alzheimers Dis. 2024;101:183-195.
     PubMed     Abstract available
     
     
     
889. LASTUKA A, Bliss E, Breshock MR, Iannucci VC, et al
     Societal Costs of Dementia: 204 Countries, 2000-2019.
     J Alzheimers Dis. 2024;101:277-292.
     PubMed     Abstract available
     
     
     
890. ZHANG Y, Li Y, Song S, Li Z, et al
     Predicting Conversion Time from Mild Cognitive Impairment to Dementia with Interval-Censored Models.
     J Alzheimers Dis. 2024;101:147-157.
     PubMed     Abstract available
     
     
     
891. SATERNOS H, Hamlett ED, Guzman S, Head E, et al
     Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
     J Alzheimers Dis. 2024;101:541-561.
     PubMed     Abstract available
     
     
     
892. ALLE MC, Joseph C, Antoine P
     Involuntary Autobiographical Memory in Alzheimer's Disease: A Double-Edged Way of Remembering the Past?
     J Alzheimers Dis. 2024;101:961-969.
     PubMed     Abstract available
     
     
     
893. SAIDO TC
     Obituary for the late Yasuo Ihara.
     J Alzheimers Dis. 2024;101:1027-1028.
     PubMed    
     
     
     
894. PEREIRA HR, Diogo VS, Prata D, Ferreira HA, et al
     Detecting Amyloid Positivity Using Morphometric Magnetic Resonance Imaging.
     J Alzheimers Dis. 2024;101:1293-1305.
     PubMed     Abstract available
     
     
     
895. LINGENBERG A, Herrmann FR, Armand S, Peron J, et al
     Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
     J Alzheimers Dis. 2024;101:1205-1216.
     PubMed     Abstract available
     
     
     
896. BECKMANN MN
     Did Reagan Decline?
     J Alzheimers Dis. 2024;101:1261-1266.
     PubMed     Abstract available
     
     
     
897. WANG J, Xu L, Chen X, Wu J, et al
     Correlation Analysis of ApoB, ApoA1, and ApoB/ApoA1 with Cortical Morphology in Patients with Memory Complaints.
     J Alzheimers Dis. 2024;101:1137-1150.
     PubMed     Abstract available
     
     
     
898. SATO K, Niimi Y, Ihara R, Iwata A, et al
     Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value.
     J Alzheimers Dis. 2024;101:1127-1132.
     PubMed     Abstract available
     
     
     
899. HAMEDANI M, Caneva S, Mancardi GL, Ali PA, et al
     Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia.
     J Alzheimers Dis. 2024;101:1083-1106.
     PubMed     Abstract available
     
     
     
900. MOREIRA PI, Avila J, Galimberti D, Pappolla MA, et al
     Therapeutic Trials in Alzheimer's Disease: Where Are We Now?
     J Alzheimers Dis. 2024;101.
     PubMed    
     
     
     
901. SAYFULLAEVA J, McLoughlin J, Kwakowsky A
     Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
902. CROOK H, Edison P
     Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
903. BROWN A, Bayley PJ
     The Therapeutic Potential of Yoga for Alzheimer's Disease: A Critical Review.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
904. ROBERTS JA, Varma VR, Jones A, Thambisetty M, et al
     Drug Repurposing for Effective Alzheimer's Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
905. PAPPOLLA MA, Martins RN, Poeggeler B, Omar RA, et al
     Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
906. TUSZYNSKI MH
     Growth Factor Gene Therapy for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
907. TAHMI M, Benitez R, Luchsinger JA
     Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
908. SUN MK, Alkon DL
     Treating Alzheimer's Disease: Focusing on Neurodegenerative Consequences.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
909. PAPPOLLA MA, Refolo L, Sambamurti K, Zambon D, et al
     Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
910. TRIUMBARI EKA, Chiaravalloti A, Schillaci O, Mercuri NB, et al
     Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer's Disease: An Overview of the Current State of the Art of Research.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
911. VINA J, Borras C, Mas-Bargues C
     Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer's Disease Patients.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
912. HOILUND-CARLSEN PF, Alavi A, Barrio JR
     PET/CT/MRI in Clinical Trials of Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
913. NOORDA K, Noorda K, Sabbagh MN, Bertelson J, et al
     Amyloid-Directed Antibodies: Past, Present, and Future.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
914. GABUZYAN R, Lee C, Nygaard HB
     Ketogenic Approaches for the Treatment of Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
915. DU B, Chen K, Wang W, Lei P, et al
     Targeting Metals in Alzheimer's Disease: An Update.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
916. MEIJER L, Chretien E, Ravel D
     Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
917. DE LA MONTE SM
     Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
918. YASSINE HN, Carrasco AS, Badie DS
     Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
919. KUCK MJ, Begde A, Hawkins K, Hogervorst E, et al
     Alzheimer's Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
920. MORATO X, Tartari JP, Pytel V, Boada M, et al
     Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
921. ALGHAMDI M, Braidy N
     Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
922. ALGHAMDI M, Braidy N
     Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
923. WATKINS EA, Vassar R
     BACE Inhibitor Clinical Trials for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
924. LI H, Xiang Q, Ren R, Wang G, et al
     Acupuncture as a Complementary Therapy for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
925. FELDMAN HH, Messer K, Qiu Y, Sabbagh M, et al
     Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
926. CURRAIS A, Raschke W, Maher P
     CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
927. THITILERTDECHA P, Brimson JM
     CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
928. MORRONI F, Caccamo A
     Advances and Challenges in Gene Therapy for Alzheimer's Disease.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
929. STEINBACH MJ, Denburg NL
     Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
930. EYOB E, Shaw JS, Bakker A, Munro C, et al
     A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST).
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
931. VASHISTH K, Sharma S, Ghosh S, Babu MA, et al
     Immunotherapy in Alzheimer's Disease: Current Status and Future Directions.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     
932. BENUSSI A, Borroni B
     Brain Stimulation in Alzheimer's Disease Trials.
     J Alzheimers Dis. 2024;101.
     PubMed     Abstract available
     
     
     December 2023
933. AHMED T, Zhang P, Kumar K
     Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
     J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
     PubMed     Abstract available
     
     
     
934. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
     Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
     J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
     PubMed     Abstract available
     
     
     
935. ALMKVIST O, Larsson M, Graff C
     Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
     PubMed     Abstract available
     
     
     
936. ZHANG E, Dai F
     Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
     J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
     PubMed     Abstract available
     
     
     
937. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
     Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
     PubMed     Abstract available
     
     
     
938. FAN X, Li H, Liu L, Zhang K, et al
     Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
     J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
     PubMed     Abstract available
     
     
     
939. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
     Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
     J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
     PubMed     Abstract available
     
     
     
940. MORIN P, Aguilar BJ, Li X, Chen J, et al
     Alzheimer's Disease Stage Transitions Among United States Veterans.
     J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230850.
     PubMed     Abstract available
     
     
     
941. MAHZARNIA A, Lutz MW, Badea A
     A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
     J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
     PubMed     Abstract available
     
     
     
942. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
     Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
     J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
     PubMed     Abstract available
     
     
     
943. ROBINSON CG, Coleman T, Buciuc M, Singh NA, et al
     Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.
     J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-230652.
     PubMed     Abstract available
     
     
     
944. EL HAFFAF LM, Ronat L, Cannizzaro A, Hanganu A, et al
     Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-220857.
     PubMed     Abstract available
     
     
     
945. LI KY, Lin BT, Hsu ST, Chien CF, et al
     Quetiapine Oral Solution in Alzheimer's Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study.
     J Alzheimers Dis. 2023 Dec 20. doi: 10.3233/JAD-231007.
     PubMed     Abstract available
     
     
     
946. LOJO-RAMIREZ JA, Guerra-Gomez M, Marin-Cabanas AM, Fernandez-Rodriguez P, et al
     Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 19. doi: 10.3233/JAD-230744.
     PubMed     Abstract available
     
     
     
947. KEIZER HG, Brands R, Oosting RS, Seinen W, et al
     The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230991.
     PubMed     Abstract available
     
     
     
948. PARK YS, Joo HJ, Jang YS, Jeon H, et al
     Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
     J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230715.
     PubMed     Abstract available
     
     
     
949. BAPAT R, Ma D, Duong TQ
     Predicting Four-Year's Alzheimer's Disease Onset Using Longitudinal Neurocognitive Tests and MRI Data Using Explainable Deep Convolutional Neural Networks.
     J Alzheimers Dis. 2023 Dec 16. doi: 10.3233/JAD-230893.
     PubMed     Abstract available
     
     
     
950. JANG YJ, Choi MG, Yoo BJ, Lee KJ, et al
     Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230927.
     PubMed     Abstract available
     
     
     
951. MALOTAUX V, Colmant L, Quenon L, Huyghe L, et al
     Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
     J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230696.
     PubMed     Abstract available
     
     
     
952. UKRAINTSEVA S, Duan H, Holmes R, Bagley O, et al
     Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-220998.
     PubMed     Abstract available
     
     
     
953. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
     A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-231034.
     PubMed     Abstract available
     
     
     
954. DA X, Hempel E, Ou Y, Rowe OE, et al
     Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-230506.
     PubMed     Abstract available
     
     
     
955. NGUYEN SA, Oughli HA, Lavretsky H
     Use of Complementary and Integrative Medicine for Alzheimer's Disease and Cognitive Decline.
     J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-230710.
     PubMed     Abstract available
     
     
     
956. SCHMUED L, Maloney B, Schmued C, Lahiri DK, et al
     Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-221285.
     PubMed     Abstract available
     
     
     November 2023
957. HAO N, Bai X, Hu A, Zhao G, et al
     Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer's Disease and Other Dementias Between 1990 and 2019.
     J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230827.
     PubMed     Abstract available
     
     
     
958. LI Y, Chen X, Zhou M, Feng S, et al
     Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230273.
     PubMed     Abstract available
     
     
     
959. CARPI M, Fernandes M, Mercuri NB, Liguori C, et al
     Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.
     J Alzheimers Dis. 2023 Nov 29. doi: 10.3233/JAD-230933.
     PubMed     Abstract available
     
     
     
960. WANG Y, Jiang R, Li M, Wang Z, et al
     Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients.
     J Alzheimers Dis. 2023 Nov 27. doi: 10.3233/JAD-230784.
     PubMed     Abstract available
     
     
     
961. ZHANG X, Wu P, Zhao Y
     COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.
     J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-231151.
     PubMed     Abstract available
     
     
     
962. CHU C, Low YLC, Ma L, Wang Y, et al
     How Can We Use Mathematical Modeling of Amyloid-beta in Alzheimer's Disease Research and Clinical Practices?
     J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-230938.
     PubMed     Abstract available
     
     
     
963. KAWARABAYASHI T, Nakamura T, Miyashita K, Segawa T, et al
     Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
     J Alzheimers Dis. 2023 Nov 23. doi: 10.3233/JAD-230419.
     PubMed     Abstract available
     
     
     
964. MELENDEZ JC, Satorres E, Pitarque A, Escudero J, et al
     Transcranial Direct Current Stimulation Intervention in Alzheimer's Disease and Its Follow-Up.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230826.
     PubMed     Abstract available
     
     
     
965. WANG X, Huang R, Huang B, Li X, et al
     S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230533.
     PubMed     Abstract available
     
     
     
966. JOHNSON CE, Duncan MJ, Murphy MP
     Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230527.
     PubMed     Abstract available
     
     
     
967. SPAMPINATO MV, Ulber JL, Fayyaz H, Sullivan A, et al
     Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-220835.
     PubMed     Abstract available
     
     
     
968. WHITE JP, Schembri A, Prenn-Gologranc C, Ondrus M, et al
     Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 21. doi: 10.3233/JAD-230352.
     PubMed     Abstract available
     
     
     
969. LEWIS JE, McDaniel HR, Woolger JM, Khan SA, et al
     The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230659.
     PubMed     Abstract available
     
     
     
970. MONLLOR P, Kumar P, Lloret MA, Ftara A, et al
     Multifactorial Causation of Alzheimer's Disease Due to COVID-19.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230396.
     PubMed     Abstract available
     
     
     
971. EL KADIRI W, Perrignon-Sommet M, Delpont B, Graber M, et al
     Changes in Taste Perception in Patients with Minor and Major Cognitive Impairment Linked to Alzheimer's Disease Recorded by Gustatory Evoked Potentials.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230270.
     PubMed     Abstract available
     
     
     
972. TETZLOFF KA, Duffy JR, Clark HM, Pham NTT, et al
     Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.
     J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230912.
     PubMed     Abstract available
     
     
     
973. ZHANG F, Petersen M, Johnson L, Hall J, et al
     Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230755.
     PubMed     Abstract available
     
     
     
974. DING P, Gurney M, Perry G, Xu R, et al
     Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230632.
     PubMed     Abstract available
     
     
     
975. GIUNTI E, Collu R, Daley S, Querfurth H, et al
     Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230551.
     PubMed     Abstract available
     
     
     
976. LIU YB, Wang XJ, Tan L, Tan CC, et al
     PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230516.
     PubMed     Abstract available
     
     
     
977. LAI D, Zhang M, Li R, Zhang C, et al
     Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score.
     J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230510.
     PubMed     Abstract available
     
     
     
978. BOZKURT AS, Yilmaz SG
     Ferroptotic Potency of ISM1 Expression in the Drug-Induced Alzheimer's Disease-Like Phenotype Under the Influence of Betulin.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230940.
     PubMed     Abstract available
     
     
     
979. LI JQ, Zhong XL, Song JH, Chi S, et al
     Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230936.
     PubMed     Abstract available
     
     
     
980. LOPES BOSCHETTI JC, Soares KL, Carvalho GR, Filho ACV, et al
     CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer's Disease: A Pilot Study.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230843.
     PubMed     Abstract available
     
     
     
981. YANG Z, Banks SJ, Ritter AR, Cummings JL, et al
     Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230631.
     PubMed     Abstract available
     
     
     
982. WU W, Shen A, Lee I, Miranda-Morales EG, et al
     Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
     J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230412.
     PubMed     Abstract available
     
     
     
983. ZENG XX, Zeng JB
     Systems Medicine as a Strategy to Deal with Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230739.
     PubMed     Abstract available
     
     
     
984. TAO S, Fan W, Liu J, Wang T, et al
     NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230567.
     PubMed     Abstract available
     
     
     
985. CERNOTOVA D, Hruzova K, Levcik D, Svoboda J, et al
     Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer's Disease: An Update.
     J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230333.
     PubMed     Abstract available
     
     
     
986. SNYTNIKOVA O, Telegina D, Savina E, Tsentalovich Y, et al
     Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
     J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230706.
     PubMed     Abstract available
     
     
     
987. FERNANDO MG, Silva R, Fernando WMADB, de Silva HA, et al
     Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
     J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230670.
     PubMed     Abstract available
     
     
     
988. MATSUMOTO H, Tagai K, Endo H, Matsuoka K, et al
     Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography.
     J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230581.
     PubMed     Abstract available
     
     
     
989. FREDERIKSEN KS, Lanctot KL, Weidner W, Hahn-Pedersen JH, et al
     A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
     J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230487.
     PubMed     Abstract available
     
     
     
990. SHINAGAWA H, Ohuchi K, Goto Y, Hashimoto K, et al
     Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230686.
     PubMed     Abstract available
     
     
     
991. AZAMI H, Daftarifard E, Humeau-Heurtier A, Fernandez A, et al
     Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
     J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230544.
     PubMed     Abstract available
     
     
     
992. LY M, Yu GZ, Chwa WJ, Raji CA, et al
     Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.
     J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230738.
     PubMed     Abstract available
     
     
     
993. LI K, Rashid T, Li J, Honnorat N, et al
     Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
     J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230389.
     PubMed     Abstract available
     
     
     
994. MANI S, Dubey R, Lai IC, Babu MA, et al
     Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
     J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
     PubMed     Abstract available
     
     
     
995. PERRON J, Scramstad C, Hyun Ko J
     Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
     J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
     PubMed     Abstract available
     
     
     October 2023
996. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
     Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
     J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
     PubMed     Abstract available
     
     
     
997. YANG J, Shi X, Wang Y, Ma M, et al
     Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
     J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
     PubMed     Abstract available
     
     
     
998. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
     How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
     J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
     PubMed     Abstract available
     
     
     
999. GRANT WB, Blake SM
     Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.
     J Alzheimers Dis. 2023 Oct 28. doi: 10.3233/JAD-230418.
     PubMed     Abstract available
     
     
     
1000. DONG Y, Hou T, Li Y, Liu R, et al
      Plasma Amyloid-beta, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
      J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230932.
      PubMed     Abstract available
      
      
      
1001. ALROUJI M, Majrashi TA, Alhumaydhi FA, Zari A, et al
      Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
      J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230828.
      PubMed     Abstract available
      
      
      
1002. INGANNATO A, Bessi V, Chiari A, Salvatori D, et al
      GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.
      J Alzheimers Dis. 2023 Oct 21. doi: 10.3233/JAD-230689.
      PubMed     Abstract available
      
      
      
1003. BEN KHEDHER MR, Haddad M, Fulop T, Laurin D, et al
      Implication of Circulating Extracellular Vesicles-Bound Amyloid-beta42 Oligomers in the Progression of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230823.
      PubMed     Abstract available
      
      
      
1004. HOANG MT, Kareholt I, Schon P, von Koch L, et al
      The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer's Disease and Other Dementias: A Swedish Nationwide Study.
      J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230388.
      PubMed     Abstract available
      
      
      
1005. TZENG IS
      Examination of Matching Methods, Sparse Effects, and Limitations in a Nationwide Database Study on Alzheimer's Disease.
      J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230701.
      PubMed     Abstract available
      
      
      
1006. LEE A, Shan D, Castle D, Rajji TK, et al
      Landscape of Phase II Trials in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230660.
      PubMed     Abstract available
      
      
      
1007. BUCHMAN AS, Leurgans SE, Kim N, Agrawal S, et al
      Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
      J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230223.
      PubMed     Abstract available
      
      
      
1008. JIANG J, Hong Y, Li W, Wang A, et al
      Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230577.
      PubMed     Abstract available
      
      
      
1009. XUE W, He W, Yan M, Zhao H, et al
      Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis.
      J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230559.
      PubMed     Abstract available
      
      
      
1010. XIA S, Chen H, Tang T
      Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.
      J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230554.
      PubMed     Abstract available
      
      
      
1011. LI A, Du J, Cai Y, Chen X, et al
      Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers.
      J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230446.
      PubMed     Abstract available
      
      
      
1012. BIAN Z, Hu X, Liu X, Yu H, et al
      Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
      J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230413.
      PubMed     Abstract available
      
      
      
1013. ROACH JC, Rapozo MK, Hara J, Glusman G, et al
      A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
      J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230403.
      PubMed     Abstract available
      
      
      
1014. KIM M, Yi D, Byun MS, Ahn H, et al
      Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
      J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
      PubMed     Abstract available
      
      
      
1015. AKUSHEVICH I, Yashkin A, Ukraintseva S, Yashin AI, et al
      The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.
      J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-221292.
      PubMed     Abstract available
      
      
      
1016. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
      Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
      J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
      PubMed     Abstract available
      
      
      
1017. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
      Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
      J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
      PubMed     Abstract available
      
      
      
1018. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
      Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
      J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
      PubMed     Abstract available
      
      
      
1019. LIU CC, Wang QH, Xin JY, Liu YH, et al
      Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
      J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
      PubMed     Abstract available
      
      
      September 2023
1020. BARBA L, Otto M, Abu-Rumeileh S
      The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
      J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
      PubMed     Abstract available
      
      
      
1021. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
      Toward Prevention and Reduction of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
      PubMed     Abstract available
      
      
      
1022. LIU Y, Shen Y
      Applications of Nanoparticles in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
      PubMed     Abstract available
      
      
      
1023. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
      Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
      PubMed     Abstract available
      
      
      
1024. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
      Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
      J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
      PubMed     Abstract available
      
      
      
1025. POLIN C, Gelle T, Auditeau E, Adou C, et al
      Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
      PubMed     Abstract available
      
      
      
1026. DALY T
      Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
      PubMed     Abstract available
      
      
      
1027. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
      Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
      J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
      PubMed     Abstract available
      
      
      
1028. ROGERS JT, Cahill CM
      Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
      PubMed     Abstract available
      
      
      
1029. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
      Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study.
      J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230458.
      PubMed     Abstract available
      
      
      
1030. CHOW TE, Veziris CR, Mundada N, Martinez-Arroyo AI, et al
      Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230367.
      PubMed     Abstract available
      
      
      
1031. QEADAN F, McCunn A, Tingey B, Price R, et al
      Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
      J Alzheimers Dis. 2023 Sep 21. doi: 10.3233/JAD-230714.
      PubMed     Abstract available
      
      
      
1032. DINNERSTEIN E
      Erratum to: The Time for Combination Therapy Research in Alzheimer's Disease is Now.
      J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-239010.
      PubMed    
      
      
      
1033. SUN Y, Moghekar A, Soldan A, Pettigrew C, et al
      Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.
      J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-230807.
      PubMed     Abstract available
      
      
      
1034. ALKON DL, Sun MK, Tuchman AJ, Thompson RE, et al
      Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.
      J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230868.
      PubMed     Abstract available
      
      
      
1035. LEIBY AC, Scambray KA, Nguyen HL, Basith F, et al
      Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
      J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230238.
      PubMed     Abstract available
      
      
      
1036. LARDELLI M, Baer L, Hin N, Allen A, et al
      The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer's Disease and Other Inherited Neurodegenerative Conditions.
      J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230522.
      PubMed     Abstract available
      
      
      
1037. ZHANG Y, Xue Y, Wang L, Han Z, et al
      rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
      J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230327.
      PubMed     Abstract available
      
      
      
1038. MERLO S, Costa L, Chiechio S, Busceti CL, et al
      Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230148.
      PubMed     Abstract available
      
      
      
1039. BLUSZTAJN JK, Aytan N, Rajendiran T, Mellott TJ, et al
      Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230543.
      PubMed     Abstract available
      
      
      
1040. PARRENO TORRES A, Roncero-Parra C, Borja AL, Mateo-Sotos J, et al
      Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via Classical Machine Learning Algorithms.
      J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230525.
      PubMed     Abstract available
      
      
      
1041. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
      Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230441.
      PubMed     Abstract available
      
      
      
1042. NIK AKHTAR S, Lu Q
      RhoA-LIMK Signaling Axis Reveals Rostral-Caudal Plane and Spatial Dysregulation in the Brain of Alzheimer's Disease Mouse Models.
      J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230408.
      PubMed     Abstract available
      
      
      
1043. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
      Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study.
      J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230317.
      PubMed     Abstract available
      
      
      
1044. YANG Y, Li M, Leng B, Yao R, et al
      Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
      J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-221288.
      PubMed     Abstract available
      
      
      
1045. TANG H, Sun Y, Fachim HA, Cheung TKD, et al
      Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
      J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230616.
      PubMed     Abstract available
      
      
      
1046. WITUCKI L, Borowczyk K, Suszynska-Zajczyk J, Warzych E, et al
      Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230578.
      PubMed     Abstract available
      
      
      
1047. GUIEYSSE T, Lamothe R, Houot M, Razafimahatratra S, et al
      Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230552.
      PubMed     Abstract available
      
      
      
1048. FERNANDES C, Montalvo G, Caligiuri M, Pertsinakis M, et al
      Handwriting Changes in Alzheimer's Disease: A Systematic Review.
      J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230438.
      PubMed     Abstract available
      
      
      
1049. XU X, Wang H, Zhang QY, Meng XY, et al
      Dissecting Mitochondrial Mechanisms of Alzheimer's Disease Using Gene Dependency Network and Its Implications for Discovering Nutrients Combatting the Disease.
      J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230366.
      PubMed     Abstract available
      
      
      
1050. LARDELLI M
      An Alternative View of Familial Alzheimer's Disease Genetics.
      J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230313.
      PubMed     Abstract available
      
      
      
1051. DE LA MONTE SM
      Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
      J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230555.
      PubMed     Abstract available
      
      
      
1052. FORTEL I, Zhan L, Ajilore O, Wu Y, et al
      Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230035.
      PubMed     Abstract available
      
      
      
1053. DAVIDSON S, Allenback G, Decourt B, Sabbagh MN, et al
      Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230489.
      PubMed     Abstract available
      
      
      
1054. FUKUDA H, Kanzaki H, Murata F, Maeda M, et al
      Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
      J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230471.
      PubMed     Abstract available
      
      
      
1055. ZIYAD SR, Altulyan M, Alharbi M
      SHMAD: A Smart Health Care System to Monitor Alzheimer's Disease Patients.
      J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230402.
      PubMed     Abstract available
      
      
      
1056. NAKAMURA Y, Narita K, Kim R, Nishiyama K, et al
      Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230386.
      PubMed     Abstract available
      
      
      
1057. VERDE F, Aiello EN, Adobbati L, Poletti B, et al
      Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
      J Alzheimers Dis. 2023 Sep 7. doi: 10.3233/JAD-230562.
      PubMed     Abstract available
      
      
      
1058. DU Y, Chen X, Zhang B, Jin X, et al
      Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230565.
      PubMed     Abstract available
      
      
      
1059. LEHMANN DJ, Elshorbagy A, Hurley MJ
      Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors.
      J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230295.
      PubMed     Abstract available
      
      
      
1060. KOPPELMANS V, Ruitenberg MFL, Schaefer SY, King JB, et al
      Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.
      J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221297.
      PubMed     Abstract available
      
      
      
1061. ADEWALE BA, Coker MM, Ogunniyi A, Kalaria RN, et al
      Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.
      J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221030.
      PubMed     Abstract available
      
      
      
1062. MAKRI M, Gkioka M, Moraitou D, Fidani L, et al
      Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.
      J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954.
      PubMed     Abstract available
      
      
      August 2023
1063. LI Z, Wu H, Ji Y, Shi Z, et al
      Toward Reagent-Free Discrimination of Alzheimer's Disease Using Blood Plasma Spectral Digital Biomarkers and Machine Learning.
      J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230248.
      PubMed     Abstract available
      
      
      
1064. GEZEN-AK D, Dursun E
      Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.
      J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230214.
      PubMed     Abstract available
      
      
      
1065. ZHANG J, Liu Q, Zhang H, Dai M, et al
      Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230027.
      PubMed     Abstract available
      
      
      
1066. FAZLOLLAHI A, Lee S, Coleman F, McCann E, et al
      Increased Resolution of Structural MRI at 3T Improves Estimation of Regional Cortical Degeneration in Individual Dementia Patients Using Surface Thickness Maps.
      J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230030.
      PubMed     Abstract available
      
      
      
1067. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
      Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
      J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
      PubMed     Abstract available
      
      
      
1068. WU Y, Eisel ULM
      Microglia-Astrocyte Communication in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
      PubMed     Abstract available
      
      
      
1069. SCHORK NJ, Elman JA
      Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
      J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230548.
      PubMed     Abstract available
      
      
      
1070. BEI J, Miranda-Morales EG, Gan Q, Qiu Y, et al
      Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.
      J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230347.
      PubMed     Abstract available
      
      
      
1071. SATTAROV R, Toresson H, Orbjorn C, Mattsson-Carlgren N, et al
      Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review.
      J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230119.
      PubMed     Abstract available
      
      
      
1072. HEIDARZADEH N, Ratte S
      'Eye-Tracking' with Words for Alzheimer's Disease Detection: Time Alignment of Words Enunciation with Image Regions During Image Description Tasks.
      J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-220711.
      PubMed     Abstract available
      
      
      
1073. LI J, Mountz EJ, Mizuno A, Shah AM, et al
      Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
      J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
      PubMed     Abstract available
      
      
      
1074. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
      Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
      J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
      PubMed     Abstract available
      
      
      
1075. JIANG J, Wang A, Liu Y, Yao Z, et al
      Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
      PubMed     Abstract available
      
      
      
1076. KIM DY, Kim JS, Seo YS, Park WY, et al
      Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
      J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
      PubMed     Abstract available
      
      
      
1077. ABYADEH M, Yadav VK, Kaya A
      Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
      J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
      PubMed     Abstract available
      
      
      
1078. JANN K, Boudreau J, Albrecht D, Cen SY, et al
      FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 18. doi: 10.3233/JAD-220851.
      PubMed     Abstract available
      
      
      
1079. MAMELAK M
      The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
      J Alzheimers Dis. 2023 Aug 14. doi: 10.3233/JAD-230415.
      PubMed     Abstract available
      
      
      
1080. KATISKO K, Kruger J, Soppela H, Hartikainen P, et al
      Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 12. doi: 10.3233/JAD-230494.
      PubMed     Abstract available
      
      
      
1081. KOBRO-FLATMOEN A, Hormann TM, Gouras G
      Intracellular Amyloid-beta in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 10. doi: 10.3233/JAD-230349.
      PubMed     Abstract available
      
      
      
1082. YANG H, Wang W, Jia L, Qin W, et al
      Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
      J Alzheimers Dis. 2023 Aug 8. doi: 10.3233/JAD-239007.
      PubMed    
      
      
      
1083. WANG X, Sundermann EE, Buckley RF, Reas ET, et al
      Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
      J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230466.
      PubMed     Abstract available
      
      
      
1084. KENKPEN AK, Storey JJ, Olson ER, Guden TE, et al
      Developing Connections Between LINC00298 RNA and Alzheimer's Disease Through Mapping Its Interactome and Through Biochemical Characterization.
      J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230057.
      PubMed     Abstract available
      
      
      
1085. HARRIS K, Ling Y, Bukhbinder AS, Chen L, et al
      The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.
      J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-221231.
      PubMed     Abstract available
      
      
      
1086. CONTI E, Grana D, Angiulli F, Karantzoulis A, et al
      TSPO Modulates Oligomeric Amyloid-beta-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 5. doi: 10.3233/JAD-230239.
      PubMed     Abstract available
      
      
      
1087. CAI HY, Yang D, Qiao J, Yang JT, et al
      Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 2. doi: 10.3233/JAD-239006.
      PubMed    
      
      
      
1088. QAISER H, Uzair M, Al-Regaiey K, Rafiq S, et al
      Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230394.
      PubMed     Abstract available
      
      
      
1089. MENDEZ MF
      Can Speaking More Than One Language Help Prevent Alzheimer's Disease?
      J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230285.
      PubMed     Abstract available
      
      
      
1090. SONG S, Asken B, Armstrong MJ, Yang Y, et al
      Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
      J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230208.
      PubMed     Abstract available
      
      
      
1091. BACHMAN SL, Blankenship JM, Busa M, Serviente C, et al
      Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development.
      J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230152.
      PubMed     Abstract available
      
      
      
1092. BAUMARD J
      Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?
      J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230731.
      PubMed     Abstract available
      
      
      July 2023
1093. LA BARBERA L, D'Amelio M
      Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model.
      J Alzheimers Dis. 2023 Jul 28. doi: 10.3233/JAD-230681.
      PubMed     Abstract available
      
      
      
1094. LIN Y, Hu T, Cheng L, Chen Y, et al
      Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
      J Alzheimers Dis. 2023 Jul 26. doi: 10.3233/JAD-230159.
      PubMed     Abstract available
      
      
      
1095. LEITAO ADG, Spencer B, Sarsoza F, Ngolab J, et al
      Hippocampal Reduction of alpha-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
      J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230232.
      PubMed     Abstract available
      
      
      
1096. VICENTE MC, Paneghini JL, Stabile AM, Amorim M, et al
      Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230151.
      PubMed     Abstract available
      
      
      
1097. NADEAU PA, Jobin B, Boller B
      Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-220991.
      PubMed     Abstract available
      
      
      
1098. VOSSEL K
      Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
      J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230613.
      PubMed     Abstract available
      
      
      
1099. WHITE LR, Corrada MM, Kawas CH, Cholerton BA, et al
      Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
      J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230331.
      PubMed     Abstract available
      
      
      
1100. NOWRANGI MA, Outen JD, Kim J, Avramopoulos D, et al
      Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development.
      J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-221247.
      PubMed     Abstract available
      
      
      
1101. 
      Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD, are the recipients of the 2023 Alzheimer Award.
      J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-239005.
      PubMed    
      
      
      
1102. LI J, Zeng Q, Luo X, Li K, et al
      Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Continuum.
      J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230503.
      PubMed     Abstract available
      
      
      
1103. LOPEZ-MARTOS D, Brugulat-Serrat A, Canas-Martinez A, Canals-Gispert L, et al
      Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
      J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230290.
      PubMed     Abstract available
      
      
      
1104. KILPATRICK LA, Siddarth P, Krause-Sorio B, Milillo MM, et al
      Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-221159.
      PubMed     Abstract available
      
      
      
1105. STALLARD E, Kociolek A, Jin Z, Ryu H, et al
      Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.
      J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-220811.
      PubMed     Abstract available
      
      
      
1106. YU Y, Xia X, Meng X, Li D, et al
      Plasma Phosphorylated Tau181 and Amyloid-beta42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
      J Alzheimers Dis. 2023 Jul 18. doi: 10.3233/JAD-230085.
      PubMed     Abstract available
      
      
      
1107. HARTLEY SL, Fleming V, Schworer EK, Peven J, et al
      Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
      J Alzheimers Dis. 2023 Jul 17. doi: 10.3233/JAD-230200.
      PubMed     Abstract available
      
      
      
1108. PUENTES-DIAZ N, Chaparro D, Reyes-Marquez V, Morales-Morales D, et al
      Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-230542.
      PubMed     Abstract available
      
      
      
1109. OLMOS-VILLASENOR R, Sepulveda-Silva C, Julio-Ramos T, Fuentes-Lopez E, et al
      Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-221272.
      PubMed     Abstract available
      
      
      
1110. CHENG C, Yang C, Jia C, Wang Q, et al
      The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner.
      J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230381.
      PubMed     Abstract available
      
      
      
1111. CHUM PP, Bishara MA, Solis SR, Behringer EJ, et al
      Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
      J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230300.
      PubMed     Abstract available
      
      
      
1112. CHEN R, Morris BJ, Donlon TA, Ross GW, et al
      Incidence of Alzheimer's Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype.
      J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230350.
      PubMed     Abstract available
      
      
      
1113. XU Y, Vasiljevic E, Deming YK, Jonaitis EM, et al
      Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
      J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230097.
      PubMed     Abstract available
      
      
      
1114. TIO ES, Hohman TJ, Milic M, Bennett DA, et al
      Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer's Disease and Aging.
      J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230434.
      PubMed     Abstract available
      
      
      
1115. KUDO S, Funayama M, Kurose S, Shimizu Y, et al
      Shadowing Behavior May Be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy.
      J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230257.
      PubMed     Abstract available
      
      
      
1116. MIGUEL L, Gervais J, Nicolas G, Lecourtois M, et al
      SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants.
      J Alzheimers Dis. 2023 Jul 8. doi: 10.3233/JAD-230211.
      PubMed     Abstract available
      
      
      
1117. YANG Y, Lv J, Bai H, Ren L, et al
      Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jul 7. doi: 10.3233/JAD-230291.
      PubMed     Abstract available
      
      
      
1118. XIA ZD, Ma RX, Wen JF, Zhai YF, et al
      Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230326.
      PubMed     Abstract available
      
      
      
1119. MAO M, Wang C, Hou T, Han X, et al
      Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
      J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230056.
      PubMed     Abstract available
      
      
      
1120. ZHANG HQ, Chau ACM, Shea YF, Chiu PK, et al
      Disrupted Structural White Matter Network in Alzheimer's Disease Continuum, Vascular Dementia, and Mixed Dementia: A Diffusion Tensor Imaging Study.
      J Alzheimers Dis. 2023 Jul 3. doi: 10.3233/JAD-230341.
      PubMed     Abstract available
      
      
      June 2023
1121. CAI HY, Hou SJ, Wen R, Feng QF, et al
      Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
      J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230128.
      PubMed     Abstract available
      
      
      
1122. AKADA K, Koyama N, Miura Y, Takahashi K, et al
      Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230106.
      PubMed     Abstract available
      
      
      
1123. HANSEN SB
      Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
      J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-230538.
      PubMed     Abstract available
      
      
      
1124. MOBASHERI K, Zaefizadeh M, Ghobeh M, Eidi A, et al
      Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats.
      J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-221095.
      PubMed     Abstract available
      
      
      
1125. MERTEN N, Pinto AA, Paulsen AJ, Chen Y, et al
      Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
      J Alzheimers Dis. 2023 Jun 28. doi: 10.3233/JAD-221287.
      PubMed     Abstract available
      
      
      
1126. SCHAFER HACKENHAAR F, Josefsson M, Nordin Adolfsson A, Landfors M, et al
      Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-230039.
      PubMed     Abstract available
      
      
      
1127. CHHIMPA N, Singh N, Puri N, Kayath HP, et al
      The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-220514.
      PubMed     Abstract available
      
      
      
1128. KANG JM, Shin JH, Kim WR, Seo S, et al
      Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230339.
      PubMed     Abstract available
      
      
      
1129. SORRENTINO F, Fenoglio C, Sacchi L, Serpente M, et al
      Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.
      J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230322.
      PubMed     Abstract available
      
      
      
1130. ALVES SS, de Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, et al
      Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
      J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230153.
      PubMed     Abstract available
      
      
      
1131. ZHANG J, Gao S, Liu W
      Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230177.
      PubMed     Abstract available
      
      
      
1132. AUDRONYTE E, Pakulaite-Kazliene G, Sutnikiene V, Kaubrys G, et al
      Odor Discrimination as a Marker of Early Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230077.
      PubMed     Abstract available
      
      
      
1133. KULMINSKI AM, Feng F, Loiko E, Nazarian A, et al
      Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
      J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230397.
      PubMed     Abstract available
      
      
      
1134. JEONG SH, Cha J, Jung JH, Yun M, et al
      Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer's Disease Continuum.
      J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230187.
      PubMed     Abstract available
      
      
      
1135. HAUTECLOQUE-RAYSZ G, Sellal F, Bousiges O, Phillipi N, et al
      Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
      J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-221197.
      PubMed     Abstract available
      
      
      
1136. BELAN AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, et al
      Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230250.
      PubMed     Abstract available
      
      
      
1137. CHEN W, Lin C, Su F, Fang Y, et al
      Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.
      J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230182.
      PubMed     Abstract available
      
      
      
1138. FU XX, Wei B, Cao HM, Duan R, et al
      Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
      J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-230133.
      PubMed     Abstract available
      
      
      
1139. ORTI-CASAN N, Wajant H, Kuiperij HB, Hooijsma A, et al
      Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
      J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-221230.
      PubMed     Abstract available
      
      
      
1140. BOLLINGER RM, Gabel M, Coble DW, Chen SW, et al
      Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.
      J Alzheimers Dis. 2023 Jun 18. doi: 10.3233/JAD-230079.
      PubMed     Abstract available
      
      
      
1141. NAKAMURA Y, Omori T, Kim R, Nishiyama K, et al
      Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study.
      J Alzheimers Dis. 2023 Jun 14. doi: 10.3233/JAD-230387.
      PubMed     Abstract available
      
      
      
1142. YAN R, Wang W, Yang W, Huang M, et al
      Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.
      J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230314.
      PubMed     Abstract available
      
      
      
1143. JIANG WR, Wu W, Yang LJ, Yang W, et al
      Alteration of Cognitive Function in Aging and Alzheimer's Disease Mice Is Related to Dysfunction of the Neuroimmune System.
      J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230292.
      PubMed     Abstract available
      
      
      
1144. MANSOR NI, Ling KH, Rosli R, Hassan Z, et al
      Centella asiatica (L.) Urban. Attenuates Cell Damage in Hydrogen Peroxide-Induced Oxidative Stress in Transgenic Murine Embryonic Stem Cell Line-Derived Neural-Like Cells: A Preliminary Study for Potential Treatment of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-221233.
      PubMed     Abstract available
      
      
      
1145. XU GY, Liu YH, Zeng XQ, Chen DW, et al
      The Diagnostic Potential of Circulating Autoantibodies to Amyloid-beta in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230252.
      PubMed     Abstract available
      
      
      
1146. QAISAR R, Karim A, Iqbal MS, Alkahtani SA, et al
      ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230201.
      PubMed     Abstract available
      
      
      
1147. PATEL S, Wei J, Shi Z, Rifkin AS, et al
      Refining Risk for Alzheimer's Disease Among Heterozygous APOEvarepsilon4 Carriers.
      J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230156.
      PubMed     Abstract available
      
      
      
1148. PEAVY GM
      Can't Have One Without the Other: Study Partner Retention in Alzheimer's Disease Research.
      J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230455.
      PubMed     Abstract available
      
      
      
1149. VANNINEN A, Lukkarinen H, Kokkola T, Koivisto AM, et al
      Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
      J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230144.
      PubMed     Abstract available
      
      
      
1150. MILANO C, Hoxhaj D, Del Chicca M, Pascazio A, et al
      Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.
      J Alzheimers Dis. 2023 Jun 9. doi: 10.3233/JAD-230170.
      PubMed     Abstract available
      
      
      
1151. HU D, Dong X, Wang Q, Liu M, et al
      PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-beta Protein Precursor Processing.
      J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230192.
      PubMed     Abstract available
      
      
      
1152. ZHANG X, Liu Y, Huang M, Gunewardena S, et al
      Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals.
      J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230316.
      PubMed     Abstract available
      
      
      
1153. RUDGE JD
      The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Jun 3. doi: 10.3233/JAD-221175.
      PubMed     Abstract available
      
      
      May 2023
1154. SUN L, Ye KX, Wong HLK, Wang L, et al
      The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
      PubMed     Abstract available
      
      
      
1155. HAZAN J, Liu K, Fox N, Howard R, et al
      Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
      J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
      PubMed     Abstract available
      
      
      
1156. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
      Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
      J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
      PubMed     Abstract available
      
      
      
1157. LI D, Yu YY, Hu N, Zhang M, et al
      Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
      J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221227.
      PubMed     Abstract available
      
      
      
1158. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
      The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
      J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
      PubMed     Abstract available
      
      
      
1159. LIU M, Li M, He J, He Y, et al
      Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
      PubMed     Abstract available
      
      
      
1160. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
      Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
      J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
      PubMed     Abstract available
      
      
      
1161. LIU J, Xie Y, Lu Y, Zhao Z, et al
      APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
      J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
      PubMed     Abstract available
      
      
      
1162. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
      Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
      PubMed     Abstract available
      
      
      
1163. MI Z, Abrahamson EE, Ryu AY, Malek-Ahmadi M, et al
      Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 19. doi: 10.3233/JAD-221063.
      PubMed     Abstract available
      
      
      
1164. PUOYAN-MAJD S, Parnow A, Rashno M, Heidarimoghadam R, et al
      The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230096.
      PubMed     Abstract available
      
      
      
1165. MORI H, Yoshino Y, Iga JI, Ochi S, et al
      Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230078.
      PubMed     Abstract available
      
      
      
1166. HUI HYH, Ran AR, Dai JJ, Cheung CY, et al
      Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.
      J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230055.
      PubMed     Abstract available
      
      
      
1167. ELZAYAT EM, Shahien SA, El-Sherif AA, Hosney M, et al
      miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221298.
      PubMed     Abstract available
      
      
      
1168. QUERRY M, Blanc F, Bousiges O, Philippi N, et al
      Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
      J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221243.
      PubMed     Abstract available
      
      
      
1169. GONZALEZ C, Mimmack KJ, Amariglio RE, Becker JA, et al
      Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
      J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-220885.
      PubMed     Abstract available
      
      
      
1170. VOLLOCH V, Rits-Volloch S
      Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
      J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-230164.
      PubMed     Abstract available
      
      
      
1171. ORTNER M, Lanz K, Goldhardt O, Muller-Sarnowski F, et al
      Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
      J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-221187.
      PubMed     Abstract available
      
      
      
1172. WHEELERA CJ
      Evolutionary Selection of APOEvarepsilon4 Encourages Increased Focus on Immunity in Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230390.
      PubMed     Abstract available
      
      
      
1173. DINNERSETIN E
      The Time for Combination Therapy Research in Alzheimer's Disease is Now.
      J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230254.
      PubMed    
      
      
      
1174. HIROTA Y, Sakakibara Y, Takei K, Nishijima R, et al
      Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology.
      J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230121.
      PubMed     Abstract available
      
      
      
1175. WHITE LR
      If Midlife Brain Injury Is a Risk Factor for Alzheimer's Disease and Related Dementias, What Is the Neuropathologic Mechanism?
      J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230332.
      PubMed     Abstract available
      
      
      
1176. TOPPING M, Kim J, Fletcher J
      Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth.
      J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230086.
      PubMed     Abstract available
      
      
      
1177. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
      Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
      J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
      PubMed     Abstract available
      
      
      
1178. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
      Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
      J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
      PubMed     Abstract available
      
      
      
1179. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
      Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
      J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
      PubMed     Abstract available
      
      
      
1180. LIN H, Pan T, Wang M, Ge J, et al
      Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
      PubMed     Abstract available
      
      
      
1181. YAN Y, Wu Y, Xiao G, Wang L, et al
      White Matter Changes as an Independent Predictor of Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
      PubMed     Abstract available
      
      
      
1182. CHENG J, Zheng H, Liu C, Jin J, et al
      Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
      PubMed     Abstract available
      
      
      
1183. LI Y, Chang J, Chen X, Liu J, et al
      Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
      PubMed     Abstract available
      
      
      
1184. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
      Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
      PubMed     Abstract available
      
      
      
1185. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
      Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
      PubMed     Abstract available
      
      
      
1186. BLUSZTAJN JK, Slack BE
      Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
      PubMed     Abstract available
      
      
      
1187. ABBATE C
      The Adult Neurogenesis Theory of Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
      PubMed     Abstract available
      
      
      
1188. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
      Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
      PubMed     Abstract available
      
      
      
1189. MOYAERT P, Beun S, Achten E, Clement P, et al
      Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
      PubMed     Abstract available
      
      
      
1190. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
      Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
      J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
      PubMed     Abstract available
      
      
      April 2023
1191. HSIAO WW, Angela S, Le TN, Ku CC, et al
      Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays.
      J Alzheimers Dis. 2023 Apr 28. doi: 10.3233/JAD-221202.
      PubMed     Abstract available
      
      
      
1192. PRESS DZ, Musaeus CS, Zhao L, Breton J, et al
      Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI.
      J Alzheimers Dis. 2023 Apr 26. doi: 10.3233/JAD-220614.
      PubMed     Abstract available
      
      
      
1193. ZHANG K, Du X, Gao Y, Liu S, et al
      Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment.
      J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221253.
      PubMed     Abstract available
      
      
      
1194. LIU R, Zhang L, You H
      Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221147.
      PubMed     Abstract available
      
      
      
1195. LIEW Y, Retinasamy T, Arulsamy A, Ali I, et al
      Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
      J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-230059.
      PubMed     Abstract available
      
      
      
1196. LIANG J, LeFleur B, Hussainy S, Perry G, et al
      Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
      J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-221241.
      PubMed     Abstract available
      
      
      
1197. OTOKI Y, Yu D, Shen Q, Sahlas DJ, et al
      Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
      J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-220795.
      PubMed     Abstract available
      
      
      
1198. SINGH M, Jindal D, Kumar R, Pancham P, et al
      Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221222.
      PubMed     Abstract available
      
      
      
1199. WILLIAMS E, Mutlu-Smith M, Alex A, Chin XW, et al
      Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221185.
      PubMed     Abstract available
      
      
      
1200. STARK J, Hiersche KJ, Yu JC, Hasselbach AN, et al
      Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
      J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221084.
      PubMed     Abstract available
      
      
      
1201. HENDRIE HC
      Screening and Assessment for Alzheimer's Disease in the Days of Biological Biomarkers.
      J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230215.
      PubMed     Abstract available
      
      
      
1202. TIAN J, Stucky C, Wang T, Muma NA, et al
      Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230072.
      PubMed     Abstract available
      
      
      
1203. ZHAO Z, Wang J, Wang Y, Liu X, et al
      18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
      J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-221251.
      PubMed     Abstract available
      
      
      
1204. EITHZ N, Sorensen J, Sopina L
      Healthcare Costs in the Year Before and After Alzheimer's Disease Diagnosis: A Danish Register-Based Matched Cohort Study.
      J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-220821.
      PubMed     Abstract available
      
      
      
1205. JIA J, Zhang Y, Shi Y, Yina X, et al
      Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
      PubMed    
      
      
      
1206. MAO C, You H, Hou B, Chu S, et al
      Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
      J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
      PubMed     Abstract available
      
      
      
1207. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
      Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
      J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
      PubMed     Abstract available
      
      
      
1208. QIAN L, Bian W, Wang D, Ming Z, et al
      Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
      PubMed     Abstract available
      
      
      
1209. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
      Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
      J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
      PubMed     Abstract available
      
      
      March 2023
1210. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
      Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-230068.
      PubMed     Abstract available
      
      
      
1211. RAHMANI F, Ghezzi L, Tosti V, Liu J, et al
      Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-221007.
      PubMed     Abstract available
      
      
      
1212. ZIYAD SR, Alharbi M, Altulyan M
      Artificial Intelligence Model for Alzheimer's Disease Detection with Convolution Neural Network for Magnetic Resonance Images.
      J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221250.
      PubMed     Abstract available
      
      
      
1213. SUN Y, Hu HY, Hu H, Huang LY, et al
      Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221207.
      PubMed     Abstract available
      
      
      
1214. FORTEA J, Garcia-Arcelay E, Terrancle A, Galvez B, et al
      Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221160.
      PubMed     Abstract available
      
      
      
1215. WIDJAYA MA, Cheng YJ, Kuo YM, Liu CH, et al
      Transcriptomic Analyses of Exercise Training in Alzheimer's Disease Cerebral Cortex.
      J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221139.
      PubMed     Abstract available
      
      
      
1216. NAKAMURA T, Kawarabayashi T, Ueda T, Shimomura S, et al
      Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta 40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-220996.
      PubMed     Abstract available
      
      
      
1217. HOOK G, Kindy M, Hook V
      Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-beta in hAbetaPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
      J Alzheimers Dis. 2023 Mar 21. doi: 10.3233/JAD-221005.
      PubMed     Abstract available
      
      
      
1218. FILLENBAUM GG, Mohs R
      CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
      J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-230026.
      PubMed     Abstract available
      
      
      
1219. BAYAT S, Roe CM, Schindler S, Murphy SA, et al
      Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
      J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268.
      PubMed     Abstract available
      
      
      
1220. DOLCET-NEGRE MM, Imaz Aguayo L, de Eulate RG, Marti-Andres G, et al
      Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
      J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221002.
      PubMed     Abstract available
      
      
      
1221. MOON SW, Byun MS, Yi D, Kim MJ, et al
      Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
      J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-220911.
      PubMed     Abstract available
      
      
      
1222. MAN S, Chen B, Zhang Y, Xu H, et al
      The Associations Between Cataracts and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
      J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221137.
      PubMed     Abstract available
      
      
      
1223. GOLAS AC, Salwierz P, Rajji TK, Bowie CR, et al
      Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221097.
      PubMed     Abstract available
      
      
      
1224. HE Y, Li J, Yi L, Li X, et al
      Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer's Disease Models.
      J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221115.
      PubMed     Abstract available
      
      
      
1225. HOLLENBENDERS Y, Pobiruchin M, Reichenbach A
      Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions.
      J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221061.
      PubMed     Abstract available
      
      
      
1226. BONOMI CG, Assogna M, Di Donna MG, Bernocchi F, et al
      Cerebrospinal Fluid sTREM-2, GFAP, and beta-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
      J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221010.
      PubMed     Abstract available
      
      
      
1227. XU S, Xie L, Zhang Y, Wu X, et al
      Inferior Frontal Sulcal Hyperintensity on FLAIR Is Associated with Small Vessel Disease but not Alzheimer's Disease Pathology.
      J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-220843.
      PubMed     Abstract available
      
      
      
1228. XU Y, Zheng F, Zhong Q, Zhu Y, et al
      Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
      J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
      PubMed     Abstract available
      
      
      
1229. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
      NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
      PubMed     Abstract available
      
      
      
1230. SHAH J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, et al
      Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
      J Alzheimers Dis. 2023 Mar 3. doi: 10.3233/JAD-221261.
      PubMed     Abstract available
      
      
      
1231. LIU H, Reynolds GP, Wei X
      The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
      J Alzheimers Dis. 2023 Mar 2. doi: 10.3233/JAD-221226.
      PubMed     Abstract available
      
      
      February 2023
1232. LOUGHMAN A, Adler C, Macpherson H
      Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?
      J Alzheimers Dis. 2023 Feb 27. doi: 10.3233/JAD-220760.
      PubMed     Abstract available
      
      
      
1233. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M, et al
      Neuroprotective Effect of Combined Treatment with Epigallocatechin 3-Gallate and Melatonin on Familial Alzheimer's Disease PSEN1 E280A Cerebral Spheroids Derived from Menstrual Mesenchymal Stromal Cells.
      J Alzheimers Dis. 2023 Feb 24. doi: 10.3233/JAD-220903.
      PubMed     Abstract available
      
      
      
1234. ATWOOD CS, Perry G
      Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke?
      J Alzheimers Dis. 2023 Feb 22. doi: 10.3233/JAD-230040.
      PubMed     Abstract available
      
      
      
1235. WALKER JM, Gonzales MM, Goette W, Farrell K, et al
      Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
      J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-230022.
      PubMed     Abstract available
      
      
      
1236. DEMARSHALL CA, Viviano J, Emrani S, Thayasivam U, et al
      Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers.
      J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-221091.
      PubMed     Abstract available
      
      
      
1237. ACOSTA-BAENA N, Lopera-Gomez CM, Jaramillo-Elorza MC, Velilla-Jimenez L, et al
      Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
      J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221294.
      PubMed     Abstract available
      
      
      
1238. YIN W, Wan K, Zhu W, Zhou X, et al
      Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
      J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221174.
      PubMed     Abstract available
      
      
      
1239. DING P, Gorenflo MP, Zhu X, Xu R, et al
      Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.
      J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-220787.
      PubMed     Abstract available
      
      
      January 2023
1240. MASCARENHAS FONSECA L, Sage Chaytor N, Olufadi Y, Buchwald D, et al
      Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
      J Alzheimers Dis. 2023;91:1395-1407.
      PubMed     Abstract available
      
      
      
1241. SACRIPANTE R, Girtler N, Doglione E, Nobili F, et al
      Forgetting Rates of Prose Memory in Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;91:1385-1394.
      PubMed     Abstract available
      
      
      
1242. HAYS WEEKS CC, Zlatar ZZ, Meloy MJ, Shin DD, et al
      APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance.
      J Alzheimers Dis. 2023;91:1371-1383.
      PubMed     Abstract available
      
      
      
1243. JANSE A, van de Rest O, de Groot LCPGM, Witkamp RF, et al
      The Association of Vitamin D Status with Mild Cognitive Impairment and Dementia Subtypes: A Cross-Sectional Analysis in Dutch Geriatric Outpatients.
      J Alzheimers Dis. 2023;91:1359-1369.
      PubMed     Abstract available
      
      
      
1244. MARIN-MARIN L, Miro-Padilla A, Costumero V
      Structural But Not Functional Connectivity Differences within Default Mode Network Indicate Conversion to Dementia.
      J Alzheimers Dis. 2023;91:1483-1494.
      PubMed     Abstract available
      
      
      
1245. LIU C, Lee SH, Loewenstein DA, Galvin JE, et al
      Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.
      J Alzheimers Dis. 2023;91:1313-1322.
      PubMed     Abstract available
      
      
      
1246. HUQUE H, Eramudugolla R, Chidiac B, Ee N, et al
      Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023;91:1231-1241.
      PubMed     Abstract available
      
      
      
1247. BOUGES S, Fischer BL, Norton DL, Wyman MF, et al
      Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.
      J Alzheimers Dis. 2023;92:285-294.
      PubMed     Abstract available
      
      
      
1248. YOSHIDA M, Uemura T, Mizoi M, Waragai M, et al
      Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
      J Alzheimers Dis. 2023;92:361-369.
      PubMed     Abstract available
      
      
      
1249. BAEZ S, Trujillo-Llano C, de Souza LC, Lillo P, et al
      Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.
      J Alzheimers Dis. 2023;92:153-169.
      PubMed     Abstract available
      
      
      
1250. HUANG Z
      A Function of Amyloid-beta in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
      J Alzheimers Dis. 2023;92:29-57.
      PubMed     Abstract available
      
      
      
1251. GRASSET L, Power MC, Crivello F, Tzourio C, et al
      How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.
      J Alzheimers Dis. 2023;92:183-193.
      PubMed     Abstract available
      
      
      
1252. CORRERO II AN, Gauthreaux K, Perales-Puchalt J, Chen YC, et al
      Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.
      J Alzheimers Dis. 2023;92:109-128.
      PubMed     Abstract available
      
      
      
1253. MOEBIUS HJ, Church KJ
      The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
      J Alzheimers Dis. 2023;92:1-12.
      PubMed     Abstract available
      
      
      
1254. YANG M, Qi R, Liu Y, Shen X, et al
      Casein Kinase 1delta Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
      J Alzheimers Dis. 2023;91:1527-1539.
      PubMed     Abstract available
      
      
      
1255. ONO R, Sakurai T, Sugimoto T, Uchida K, et al
      Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
      J Alzheimers Dis. 2023;92:487-498.
      PubMed     Abstract available
      
      
      
1256. GABRIELLI AP, Weidling I, Ranjan A, Wang X, et al
      Mitochondria Profoundly Influence Apolipoprotein E Biology.
      J Alzheimers Dis. 2023;92:591-604.
      PubMed     Abstract available
      
      
      
1257. TAN YJ, Siow I, Saffari SE, Ting SKS, et al
      Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
      J Alzheimers Dis. 2023;92:573-580.
      PubMed     Abstract available
      
      
      
1258. ROYALL DR, Palmer RF
      Multiple Adipokines Predict Dementia Severity as Measured by delta: Replication Across Biofluids and Cohorts.
      J Alzheimers Dis. 2023;92:639-652.
      PubMed     Abstract available
      
      
      
1259. MANN FD, Clouston SAP, Cuevas A, Waszczuk MA, et al
      Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders.
      J Alzheimers Dis. 2023;92:701-712.
      PubMed     Abstract available
      
      
      
1260. TANG M, Su N, Zhang D, Dai Y, et al
      The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations.
      J Alzheimers Dis. 2023;92:691-700.
      PubMed     Abstract available
      
      
      
1261. GYLLENHAMMAR M, Rennie A, Padilla DF, Wallert J, et al
      The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.
      J Alzheimers Dis. 2023;92:605-614.
      PubMed     Abstract available
      
      
      
1262. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
      Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
      J Alzheimers Dis. 2023;92:1027-1035.
      PubMed     Abstract available
      
      
      
1263. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
      Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
      J Alzheimers Dis. 2023;92:1093-1109.
      PubMed     Abstract available
      
      
      
1264. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
      The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
      J Alzheimers Dis. 2023;92:769-789.
      PubMed     Abstract available
      
      
      
1265. LI QY, Li XM, Hu HY, Ma YH, et al
      Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
      J Alzheimers Dis. 2023;92:853-873.
      PubMed     Abstract available
      
      
      
1266. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
      Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
      J Alzheimers Dis. 2023;92:959-974.
      PubMed     Abstract available
      
      
      
1267. KIM BS, Jun S, Kim H
      Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;92:803-814.
      PubMed     Abstract available
      
      
      
1268. ZHANG F, Niu L, Zhong R, Li S, et al
      Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AbetaPP/PS1 AD Mice and Their Wild-Type Littermates.
      J Alzheimers Dis. 2023;92:1341-1355.
      PubMed     Abstract available
      
      
      
1269. BUKHBINDER AS, Hinojosa M, Harris K, Li X, et al
      Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
      J Alzheimers Dis. 2023;92:1323-1339.
      PubMed     Abstract available
      
      
      
1270. KAWAKATSU S, Kobayashi R
      Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
      J Alzheimers Dis. 2023;93:389-392.
      PubMed     Abstract available
      
      
      
1271. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
      Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
      J Alzheimers Dis. 2023;93:247-262.
      PubMed     Abstract available
      
      
      
1272. GAO Y, Liu Y, Zhang Y, Wang Y, et al
      Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
      J Alzheimers Dis. 2023;93:169-178.
      PubMed     Abstract available
      
      
      
1273. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
      Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
      J Alzheimers Dis. 2023;93:365-378.
      PubMed     Abstract available
      
      
      
1274. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
      Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
      J Alzheimers Dis. 2023;93:151-167.
      PubMed     Abstract available
      
      
      
1275. LV X, Chu M, Liu Y, Jing D, et al
      Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
      J Alzheimers Dis. 2023;93:295-305.
      PubMed     Abstract available
      
      
      
1276. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
      The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
      J Alzheimers Dis. 2023;93:307-319.
      PubMed     Abstract available
      
      
      
1277. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
      Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
      J Alzheimers Dis. 2023;93:211-224.
      PubMed     Abstract available
      
      
      
1278. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
      The Future of Cognitive Screening in Neurodegenerative Diseases.
      J Alzheimers Dis. 2023;93:47-59.
      PubMed     Abstract available
      
      
      
1279. KREBS C, Brill E, Minkova L, Federspiel A, et al
      Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
      J Alzheimers Dis. 2023;93:107-124.
      PubMed     Abstract available
      
      
      
1280. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
      Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
      J Alzheimers Dis. 2023;93:61-74.
      PubMed     Abstract available
      
      
      
1281. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
      Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;93:75-86.
      PubMed     Abstract available
      
      
      
1282. FLETCHER E
      Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
      J Alzheimers Dis. 2023;93:815-819.
      PubMed     Abstract available
      
      
      
1283. CASTELLANI RJ, Shanes ED, McCord M, Reish NJ, et al
      Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report.
      J Alzheimers Dis. 2023;93:803-813.
      PubMed     Abstract available
      
      
      
1284. XIAO Y, Liao L, Huang K, Yao S, et al
      Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
      J Alzheimers Dis. 2023;93:791-801.
      PubMed     Abstract available
      
      
      
1285. HICKEY M, Hueg TK, Priskorn L, Uldbjerg CS, et al
      Depression in Mid- and Later-Life and Risk of Dementia in Women: A Prospective Study within the Danish Nurses Cohort.
      J Alzheimers Dis. 2023;93:779-789.
      PubMed     Abstract available
      
      
      
1286. CHEN CD, Ponisio MR, Lang JA, Flores S, et al
      Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.
      J Alzheimers Dis. 2023;93:765-777.
      PubMed     Abstract available
      
      
      
1287. HATTORI Y, Saito S, Nakaoku Y, Ogata S, et al
      Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
      J Alzheimers Dis. 2023;93:743-754.
      PubMed     Abstract available
      
      
      
1288. ZHANG LY, Wang DZ, Wang J, Guo L, et al
      Associations of Serum Antimicrobial Peptide LL-37 with Longitudinal Cognitive Decline and Neurodegeneration Among Older Adults with Memory Complaints.
      J Alzheimers Dis. 2023;93:595-603.
      PubMed     Abstract available
      
      
      
1289. AGUILAR-BARBERA M, Soler-Girabau P, Tabuenca-Martin AI, Prieto-Del Val L, et al
      Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
      J Alzheimers Dis. 2023;93:621-631.
      PubMed     Abstract available
      
      
      
1290. SIBLE IJ, Nation DA
      Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes.
      J Alzheimers Dis. 2023;93:533-543.
      PubMed     Abstract available
      
      
      
1291. BISWAS R, Kawas C, Montine TJ, Bukhari SA, et al
      Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
      J Alzheimers Dis. 2023;93:561-575.
      PubMed     Abstract available
      
      
      
1292. BROOK ES, D'Alonzo ZJ, Lam V, Chan DC, et al
      Plasma Amyloid-beta Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.
      J Alzheimers Dis. 2023;93:653-664.
      PubMed     Abstract available
      
      
      
1293. RHYU JM, Park J, Shin BS, Kim YE, et al
      A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia.
      J Alzheimers Dis. 2023;93:403-409.
      PubMed     Abstract available
      
      
      
1294. DUFF K, Wan L, Embree L, Hoffman JM, et al
      Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.
      J Alzheimers Dis. 2023;93:449-457.
      PubMed     Abstract available
      
      
      
1295. ZHANG J, Zhang T, Wang Y, Yao L, et al
      Galpha13-Mediated Signaling Cascade Is Related to the Tau Pathology Caused by Anesthesia and Surgery in 5XFAD Transgenic Mice.
      J Alzheimers Dis. 2023;93:545-560.
      PubMed     Abstract available
      
      
      
1296. IMAI A, Matsuoka T, Narumoto J
      Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.
      J Alzheimers Dis. 2023;93:521-532.
      PubMed     Abstract available
      
      
      
1297. ZHENG YB, Sun J, Shi L, Su SZ, et al
      Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
      J Alzheimers Dis. 2023;93:483-493.
      PubMed     Abstract available
      
      
      
1298. NOBLE JM, Papapanou PN
      With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease.
      J Alzheimers Dis. 2023;93:991-994.
      PubMed     Abstract available
      
      
      
1299. GOLLOP C, Zingel R, Jacob L, Smith L, et al
      Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study.
      J Alzheimers Dis. 2023;93:1033-1040.
      PubMed     Abstract available
      
      
      
1300. FAN J, Zhu Z, Chen Y, Yang C, et al
      SORL1 rs1699102 Moderates the Effect of Sex on Language Network.
      J Alzheimers Dis. 2023;93:1051-1063.
      PubMed     Abstract available
      
      
      
1301. WU J, Su Y, Chen Y, Zhu W, et al
      A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry.
      J Alzheimers Dis. 2023;93:1153-1168.
      PubMed     Abstract available
      
      
      
1302. JIANG C, Wang Y, Dong Y, Liu R, et al
      Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
      J Alzheimers Dis. 2023;93:1111-1124.
      PubMed     Abstract available
      
      
      
1303. MARSHALL AJ, Gaubert A, Kapoor A, Tan A, et al
      Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?
      J Alzheimers Dis. 2023;93:1041-1050.
      PubMed     Abstract available
      
      
      
1304. NIJSKENS C, Henstra M, Rhodius-Meester H, Yasar S, et al
      Cardiovascular Risk Management in Persons with Dementia.
      J Alzheimers Dis. 2023;93:879-889.
      PubMed     Abstract available
      
      
      
1305. GIBBONS LE, Power MC, Walker RL, Kumar RG, et al
      Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.
      J Alzheimers Dis. 2023;93:949-961.
      PubMed     Abstract available
      
      
      
1306. SMITH CJ, Ashford JW
      Apolipoprotein varepsilon4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations.
      J Alzheimers Dis. 2023;93:907-918.
      PubMed     Abstract available
      
      
      
1307. BAUERNSCHMIDT D, Hirt J, Langer G, Meyer G, et al
      Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023;93:891-906.
      PubMed     Abstract available
      
      
      
1308. PILONIETA G, Pisu M, Martin RC, Shan L, et al
      Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.
      J Alzheimers Dis. 2023;93:927-937.
      PubMed     Abstract available
      
      
      
1309. XIANG Q, Andersen SL, Sweigart B, Gunn S, et al
      Signatures of Neuropsychological Test Results in the Long Life Family Study: A Cluster Analysis.
      J Alzheimers Dis. 2023;93:1457-1469.
      PubMed     Abstract available
      
      
      
1310. BEST MN, Lim Y, Ferenc NN, Kim N, et al
      Extracellular Tau Oligomers Damage the Axon Initial Segment.
      J Alzheimers Dis. 2023;93:1425-1441.
      PubMed     Abstract available
      
      
      
1311. XU S, Ren Y, Liu R, Li Y, et al
      Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
      J Alzheimers Dis. 2023;93:1355-1368.
      PubMed     Abstract available
      
      
      
1312. YANG F, Yang L, Fang X, Deng Y, et al
      Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
      J Alzheimers Dis. 2023;93:1341-1354.
      PubMed     Abstract available
      
      
      
1313. NALLAPU BT, Petersen KK, Lipton RB, Grober E, et al
      Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
      J Alzheimers Dis. 2023;93:1381-1393.
      PubMed     Abstract available
      
      
      
1314. ANDERSSON MJ, Stone J
      Best Medicine for Dementia: The Life-Long Defense of the Brain.
      J Alzheimers Dis. 2023;94:51-66.
      PubMed     Abstract available
      
      
      
1315. DI J, Nelson RS, Jicha GA, Moga DC, et al
      Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
      J Alzheimers Dis. 2023;94:333-346.
      PubMed     Abstract available
      
      
      
1316. MEDURI G, Guillemeau K, Daguinot C, Dounane O, et al
      Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
      J Alzheimers Dis. 2023;94:313-331.
      PubMed     Abstract available
      
      
      
1317. SINHA N, Fausto BA, Mander B, Gluck MA, et al
      High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans.
      J Alzheimers Dis. 2023;94:281-290.
      PubMed     Abstract available
      
      
      
1318. BUAWANGPONG N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, et al
      Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
      J Alzheimers Dis. 2023;94:163-175.
      PubMed     Abstract available
      
      
      
1319. DE ANDA-DURAN I, Kolachalama VB, Carmichael OT, Hwang PH, et al
      Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.
      J Alzheimers Dis. 2023;94:101-113.
      PubMed     Abstract available
      
      
      
1320. LOUGHREY DG, Leroi I
      Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy.
      J Alzheimers Dis. 2023;94:597-599.
      PubMed     Abstract available
      
      
      
1321. OLIVEIRA FF
      Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases.
      J Alzheimers Dis. 2023;94:777-780.
      PubMed     Abstract available
      
      
      
1322. CURTIS ME, Smith T, Nenov M, Blass BE, et al
      Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome.
      J Alzheimers Dis. 2023;94:513-518.
      PubMed     Abstract available
      
      
      
1323. LI B, Shi K, Ren C, Kong M, et al
      Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features.
      J Alzheimers Dis. 2023;94:627-640.
      PubMed     Abstract available
      
      
      
1324. TOCCACELI BLASI M, Valletta M, Trebbastoni A, D'Antonio F, et al
      Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
      J Alzheimers Dis. 2023;94:601-610.
      PubMed     Abstract available
      
      
      
1325. WANG J, Wang M, Ren S, Huang L, et al
      The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
      J Alzheimers Dis. 2023;94:763-775.
      PubMed     Abstract available
      
      
      
1326. FARINA FR, Booi L, Occhipinti JA, Quoidbach V, et al
      Young Adult Brain Capital: A New Opportunity for Dementia Prevention.
      J Alzheimers Dis. 2023;94:415-423.
      PubMed     Abstract available
      
      
      
1327. MAURER A, Himmel G, Lange C, Mathies F, et al
      Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients.
      J Alzheimers Dis. 2023;94:559-584.
      PubMed     Abstract available
      
      
      
1328. EDWARDS L, Thomas KR, Weigand AJ, Edmonds EC, et al
      White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
      J Alzheimers Dis. 2023;94:695-707.
      PubMed     Abstract available
      
      
      
1329. CHOU OHI, Zhou J, Li L, Chan JSK, et al
      The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
      J Alzheimers Dis. 2023;94:547-557.
      PubMed     Abstract available
      
      
      
1330. LI T, Pappas C, Klinedinst B, Pollpeter A, et al
      Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults.
      J Alzheimers Dis. 2023;94.
      PubMed     Abstract available
      
      
      
1331. KOSTEV K
      Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk.
      J Alzheimers Dis. 2023;94:961-962.
      PubMed     Abstract available
      
      
      
1332. CASTELBLANCO-TORO SM, Jurado-Delgado J, Meneses-Bernal JF, Santacruz-Escudero JM, et al
      Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population.
      J Alzheimers Dis. 2023;94:1197-1207.
      PubMed     Abstract available
      
      
      
1333. CUBERO-PLAZAS L, Sancho-Cantus D, de la Rubia Orti JE, Prieto-Contreras L, et al
      Impact of Family Function on the Quality of Life and Health Perception of Non-Institutionalized Dementia Patients.
      J Alzheimers Dis. 2023;94:963-975.
      PubMed     Abstract available
      
      
      
1334. PANZA F, Solfrizzi V, Sardone R, Dibello V, et al
      Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
      J Alzheimers Dis. 2023;94:879-898.
      PubMed     Abstract available
      
      
      
1335. BAYRAM E, Holden SK, Fullard M, Armstrong MJ, et al
      Race and Ethnicity in Lewy Body Dementia: A Narrative Review.
      J Alzheimers Dis. 2023;94:861-878.
      PubMed     Abstract available
      
      
      
1336. WANG G, Li DY, Vance DE, Li W, et al
      Alcohol Use Disorder as a Risk Factor for Cognitive Impairment.
      J Alzheimers Dis. 2023;94:899-907.
      PubMed     Abstract available
      
      
      
1337. CAILLAUD M, Maltezos S, Hudon C, Mellah S, et al
      Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
      J Alzheimers Dis. 2023;94:1047-1056.
      PubMed     Abstract available
      
      
      
1338. CHWA WJ, Lopez OL, Longstreth WT, Dai W, et al
      Longitudinal Patterns of Brain Changes in a Community Sample in Relation to Aging and Cognitive Status.
      J Alzheimers Dis. 2023;94:1035-1045.
      PubMed     Abstract available
      
      
      
1339. SANDISON H, Callan NGL, Rao RV, Phipps J, et al
      Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.
      J Alzheimers Dis. 2023;94:993-1004.
      PubMed     Abstract available
      
      
      
1340. LI D, Yang H, Lyu M, Wang J, et al
      Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.
      J Alzheimers Dis. 2023;94.
      PubMed     Abstract available
      
      
      
1341. GOTTSCHALK WK, Mahon S, Hodgson D, Barrera J, et al
      The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
      J Alzheimers Dis. 2023;94:1563-1576.
      PubMed     Abstract available
      
      
      
1342. SUSAC J, Vukojevic J, Debogovic S, Bajic Z, et al
      Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
      J Alzheimers Dis. 2023;94:1417-1430.
      PubMed     Abstract available
      
      
      
1343. BAYER TA, Jiang L, Erqou S, Kunicki ZJ, et al
      Incidence of New Dementia Diagnosis in Veterans Admitted to Nursing Homes After Heart Failure Hospitalization.
      J Alzheimers Dis. 2023;94:1397-1404.
      PubMed     Abstract available
      
      
      
1344. LANSDELL TA, Xu H, Galligan JJ, Dorrance AM, et al
      Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.
      J Alzheimers Dis. 2023;94:1361-1375.
      PubMed     Abstract available
      
      
      
1345. YABUUCHI K, Kimura N, Masuda T, Matsubara E, et al
      Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
      J Alzheimers Dis. 2023;95:299-306.
      PubMed     Abstract available
      
      
      
1346. HUANG L, Li Y, Wu J, Chen N, et al
      Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.
      J Alzheimers Dis. 2023;95:227-236.
      PubMed     Abstract available
      
      
      
1347. CASTILLO C, Bravo-Arrepol G, Wendt A, Saez-Orellana F, et al
      Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity.
      J Alzheimers Dis. 2023;94.
      PubMed     Abstract available
      
      
      
1348. NORRIS CM
      Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
      J Alzheimers Dis. 2023;95:599-602.
      PubMed     Abstract available
      
      
      
1349. PANIKKAR D, Vivek S, Crimmins E, Faul J, et al
      Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
      J Alzheimers Dis. 2023;95:735-748.
      PubMed     Abstract available
      
      
      
1350. PASSMORE SR, Longhurst C, Gerbitz A, Green-Harris G, et al
      "I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.
      J Alzheimers Dis. 2023;95:663-675.
      PubMed     Abstract available
      
      
      
1351. ROSALES-LAGARDE A, Cubero-Rego L, Menendez-Conde F, Rodriguez-Torres EE, et al
      Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study.
      J Alzheimers Dis. 2023;95:477-491.
      PubMed     Abstract available
      
      
      
1352. VOLGMAN AS, Engelstein E, Aggarwal NT
      Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men?
      J Alzheimers Dis. 2023;95:407-409.
      PubMed     Abstract available
      
      
      
1353. MIYAWAKI CE, McClellan A, Bouldin ED, Brohard C, et al
      Feasibility and Efficacy of Life Review Delivered by Virtually-Trained Family Caregivers.
      J Alzheimers Dis. 2023;95:573-583.
      PubMed     Abstract available
      
      
      
1354. MACYCZKO JR, Wang N, Lu W, Jeevaratnam S, et al
      Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
      J Alzheimers Dis. 2023;95:399-405.
      PubMed     Abstract available
      
      
      
1355. BOGDAN A, Fabre R, Desmidt T, Golebiowski J, et al
      Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
      J Alzheimers Dis. 2023;95:415-426.
      PubMed     Abstract available
      
      
      
1356. GUEVARA JE, Kurniadi NE, Duff K
      Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.
      J Alzheimers Dis. 2023;95:509-521.
      PubMed     Abstract available
      
      
      
1357. NG PY, Zhang C, Li H, Baker DJ, et al
      Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
      J Alzheimers Dis. 2023;95:493-507.
      PubMed     Abstract available
      
      
      
1358. LOPES DAS NEVES P, Duraes J, Silva-Spinola A, Lima M, et al
      Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
      J Alzheimers Dis. 2023;95:391-397.
      PubMed     Abstract available
      
      
      
1359. DALY T
      JAD: A Forum for Philosophy in Science.
      J Alzheimers Dis. 2023;95:411-413.
      PubMed     Abstract available
      
      
      
1360. HUA S, Peters BA, Lee S, Fitzgerald K, et al
      Gut Microbiota and Cognitive Function Among Women Living with HIV.
      J Alzheimers Dis. 2023;95:1147-1161.
      PubMed     Abstract available
      
      
      
1361. COSTA T, Premi E, Liloia D, Cauda F, et al
      Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
      J Alzheimers Dis. 2023;95:1059-1065.
      PubMed     Abstract available
      
      
      
1362. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
      Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
      J Alzheimers Dis. 2023;95:829-845.
      PubMed     Abstract available
      
      
      
1363. AL-LAHHAM R, Mendez N
      Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
      J Alzheimers Dis. 2023;95:1041-1058.
      PubMed     Abstract available
      
      
      
1364. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
      Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
      J Alzheimers Dis. 2023;95:931-940.
      PubMed     Abstract available
      
      
      
1365. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
      Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
      J Alzheimers Dis. 2023;95:1067-1075.
      PubMed     Abstract available
      
      
      
1366. FLEISCHMAN DA, Arfanakis K, Zhang S, Leurgans SE, et al
      Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study.
      J Alzheimers Dis. 2023;95:1585-1595.
      PubMed     Abstract available
      
      
      
1367. WANG S, Liu S, Ke S, Zhou W, et al
      APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia.
      J Alzheimers Dis. 2023;95:1509-1518.
      PubMed     Abstract available
      
      
      
1368. WATTS A, Haneline S, Welsh-Bohmer KA, Wu J, et al
      TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEvarepsilon3 Homozygotes.
      J Alzheimers Dis. 2023;95:1697-1707.
      PubMed     Abstract available
      
      
      
1369. AMOFA-HO PA, Stickel AM, Chen R, Kobayashi LC, et al
      The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition.
      J Alzheimers Dis. 2023;95:1405-1416.
      PubMed     Abstract available
      
      
      
1370. MARCOLINI S, Rojczyk P, Seitz-Holland J, Koerte IK, et al
      Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
      J Alzheimers Dis. 2023;95:1427-1448.
      PubMed     Abstract available
      
      
      
1371. WANG R, Kuang C, Guo C, Chen Y, et al
      Automatic Detection of Putative Mild Cognitive Impairment from Speech Acoustic Features in Mandarin-Speaking Elders.
      J Alzheimers Dis. 2023;95:901-914.
      PubMed     Abstract available
      
      
      
1372. DAAMEN M, Scheef L, Li S, Grothe MJ, et al
      Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
      J Alzheimers Dis. 2023;95:1013-1028.
      PubMed     Abstract available
      
      
      
1373. CODY SL, Miller GH, Fazeli PL, Wang G, et al
      Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.
      J Alzheimers Dis. 2023;95:753-768.
      PubMed     Abstract available
      
      
      
1374. KEPP KP, Sensi SL, Johnsen KB, Barrio JR, et al
      The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
      J Alzheimers Dis. 2023;94:497-507.
      PubMed     Abstract available
      
      
      
1375. SAJI N, Ishihara Y, Murotani K, Uchiyama A, et al
      Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.
      J Alzheimers Dis. 2023;96:369-380.
      PubMed     Abstract available
      
      
      
1376. DATLOW LY, King J, Leventhal M, Wallace TC, et al
      Association of Pork Intake with Cognitive Performance in Older Adults Enrolled in the National Health and Nutrition Examination Survey (NHANES), 2011-2014 Data Cycles.
      J Alzheimers Dis. 2023;96:351-358.
      PubMed     Abstract available
      
      
      
1377. PACHECO PACHADO M, Casas AI, Elbatreek MH, Nogales C, et al
      Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
      J Alzheimers Dis. 2023;96:47-56.
      PubMed     Abstract available
      
      
      
1378. CHEN S, Huang W, He T, Zhang M, et al
      Exploring the Causality Between Plasma Brain-Derived Neurotrophic Factor and Neurological Diseases: A Mendelian Randomization Study.
      J Alzheimers Dis. 2023;96:135-148.
      PubMed     Abstract available
      
      
      
1379. UTZ J, Olm P, Jablonowski J, Siegmann EM, et al
      Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.
      J Alzheimers Dis. 2023;96:265-275.
      PubMed     Abstract available
      
      
      
1380. HAMMERS DB, Lin JH, Polsinelli AJ, Logan PE, et al
      Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.
      J Alzheimers Dis. 2023;96:197-214.
      PubMed     Abstract available
      
      
      
1381. DING H, Mandapati A, Hamel AP, Karjadi C, et al
      Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
      J Alzheimers Dis. 2023;96:277-286.
      PubMed     Abstract available
      
      
      
1382. LINDH-RENGIFO M, Jonasson SB, Ullen S, Palmqvist S, et al
      Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.
      J Alzheimers Dis. 2023;96:161-171.
      PubMed     Abstract available
      
      
      
1383. CAVUOTO MG, Robinson SR, O'Donoghue FJ, Barnes M, et al
      Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
      J Alzheimers Dis. 2023;96:149-159.
      PubMed     Abstract available
      
      
      
1384. SMITH GS, Kuwabara H, Yan H, Nassery N, et al
      Serotonin Degeneration and Amyloid-beta Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
      J Alzheimers Dis. 2023;96:215-227.
      PubMed     Abstract available
      
      
      
1385. 
      Erratum to: Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
      J Alzheimers Dis. 2023;96:859-860.
      PubMed    
      
      
      
1386. BAHRANI AA, Abner EL, DeCarli CS, Barber JM, et al
      Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
      J Alzheimers Dis. 2023;96:683-693.
      PubMed     Abstract available
      
      
      
1387. KARJADI C, Xue C, Cordella C, Kiran S, et al
      Fusion of Low-Level Descriptors of Digital Voice Recordings for Dementia Assessment.
      J Alzheimers Dis. 2023;96:507-514.
      PubMed     Abstract available
      
      
      
1388. LI J, Weiss J, Rajadhyaksha A, Acosta D, et al
      Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
      J Alzheimers Dis. 2023;96:801-811.
      PubMed     Abstract available
      
      
      
1389. MICHOPOULOU S, Prosser A, Dickson J, Guy M, et al
      Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.
      J Alzheimers Dis. 2023;96:1317-1327.
      PubMed     Abstract available
      
      
      
1390. ZHOU J, Wang ZB, Sun Y, Fu Y, et al
      Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly.
      J Alzheimers Dis. 2023;96:1071-1081.
      PubMed     Abstract available
      
      
      
1391. CHWA WJ, Raji CA, Toups K, Hathaway A, et al
      Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
      J Alzheimers Dis. 2023;96:1051-1058.
      PubMed     Abstract available
      
      
      
1392. TU MC, Chung HW, Hsu YH, Yang JJ, et al
      Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
      J Alzheimers Dis. 2023;96:1329-1338.
      PubMed     Abstract available
      
      
      
1393. BROSENS N, Samouil D, Stolker S, Katsika EV, et al
      Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.
      J Alzheimers Dis. 2023;96:1097-1113.
      PubMed     Abstract available
      
      
      
1394. ZHU Y, Olchanski N, Cohen JT, Freund KM, et al
      Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.
      J Alzheimers Dis. 2023;96:1183-1193.
      PubMed     Abstract available
      
      
      
1395. BERNARDES C, Lima M, Duro D, Silva-Spinola A, et al
      Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
      J Alzheimers Dis. 2023;96:1173-1182.
      PubMed     Abstract available
      
      
      
1396. NAISMITH SL, Michaelian JC, Santos C, Mehrani I, et al
      Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.
      J Alzheimers Dis. 2023;96:913-925.
      PubMed     Abstract available
      
      
      
1397. KOULOUSAKIS P, Willems E, Schepers M, Rombaut B, et al
      Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
      J Alzheimers Dis. 2023;96:1207-1219.
      PubMed     Abstract available
      
      
      
1398. HEALY E
      Impact of the MIND Diet on Cognition in Individuals with Dementia.
      J Alzheimers Dis. 2023;96:967-977.
      PubMed     Abstract available
      
      
      
1399. ZHAO B, Ou YN, Zhang XY, Fu Y, et al
      Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.
      J Alzheimers Dis. 2023;96:1813-1825.
      PubMed     Abstract available
      
      
      
1400. ROBINSON MJ, Newbury S, Singh K, Leonenko Z, et al
      The Interplay Between Cholesterol and Amyloid-beta on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling.
      J Alzheimers Dis. 2023;96:1663-1683.
      PubMed     Abstract available
      
      
      
1401. TIAN J, Du E, Jia K, Wang T, et al
      Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-beta Knockin Mice During Aging.
      J Alzheimers Dis. 2023;96:1579-1592.
      PubMed     Abstract available
      
      
      
1402. SLUGGETT JK, Air T, Cations M, Caughey GE, et al
      Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services.
      J Alzheimers Dis. 2023;96:1747-1758.
      PubMed     Abstract available
      
      
      
1403. GAO Y, Duan X, Li W, Zhang X, et al
      Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
      J Alzheimers Dis. 2023;96:1739-1746.
      PubMed     Abstract available
      
      
      
1404. YOON J, Sasaki K, Tateoka K, Arai T, et al
      Evaluation of Cognitive and Physical Function Among Older Adults by Their Physical Activity: A Cross-Sectional Kasama Study, Japan.
      J Alzheimers Dis. 2023;96:1801-1812.
      PubMed     Abstract available
      
      
      
1405. SOLIS-URRA P, Rodriguez-Ayllon M, Alvarez-Ortega M, Molina-Hidalgo C, et al
      Physical Performance and Amyloid-beta in Humans: A Systematic Review and Meta-Analysis of Observational Studies.
      J Alzheimers Dis. 2023;96:1427-1439.
      PubMed     Abstract available
      
      
      
1406. GARCIA-ALBERCA JM, de la Rosa MD, Solo de Zaldivar P, Ledesma M, et al
      Effect of Nordic Sensi(R) Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.
      J Alzheimers Dis. 2023;96:1609-1622.
      PubMed     Abstract available
      
      
      
1407. SHORT MI, Fohner AE, Skjellegrind HK, Beiser A, et al
      Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
      J Alzheimers Dis. 2023;96:1767-1780.
      PubMed     Abstract available
      
      
      
1408. BRICENO EM, Dhakal U, Sharma U, Adhikari N, et al
      Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.
      J Alzheimers Dis. 2023;96:1339-1352.
      PubMed     Abstract available
      
      
      
1409. AXELSSON ANDREN E, Kettunen P, Bjerke M, Rolstad S, et al
      Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-beta Protein Precursor beta in the Subcortical Small Vessel Type of Dementia.
      J Alzheimers Dis. 2023;96:1515-1528.
      PubMed     Abstract available
      
      
      
1410. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
      Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
      J Alzheimers Dis. 2023;95:1417-1425.
      PubMed     Abstract available